data_1j8k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j8k _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.972 0.415 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.587 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' SER . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.533 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG12 ' CD1' ' A' ' 32' ' ' TYR . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.406 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.542 ' O ' ' CG2' ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 82' ' ' GLN . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 86' ' ' GLY . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 65' ' ' GLY . 1.6 pp . . . . . 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.118 0.485 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' CD2' ' HA3' ' A' ' 86' ' ' GLY . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.527 ' CG2' ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 18' ' ' ILE . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' CB ' ' OD1' ' A' ' 3' ' ' ASP . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.523 ' N ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.543 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 HG12 ' A' ' 34' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 29.1 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.543 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' CA ' HG21 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.414 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CE1' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 86' ' ' GLY . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' OE1' ' CG2' ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.525 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 43.6 mm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.226 0.536 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD2' ' CB ' ' A' ' 26' ' ' GLN . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 19' ' ' LYS . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG23 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 64' ' ' PRO . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 62' ' ' LEU . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HB3' HD11 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' NH1' ' OE2' ' A' ' 80' ' ' GLU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.551 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 18' ' ' ILE . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 31' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 8' ' ' LEU . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.524 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.466 ' OE1' HG23 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.472 HD13 ' HB2' ' A' ' 76' ' ' HIS . 8.5 tt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.488 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.534 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 62' ' ' LEU . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB1' HG23 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.562 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.413 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.549 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 2.6 t60 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.472 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' HB1' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.454 ' HA ' HG21 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.514 ' CG1' ' OH ' ' A' ' 32' ' ' TYR . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.472 ' HB2' HD13 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 91' ' ' ALA . 2.6 pp . . . . . 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.543 ' CD1' ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.543 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' CG2' ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' CD1' ' CG2' ' A' ' 13' ' ' VAL . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.524 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.541 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.577 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.535 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.475 ' HB2' HD13 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 tt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.109 0.481 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.525 ' HD3' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' CD1' HG22 ' A' ' 13' ' ' VAL . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.487 ' CZ3' ' HB3' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' A' ' 50' ' ' PRO . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.583 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' THR . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.543 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB3' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' NE2' ' HD3' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 89' ' ' SER . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.485 ' C ' ' CD1' ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.026 0.441 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 20' ' ' ILE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' SER . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' N ' ' CB ' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.52 HG12 ' CG2' ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 10' ' ' PHE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.509 ' HB3' ' CG2' ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.556 ' CE3' HG13 ' A' ' 72' ' ' VAL . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.54 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.449 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 37' ' ' SER . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.545 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.403 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.516 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' HG21 ' A' ' 87' ' ' THR . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.556 HG13 ' CE3' ' A' ' 22' ' ' TRP . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 23.7 t60 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HB3' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.547 ' CB ' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.537 ' N ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.48 ' CG2' ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HG2' ' CG2' ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 59' ' ' LEU . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 57' ' ' ALA . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.462 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.644 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HB3' ' CG1' ' A' ' 20' ' ' ILE . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.531 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.469 ' HG ' ' N ' ' A' ' 85' ' ' ILE . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.469 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.443 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 11.2 mm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.299 0.571 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.526 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 5' ' ' PRO . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.573 HD12 ' CZ ' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' CZ ' HD12 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 91' ' ' ALA . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 20' ' ' ILE . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 46' ' ' LEU . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.531 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CE2' HG22 ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.468 HG21 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 68' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.504 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HB3' HG21 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' N ' HD11 ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.59 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.482 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.504 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG21 ' CG2' ' A' ' 20' ' ' ILE . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CG2' HG21 ' A' ' 18' ' ' ILE . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' CG ' ' CG2' ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.543 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.526 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.545 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.521 HG23 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.535 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.528 ' CG ' HG23 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.433 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.495 HG21 HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.069 0.461 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' CD1' ' A' ' 62' ' ' LEU . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CD2' ' HA ' ' A' ' 74' ' ' ALA . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' HD23 ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.537 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD21 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CE2' HD21 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 2' ' ' ILE . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' HG21 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 85' ' ' ILE . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.502 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.561 HG23 ' CE1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 9' ' ' ALA . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.518 ' HB2' ' CD ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.467 ' HB2' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 32' ' ' TYR . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.539 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD11 HD12 ' A' ' 20' ' ' ILE . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 91' ' ' ALA . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.456 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.44 0.638 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.491 ' CB ' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.465 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' C ' ' CD1' ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' C ' ' A' ' 55' ' ' ASP . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.548 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.58 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.483 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.545 ' C ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.532 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.504 ' CD1' HG23 ' A' ' 70' ' ' VAL . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 18.8 mm-40 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.518 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 80' ' ' GLU . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.497 HG21 ' N ' ' A' ' 86' ' ' GLY . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HG2' HG21 ' A' ' 13' ' ' VAL . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 1.6 tt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.307 0.575 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.488 ' CG ' ' OG ' ' A' ' 81' ' ' SER . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 14' ' ' ASP . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' SER . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.506 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.501 ' N ' HG11 ' A' ' 15' ' ' VAL . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 20' ' ' ILE . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.475 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' CG2' HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.43 ' NE2' ' HB3' ' A' ' 58' ' ' GLU . 24.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.592 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' HA2' ' HB ' ' A' ' 90' ' ' THR . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.477 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.526 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' GLY . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.581 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 92' ' ' ILE . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.256 0.551 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.514 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' SER . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CD1' HG21 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CH2' ' HB3' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 76' ' ' HIS . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' CE2' HG12 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 44' ' ' HIS . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.541 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.541 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 20' ' ' ILE . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 31.0 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.4 HD22 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 2' ' ' ILE . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.514 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 2.8 mm100 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.471 ' N ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' A' ' 74' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' CD1' HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CH2' ' HB1' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.543 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.507 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.523 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HB2' HD12 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.523 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.575 ' HB1' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.405 ' CA ' HG21 ' A' ' 92' ' ' ILE . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 35' ' ' THR . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.3 t-160 -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.477 HD22 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.465 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 2.0 tt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.171 0.51 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.514 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.497 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 14' ' ' ASP . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 17' ' ' SER . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' ' CA ' ' A' ' 92' ' ' ILE . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 74' ' ' ALA . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.451 ' O ' ' CH2' ' A' ' 22' ' ' TRP . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HB1' ' CH2' ' A' ' 22' ' ' TRP . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' HD22 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 90' ' ' THR . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' CG2' ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' LEU . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.463 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HB2' ' CB ' ' A' ' 71' ' ' SER . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.486 ' CG2' ' CG ' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.402 0.62 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.526 ' CB ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 14' ' ' ASP . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CG1' HD13 ' A' ' 62' ' ' LEU . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 22' ' ' TRP . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.46 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 74' ' ' ALA . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.436 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.529 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.413 ' HB2' ' CG1' ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' CG ' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' N ' ' HB3' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.569 ' CD2' ' OD2' ' A' ' 77' ' ' ASP . 52.3 t60 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.586 ' O ' ' O ' ' A' ' 81' ' ' SER . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 73' ' ' VAL . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 85' ' ' ILE . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.525 ' CG2' ' CG ' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.494 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.3 tt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.251 0.548 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.467 ' O ' HG21 ' A' ' 90' ' ' THR . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 14' ' ' ASP . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 30' ' ' SER . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.532 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.52 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 36' ' ' TYR . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t60 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.568 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.515 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 65' ' ' GLY . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 33' ' ' ARG . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.584 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 86' ' ' GLY . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.525 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.26 0.552 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.589 ' CD1' ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.589 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 17' ' ' SER . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HB2' HD13 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.526 ' O ' ' CH2' ' A' ' 22' ' ' TRP . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 70' ' ' VAL . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 68' ' ' TYR . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 33' ' ' ARG . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 81' ' ' SER . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 71' ' ' SER . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.262 0.553 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.44 178.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 109.933 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.587 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' SER . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.533 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.543 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG12 ' CD1' ' A' ' 32' ' ' TYR . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.406 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.526 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.542 ' O ' ' CG2' ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 82' ' ' GLN . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 86' ' ' GLY . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.428 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.542 ' CG2' ' O ' ' A' ' 65' ' ' GLY . 1.6 pp -55.55 167.39 0.77 Allowed Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.4 Cg_endo -73.35 83.98 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.708 1.372 . . . . 0.0 110.371 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.288 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.237 0.541 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 tt -61.5 159.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.85 . . . . 0.0 110.349 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' CD2' ' HA3' ' A' ' 86' ' ' GLY . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.458 ' CE1' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.527 ' CG2' ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 18' ' ' ILE . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' CB ' ' OD1' ' A' ' 3' ' ' ASP . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.523 ' N ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.5 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.543 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 HG12 ' A' ' 34' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 29.1 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.543 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' CA ' HG21 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.574 ' CE1' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 86' ' ' GLY . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' OE1' ' CG2' ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.684 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -130.13 18.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 46.3 Cg_endo -70.42 57.95 1.83 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 110.196 -0.732 . . . . 0.0 110.196 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 15' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.283 0.563 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 43.6 mm -63.43 139.26 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 110.254 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD2' ' CB ' ' A' ' 26' ' ' GLN . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.499 ' CZ ' ' CD2' ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' A' ' 19' ' ' LYS . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG23 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 64' ' ' PRO . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 62' ' ' LEU . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HB3' HD11 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' NH1' ' OE2' ' A' ' 80' ' ' GLU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.513 HG21 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.551 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 18' ' ' ILE . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 31' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.512 HD23 ' CB ' ' A' ' 8' ' ' LEU . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.524 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.541 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.466 ' OE1' HG23 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.527 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 1.1 pt -150.3 175.95 2.55 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.5 Cg_endo -84.96 107.85 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.717 1.377 . . . . 0.0 110.731 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.134 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.55 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 1.3 t-20 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.092 0.473 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 1' ' ' ASN . 8.5 tt 44.6 -177.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.488 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.534 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 62' ' ' LEU . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB1' HG23 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.562 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.413 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.662 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.549 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.549 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 2.6 t60 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.472 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' HB1' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.454 ' HA ' HG21 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.514 ' CG1' ' OH ' ' A' ' 32' ' ' TYR . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.472 ' HB2' HD13 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' O ' ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 91' ' ' ALA . 2.6 pp 38.42 175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 47.6 Cg_endo -89.03 102.97 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.404 1.213 . . . . 0.0 110.588 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.041 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.15 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt -70.9 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.142 -0.974 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.543 ' CD1' ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.543 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.524 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' CG2' ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' O ' ' CB ' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' CD1' ' CG2' ' A' ' 13' ' ' VAL . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.524 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.541 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.577 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.636 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.535 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.475 ' HB2' HD13 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.536 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -133.59 161.02 66.26 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD3' HG22 ' A' ' 15' ' ' VAL . 49.8 Cg_endo -87.54 116.97 1.17 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.12 1.589 . . . . 0.0 110.602 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.193 179.897 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.311 0.576 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.5 tt -56.71 -178.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.796 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.525 ' HD3' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' CD1' HG22 ' A' ' 13' ' ' VAL . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.487 ' CZ3' ' HB3' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' HD3' ' A' ' 50' ' ' PRO . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.517 ' CG2' ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.583 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' THR . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.543 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB3' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' NE2' ' HD3' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 89' ' ' SER . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 1.1 pp -144.4 36.58 0.21 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 49.9 Cg_endo -74.76 54.41 3.51 Favored 'Trans proline' 0 N--CA 1.482 0.843 0 O-C-N 123.354 1.186 . . . . 0.0 110.269 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.238 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.367 0.603 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.22 175.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.552 ' CD2' HG22 ' A' ' 20' ' ' ILE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' SER . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' N ' ' CB ' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.52 HG12 ' CG2' ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 10' ' ' PHE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' HB3' ' CG2' ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.556 ' CE3' HG13 ' A' ' 72' ' ' VAL . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 ' HB ' ' HG3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.54 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.449 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 37' ' ' SER . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.545 ' CB ' ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 21' ' ' ALA . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.403 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.516 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 ' OG1' HG21 ' A' ' 87' ' ' THR . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.556 HG13 ' CE3' ' A' ' 22' ' ' TRP . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 23.7 t60 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HB3' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.547 ' CB ' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.537 ' N ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -126.48 163.29 41.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 49.2 Cg_endo -81.86 117.64 2.97 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.376 1.724 . . . . 0.0 110.225 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.278 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.181 0.515 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.48 ' CG2' ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt -136.88 174.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.347 -0.845 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HG2' ' CG2' ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.547 HD11 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.53 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 59' ' ' LEU . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 57' ' ' ALA . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.462 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HB3' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.644 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HB3' ' CG1' ' A' ' 20' ' ' ILE . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.531 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.469 ' HG ' ' N ' ' A' ' 85' ' ' ILE . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.469 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -54.38 166.71 0.66 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 49.2 Cg_endo -81.16 105.43 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.174 1.618 . . . . 0.0 110.447 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.26 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.0 t30 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.369 0.604 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 11.2 mm -114.92 114.39 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 5' ' ' PRO . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.573 HD12 ' CZ ' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' CZ ' HD12 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.563 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 20' ' ' ILE . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 46' ' ' LEU . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.531 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CE2' HG22 ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.468 HG21 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 68' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.504 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' HB3' HG21 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.468 HG23 HG21 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -129.61 22.89 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 50.6 Cg_endo -74.84 71.44 4.88 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 O-C-N 122.554 0.765 . . . . 0.0 110.722 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.169 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.338 0.589 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt -104.66 174.16 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.504 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG21 ' CG2' ' A' ' 20' ' ' ILE . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CG2' HG21 ' A' ' 18' ' ' ILE . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' CG ' ' CG2' ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.543 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 30' ' ' SER . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.526 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.545 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.466 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.521 HG23 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.535 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' CG ' HG23 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.433 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.512 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.495 HG21 HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -139.68 164.75 36.03 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 64' ' ' PRO . 49.2 Cg_endo -79.99 112.77 2.9 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.155 1.608 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.184 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.149 0.499 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER -83.45 167.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' CD1' ' A' ' 62' ' ' LEU . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CD2' ' HA ' ' A' ' 74' ' ' ALA . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' HD23 ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD3' ' CD2' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.537 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD21 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' HG22 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' CE2' HD21 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 2' ' ' ILE . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' HG21 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' ' 85' ' ' ILE . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.502 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -51.33 165.22 0.42 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.1 Cg_endo -76.05 75.97 3.97 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.081 1.569 . . . . 0.0 110.316 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.259 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.251 0.548 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 tt -67.36 -177.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.5 ' CG2' ' HD3' ' A' ' 93' ' ' PRO . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.561 HG23 ' CE1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 9' ' ' ALA . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.518 ' HB2' ' CD ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.467 ' HB2' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.538 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.546 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 32' ' ' TYR . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.539 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD11 HD12 ' A' ' 20' ' ' ILE . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 91' ' ' ALA . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.456 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.486 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -142.32 163.58 38.62 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HD3' ' CG2' ' A' ' 15' ' ' VAL . 49.5 Cg_endo -86.35 80.67 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.204 1.633 . . . . 0.0 110.404 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.318 -179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp -118.15 169.45 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 0.0 110.606 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.497 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 ' CB ' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.465 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' C ' ' CD1' ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' C ' ' A' ' 55' ' ' ASP . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.548 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.58 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.483 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' C ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.532 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.504 ' CD1' HG23 ' A' ' 70' ' ' VAL . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 18.8 mm-40 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' CD1' ' CG1' ' A' ' 18' ' ' ILE . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.518 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 80' ' ' GLU . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.538 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD22 ' CB ' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.497 HG21 ' N ' ' A' ' 86' ' ' GLY . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' HG2' HG21 ' A' ' 13' ' ' VAL . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 92' ' ' ILE . 1.1 pp -137.38 164.27 42.89 Favored Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HD3' HG21 ' A' ' 15' ' ' VAL . 48.7 Cg_endo -78.57 85.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.264 1.665 . . . . 0.0 110.569 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.125 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.19 0.519 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 1.6 tt -121.37 -177.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.068 -1.02 . . . . 0.0 110.016 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' CG ' ' OG ' ' A' ' 81' ' ' SER . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 14' ' ' ASP . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' SER . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.506 ' HA ' ' CG2' ' A' ' 90' ' ' THR . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.501 ' N ' HG11 ' A' ' 15' ' ' VAL . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 20' ' ' ILE . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.463 ' CG2' HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.477 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.535 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' NE2' ' HB3' ' A' ' 58' ' ' GLU . 24.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.592 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' HA2' ' HB ' ' A' ' 90' ' ' THR . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.526 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HA ' HG21 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 86' ' ' GLY . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.581 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 92' ' ' ILE . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 2.2 pp -40.16 155.26 0.18 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -80.87 104.78 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.81 1.426 . . . . 0.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.111 -0.993 . . . . 0.0 110.055 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 t30 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.238 0.542 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -80.64 165.83 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.989 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.514 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' SER . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CD1' HG21 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CH2' ' HB3' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 76' ' ' HIS . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' CE2' HG12 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 44' ' ' HIS . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.541 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.541 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.402 ' HB3' ' OE1' ' A' ' 53' ' ' GLU . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 20' ' ' ILE . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 31.0 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 HD22 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 2' ' ' ILE . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.514 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 2.8 mm100 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.42 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.471 ' N ' ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -132.97 172.76 6.82 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 46.9 Cg_endo -83.12 65.89 7.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.002 1.528 . . . . 0.0 110.397 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.283 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 2' ' ' ILE . 18.2 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -48.9 177.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.16 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' CB ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.512 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' CD1' HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.575 ' CH2' ' HB1' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.543 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.507 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.523 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HB2' HD12 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.523 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' HB1' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' CA ' HG21 ' A' ' 92' ' ' ILE . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 35' ' ' THR . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.3 t-160 -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.477 HD22 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.525 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.539 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 pp -145.35 57.37 4.21 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 92' ' ' ILE . 50.1 Cg_endo -85.11 42.14 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.79 1.416 . . . . 0.0 110.356 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.371 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 81' ' ' SER . 2.0 tt -55.69 -177.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.98 . . . . 0.0 109.885 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.514 ' HB2' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.497 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 14' ' ' ASP . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 17' ' ' SER . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' HB ' ' CA ' ' A' ' 92' ' ' ILE . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' N ' HG12 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.441 HD12 HG22 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HG3' ' CG2' ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 74' ' ' ALA . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.451 ' O ' ' CH2' ' A' ' 22' ' ' TRP . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.49 ' HB1' ' CH2' ' A' ' 22' ' ' TRP . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' HD22 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 90' ' ' THR . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' CG2' ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' LEU . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.463 ' HB3' ' CG2' ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HB2' ' CB ' ' A' ' 71' ' ' SER . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.486 ' CG2' ' CG ' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -119.61 176.53 1.72 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.2 Cg_endo -74.72 86.03 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.649 1.341 . . . . 0.0 110.374 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.343 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.237 0.541 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt -111.01 170.41 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.526 ' CB ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 13' ' ' VAL . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 14' ' ' ASP . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CG1' HD13 ' A' ' 62' ' ' LEU . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 22' ' ' TRP . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 74' ' ' ALA . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.436 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.529 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.413 ' HB2' ' CG1' ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' CG ' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' N ' ' HB3' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.569 ' CD2' ' OD2' ' A' ' 77' ' ' ASP . 52.3 t60 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.586 ' O ' ' O ' ' A' ' 81' ' ' SER . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HA ' HG23 ' A' ' 73' ' ' VAL . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 85' ' ' ILE . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.525 ' CG2' ' CG ' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.494 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -134.83 165.44 36.69 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.457 ' HD3' HG23 ' A' ' 15' ' ' VAL . 49.0 Cg_endo -81.51 91.14 1.11 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.034 1.544 . . . . 0.0 110.458 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.141 179.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.159 0.504 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' ASN . 6.3 tt -46.17 172.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.589 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.55 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.467 ' O ' HG21 ' A' ' 90' ' ' THR . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.523 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 14' ' ' ASP . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' CB ' HG21 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 30' ' ' SER . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.532 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.52 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG1' ' O ' ' A' ' 36' ' ' TYR . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t60 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.568 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.515 ' C ' ' CZ3' ' A' ' 22' ' ' TRP . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 65' ' ' GLY . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 33' ' ' ARG . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.584 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 86' ' ' GLY . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -142.82 36.54 0.23 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 48.9 Cg_endo -73.43 56.17 3.25 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.227 1.12 . . . . 0.0 110.39 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.291 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.504 0.669 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 1' ' ' ASN . 13.7 tt -47.35 174.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.414 -0.804 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.589 ' CD1' ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.589 ' CE1' ' CD1' ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 17' ' ' SER . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 64' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' CB ' ' CG2' ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.46 ' HB ' ' HG3' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' HB2' HD13 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.543 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.526 ' O ' ' CH2' ' A' ' 22' ' ' TRP . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 70' ' ' VAL . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 68' ' ' TYR . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 86' ' ' GLY . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 33' ' ' ARG . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' HD22 ' A' ' 75' ' ' LEU . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 81' ' ' SER . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 71' ' ' SER . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.53 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 92' ' ' ILE . 1.2 pp -138.79 153.96 72.51 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' HD3' HG23 ' A' ' 15' ' ' VAL . 44.7 Cg_endo -75.35 77.35 3.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.945 1.498 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.178 179.894 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.557 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.972 0.415 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.982 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 90' ' ' THR . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.858 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 29' ' ' VAL . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 74' ' ' ALA . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.533 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 37' ' ' SER . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' CB ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 33' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.557 ' OG ' HG21 ' A' ' 2' ' ' ILE . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.504 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.982 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.905 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.6 pp . . . . . 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 74' ' ' ALA . 1.2 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.118 0.485 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.8 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.077 HG21 ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 90' ' ' THR . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' N ' HG13 ' A' ' 15' ' ' VAL . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 90' ' ' THR . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HG3' HG23 ' A' ' 29' ' ' VAL . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.711 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CA ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.457 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.829 HG22 ' CB ' ' A' ' 21' ' ' ALA . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 70' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' CA ' HG22 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 HD11 ' A' ' 59' ' ' LEU . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD12 ' CA ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.812 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' HD21 ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 1.077 ' OE1' HG21 ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.975 HG21 ' HB3' ' A' ' 81' ' ' SER . 43.6 mm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.226 0.536 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.014 HD21 ' CZ ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.954 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 1.014 ' CZ ' HD21 ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 12' ' ' ASP . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 11' ' ' THR . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG21 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.546 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 90' ' ' THR . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.917 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.606 ' CG2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.752 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.011 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.011 HD13 ' OH ' ' A' ' 36' ' ' TYR . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' PRO . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.917 HG22 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 61' ' ' GLY . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' SER . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 33' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.569 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' OE1' HG21 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.628 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.528 HG23 ' C ' ' A' ' 91' ' ' ALA . 1.1 pt . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 76' ' ' HIS . 8.5 tt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' ILE . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 23' ' ' GLU . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 HD12 ' A' ' 18' ' ' ILE . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.544 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.957 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 17' ' ' SER . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.805 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB3' HD12 ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' OH ' ' CG1' ' A' ' 72' ' ' VAL . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.948 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.565 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 19.0 t-160 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD11 HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.557 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.948 HG13 ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 83' ' ' PRO . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 33' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.558 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 2' ' ' ILE . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.608 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' THR . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' ALA . 2.6 pp . . . . . 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.512 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.781 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 1.048 ' CE1' HD11 ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.913 HG23 ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' H ' HD13 ' A' ' 18' ' ' ILE . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.099 HD11 HG23 ' A' ' 90' ' ' THR . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.909 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.658 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HB3' HD12 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 75' ' ' LEU . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.647 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.909 HG22 ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.5 ' CA ' HG23 ' A' ' 15' ' ' VAL . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.014 HG22 ' HA ' ' A' ' 83' ' ' PRO . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 31' ' ' ARG . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.014 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 1.099 HG23 HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 15' ' ' VAL . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 76' ' ' HIS . 3.5 tt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.109 0.481 . . . . 0.0 109.796 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.778 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.935 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 14' ' ' ASP . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.726 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.996 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.73 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.599 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.867 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.996 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.935 ' HA ' HG23 ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 87' ' ' THR . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 69' ' ' THR . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.567 ' NE2' HG21 ' A' ' 13' ' ' VAL . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.541 ' C ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.026 0.441 . . . . 0.0 109.823 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.966 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 15' ' ' VAL . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.081 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.691 HG12 HG23 ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.803 ' OH ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.444 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 36' ' ' TYR . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.591 ' O ' HG22 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.803 HD22 ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB2' ' HE ' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.718 HG23 ' OD1' ' A' ' 55' ' ' ASP . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.74 HD22 ' HE2' ' A' ' 36' ' ' TYR . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.712 ' HA ' HG23 ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 65.0 t-80 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.492 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HA ' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.966 HD21 ' CB ' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 1.081 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.881 HG23 ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.881 ' HG2' HG23 ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.558 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 12' ' ' ASP . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 11' ' ' THR . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.781 HG22 HG23 ' A' ' 20' ' ' ILE . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.781 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.864 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 35' ' ' THR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.953 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.953 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.821 HG22 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.864 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' HG23 ' A' ' 87' ' ' THR . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 83' ' ' PRO . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 ' H ' ' A' ' 8' ' ' LEU . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.453 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 69' ' ' THR . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.651 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 76' ' ' HIS . 11.2 mm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.299 0.571 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.545 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.92 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.92 ' CE2' HD11 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 18' ' ' ILE . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 57' ' ' ALA . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' C ' HD12 ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.619 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.831 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 18' ' ' ILE . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.676 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.493 ' CE2' ' CG2' ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 36' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.785 ' CB ' HD11 ' A' ' 2' ' ' ILE . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.836 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.752 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.825 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.59 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.642 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' THR . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.717 HD11 HG23 ' A' ' 90' ' ' THR . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.642 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' ' ' THR . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.831 ' O ' HG23 ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.55 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.55 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.956 HG22 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.521 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.97 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG22 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.717 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.981 HG21 ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.069 0.461 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.446 ' CE1' HD11 ' A' ' 8' ' ' LEU . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.826 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 62' ' ' LEU . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CG2' HG22 ' A' ' 18' ' ' ILE . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.979 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.454 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.528 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.613 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.958 HD23 ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.958 ' HD3' HD23 ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.979 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.519 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD22 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' HG22 ' A' ' 87' ' ' THR . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 32' ' ' TYR . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.981 ' HB3' HG21 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 8' ' ' LEU . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' CG ' ' A' ' 67' ' ' GLU . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' THR . 1.3 tm0? 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 HH21 ' A' ' 4' ' ' ARG . 1.3 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.825 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' VAL . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.059 HD12 ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.575 HG22 ' CD1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.673 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.59 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.549 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 21' ' ' ALA . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 59' ' ' LEU . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.059 ' CD1' HD12 ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' HG22 ' A' ' 29' ' ' VAL . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 33' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.618 ' CB ' HG22 ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.931 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.44 0.638 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 81' ' ' SER . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.736 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.736 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' A' ' 64' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.891 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 32' ' ' TYR . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.891 HG22 ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 59' ' ' LEU . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.8 mm100 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HA ' HG23 ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 22' ' ' TRP . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB2' HD13 ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.954 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 85' ' ' ILE . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.708 HG21 ' OG ' ' A' ' 81' ' ' SER . 1.6 tt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.307 0.575 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.99 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.789 ' H ' HD12 ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.99 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 18' ' ' ILE . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' THR . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG23 ' HA3' ' A' ' 65' ' ' GLY . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' C ' ' OG ' ' A' ' 17' ' ' SER . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 90' ' ' THR . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.868 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.564 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.543 ' HB3' HD12 ' A' ' 43' ' ' ILE . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 37' ' ' SER . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 49' ' ' ALA . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.868 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.681 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.417 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.708 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 85' ' ' ILE . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 HG22 ' CG ' ' A' ' 67' ' ' GLU . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.95 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 92' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.256 0.551 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' THR . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.983 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 29' ' ' VAL . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.711 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.859 ' HB3' HG13 ' A' ' 70' ' ' VAL . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.599 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.599 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' CB ' ' A' ' 21' ' ' ALA . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 59' ' ' LEU . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 33.8 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.827 ' HA ' HG23 ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CG ' HG22 ' A' ' 87' ' ' THR . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.619 HG11 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.711 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.589 HG22 ' CG ' ' A' ' 67' ' ' GLU . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 7.9 mm-40 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.892 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 90' ' ' THR . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.813 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 HG22 ' A' ' 18' ' ' ILE . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.813 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.687 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.724 HD22 ' OH ' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.724 ' OH ' HD22 ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HB3' HG22 ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.745 HD21 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 1.008 HG23 HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 92' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.014 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.0 tt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.171 0.51 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.495 ' HD1' HG22 ' A' ' 20' ' ' ILE . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 90' ' ' THR . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PRO . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.523 ' N ' HG13 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.495 HG22 ' HD1' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.717 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.978 ' HG3' HG23 ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.978 HG23 ' HG3' ' A' ' 25' ' ' PRO . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' LEU . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.78 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.565 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 21' ' ' ALA . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 91' ' ' ALA . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 83' ' ' PRO . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.916 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.87 ' HB1' ' CG2' ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HB2' HD12 ' A' ' 2' ' ' ILE . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.014 ' HB3' HG21 ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.916 ' HB3' HG22 ' A' ' 73' ' ' VAL . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.823 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.402 0.62 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.803 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.652 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.701 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.616 ' OD2' HG13 ' A' ' 15' ' ' VAL . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.741 ' CD1' HG23 ' A' ' 13' ' ' VAL . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.954 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 5' ' ' PRO . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 1.028 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 46' ' ' LEU . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 21' ' ' ALA . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.698 HD12 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.028 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.687 ' HB2' HD12 ' A' ' 2' ' ' ILE . 53.6 t-80 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.919 ' O ' HG13 ' A' ' 73' ' ' VAL . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.9 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD21 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.54 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' OE1' HG21 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 76' ' ' HIS . 6.3 tt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.251 0.548 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.834 HG23 HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' H ' HD13 ' A' ' 18' ' ' ILE . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.826 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD11 HG23 ' A' ' 90' ' ' THR . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.802 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.834 ' HB2' HD21 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.629 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.53 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.53 HG13 ' CA ' ' A' ' 37' ' ' SER . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.629 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 13.1 t-80 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HA ' HG22 ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.639 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' ' 62' ' ' LEU . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 59' ' ' LEU . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 90' ' ' THR . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.597 ' HB2' HD12 ' A' ' 2' ' ' ILE . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 73' ' ' VAL . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 85' ' ' ILE . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.844 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.864 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.26 0.552 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.982 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.982 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 90' ' ' THR . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.889 HD11 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.961 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.891 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.891 HD13 ' OH ' ' A' ' 36' ' ' TYR . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' H ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.961 HG22 ' CB ' ' A' ' 21' ' ' ALA . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 18' ' ' ILE . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.849 HG22 ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 29' ' ' VAL . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 75' ' ' LEU . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 73' ' ' VAL . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.849 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 8' ' ' LEU . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.889 HG23 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.855 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.262 0.553 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.557 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.5 OUTLIER -70.44 178.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 109.933 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.982 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 90' ' ' THR . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.858 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 29' ' ' VAL . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 74' ' ' ALA . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.533 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 37' ' ' SER . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' CB ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 33' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.557 ' OG ' HG21 ' A' ' 2' ' ' ILE . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.982 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.905 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.6 pp -55.55 167.39 0.77 Allowed Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.4 Cg_endo -73.35 83.98 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.708 1.372 . . . . 0.0 110.371 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.288 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.237 0.541 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 74' ' ' ALA . 1.2 tt -61.5 159.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.85 . . . . 0.0 110.349 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.8 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.077 HG21 ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 90' ' ' THR . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' N ' HG13 ' A' ' 15' ' ' VAL . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 90' ' ' THR . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HG3' HG23 ' A' ' 29' ' ' VAL . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.711 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CA ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.457 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.829 HG22 ' CB ' ' A' ' 21' ' ' ALA . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 70' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' CA ' HG22 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 HD11 ' A' ' 59' ' ' LEU . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD12 ' CA ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.812 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' HD21 ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 1.077 ' OE1' HG21 ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.13 18.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 46.3 Cg_endo -70.42 57.95 1.83 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 110.196 -0.732 . . . . 0.0 110.196 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.277 -179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.283 0.563 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.975 HG21 ' HB3' ' A' ' 81' ' ' SER . 43.6 mm -63.43 139.26 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 110.254 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.014 HD21 ' CZ ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.954 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 1.014 ' CZ ' HD21 ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 12' ' ' ASP . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 11' ' ' THR . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG21 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.546 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 90' ' ' THR . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.917 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.606 ' CG2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.752 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.011 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.011 HD13 ' OH ' ' A' ' 36' ' ' TYR . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' PRO . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.917 HG22 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 61' ' ' GLY . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' SER . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 33' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.569 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' OE1' HG21 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.628 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 1.1 pt -150.3 175.95 2.55 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.5 Cg_endo -84.96 107.85 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.717 1.377 . . . . 0.0 110.731 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.134 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 2' ' ' ILE . 1.3 t-20 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.092 0.473 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 1' ' ' ASN . 8.5 tt 44.6 -177.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' ILE . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 23' ' ' GLU . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 HD12 ' A' ' 18' ' ' ILE . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.544 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.957 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 17' ' ' SER . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.805 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB3' HD12 ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' OH ' ' CG1' ' A' ' 72' ' ' VAL . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.948 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.565 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 19.0 t-160 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD11 HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.557 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.948 HG13 ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 83' ' ' PRO . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 33' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.558 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 2' ' ' ILE . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.608 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' THR . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' ALA . 2.6 pp 38.42 175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 47.6 Cg_endo -89.03 102.97 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.404 1.213 . . . . 0.0 110.588 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.041 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.15 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt -70.9 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.142 -0.974 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.512 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.781 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 1.048 ' CE1' HD11 ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.913 HG23 ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' H ' HD13 ' A' ' 18' ' ' ILE . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.099 HD11 HG23 ' A' ' 90' ' ' THR . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.909 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.658 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HB3' HD12 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 75' ' ' LEU . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.647 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.909 HG22 ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.5 ' CA ' HG23 ' A' ' 15' ' ' VAL . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.014 HG22 ' HA ' ' A' ' 83' ' ' PRO . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 31' ' ' ARG . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.014 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.099 HG23 HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 15' ' ' VAL . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -133.59 161.02 66.26 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.54 116.97 1.17 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.12 1.589 . . . . 0.0 110.602 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.193 179.897 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.311 0.576 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 76' ' ' HIS . 3.5 tt -56.71 -178.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.796 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.778 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.935 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 14' ' ' ASP . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.726 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.996 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.73 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.599 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.867 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.996 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.935 ' HA ' HG23 ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 87' ' ' THR . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 69' ' ' THR . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.567 ' NE2' HG21 ' A' ' 13' ' ' VAL . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 1.1 pp -144.4 36.58 0.21 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 49.9 Cg_endo -74.76 54.41 3.51 Favored 'Trans proline' 0 N--CA 1.482 0.843 0 O-C-N 123.354 1.186 . . . . 0.0 110.269 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.238 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.367 0.603 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -60.22 175.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.966 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 15' ' ' VAL . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.081 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.691 HG12 HG23 ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.803 ' OH ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.444 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 36' ' ' TYR . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.591 ' O ' HG22 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.803 HD22 ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB2' ' HE ' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.718 HG23 ' OD1' ' A' ' 55' ' ' ASP . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.74 HD22 ' HE2' ' A' ' 36' ' ' TYR . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.712 ' HA ' HG23 ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 65.0 t-80 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.492 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HA ' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.966 HD21 ' CB ' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.081 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -126.48 163.29 41.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 49.2 Cg_endo -81.86 117.64 2.97 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.376 1.724 . . . . 0.0 110.225 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.278 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.181 0.515 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.881 HG23 ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt -136.88 174.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.347 -0.845 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.881 ' HG2' HG23 ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.558 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 12' ' ' ASP . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 11' ' ' THR . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.781 HG22 HG23 ' A' ' 20' ' ' ILE . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.781 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.864 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 35' ' ' THR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.953 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.953 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.821 HG22 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.864 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' HG23 ' A' ' 87' ' ' THR . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 83' ' ' PRO . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 ' H ' ' A' ' 8' ' ' LEU . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 69' ' ' THR . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.651 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -54.38 166.71 0.66 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 49.2 Cg_endo -81.16 105.43 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.174 1.618 . . . . 0.0 110.447 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.26 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.0 t30 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.369 0.604 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 76' ' ' HIS . 11.2 mm -114.92 114.39 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.545 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.92 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.92 ' CE2' HD11 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 18' ' ' ILE . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 57' ' ' ALA . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' C ' HD12 ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.619 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.831 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 18' ' ' ILE . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.676 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.493 ' CE2' ' CG2' ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 36' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.785 ' CB ' HD11 ' A' ' 2' ' ' ILE . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.836 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.752 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.617 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.825 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.61 22.89 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 50.6 Cg_endo -74.84 71.44 4.88 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 O-C-N 122.554 0.765 . . . . 0.0 110.722 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.169 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.338 0.589 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt -104.66 174.16 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.642 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' THR . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.717 HD11 HG23 ' A' ' 90' ' ' THR . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.642 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' ' ' THR . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.831 ' O ' HG23 ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.55 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.55 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.956 HG22 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.521 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.97 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG22 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.717 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -139.68 164.75 36.03 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.2 Cg_endo -79.99 112.77 2.9 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.155 1.608 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.184 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.149 0.499 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.981 HG21 ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER -83.45 167.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' CE1' HD11 ' A' ' 8' ' ' LEU . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.826 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 62' ' ' LEU . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CG2' HG22 ' A' ' 18' ' ' ILE . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.979 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.454 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.613 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.958 HD23 ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.958 ' HD3' HD23 ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.979 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.519 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD22 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' HG22 ' A' ' 87' ' ' THR . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 32' ' ' TYR . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.981 ' HB3' HG21 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 8' ' ' LEU . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' CG ' ' A' ' 67' ' ' GLU . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' THR . 1.3 tm0? 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -51.33 165.22 0.42 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.1 Cg_endo -76.05 75.97 3.97 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.081 1.569 . . . . 0.0 110.316 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.259 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.251 0.548 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 HH21 ' A' ' 4' ' ' ARG . 1.3 tt -67.36 -177.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.825 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.923 HG21 ' HD3' ' A' ' 93' ' ' PRO . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' VAL . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.059 HD12 ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.575 HG22 ' CD1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.673 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.59 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.549 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 21' ' ' ALA . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 59' ' ' LEU . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.059 ' CD1' HD12 ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' HG22 ' A' ' 29' ' ' VAL . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 33' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.618 ' CB ' HG22 ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.931 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -142.32 163.58 38.62 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.923 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.5 Cg_endo -86.35 80.67 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.204 1.633 . . . . 0.0 110.404 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.318 -179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp -118.15 169.45 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 0.0 110.606 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 81' ' ' SER . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.736 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.736 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.645 HG21 ' HD3' ' A' ' 93' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.891 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 32' ' ' TYR . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.891 HG22 ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 59' ' ' LEU . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.8 mm100 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HA ' HG23 ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 22' ' ' TRP . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB2' HD13 ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.954 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 85' ' ' ILE . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp -137.38 164.27 42.89 Favored Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD3' HG21 ' A' ' 15' ' ' VAL . 48.7 Cg_endo -78.57 85.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.264 1.665 . . . . 0.0 110.569 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.125 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.19 0.519 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.708 HG21 ' OG ' ' A' ' 81' ' ' SER . 1.6 tt -121.37 -177.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.068 -1.02 . . . . 0.0 110.016 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.99 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.789 ' H ' HD12 ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.99 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 18' ' ' ILE . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' THR . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG23 ' HA3' ' A' ' 65' ' ' GLY . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' C ' ' OG ' ' A' ' 17' ' ' SER . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 90' ' ' THR . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.868 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.564 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.543 ' HB3' HD12 ' A' ' 43' ' ' ILE . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 37' ' ' SER . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 49' ' ' ALA . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.868 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.681 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.417 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.708 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 85' ' ' ILE . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 HG22 ' CG ' ' A' ' 67' ' ' GLU . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.95 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 92' ' ' ILE . 2.2 pp -40.16 155.26 0.18 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -80.87 104.78 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.81 1.426 . . . . 0.0 110.636 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.111 -0.993 . . . . 0.0 110.055 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 t30 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.238 0.542 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -80.64 165.83 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.989 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' THR . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.983 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 29' ' ' VAL . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.711 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.859 ' HB3' HG13 ' A' ' 70' ' ' VAL . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.599 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.599 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' CB ' ' A' ' 21' ' ' ALA . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 59' ' ' LEU . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 33.8 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.827 ' HA ' HG23 ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CG ' HG22 ' A' ' 87' ' ' THR . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.619 HG11 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.589 HG22 ' CG ' ' A' ' 67' ' ' GLU . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 7.9 mm-40 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.892 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.97 172.76 6.82 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 46.9 Cg_endo -83.12 65.89 7.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.002 1.528 . . . . 0.0 110.397 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.283 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 2' ' ' ILE . 18.2 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -48.9 177.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.16 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 90' ' ' THR . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.813 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 HG22 ' A' ' 18' ' ' ILE . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.813 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.687 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.724 HD22 ' OH ' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.724 ' OH ' HD22 ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.3 t-160 -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HB3' HG22 ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.745 HD21 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 1.008 HG23 HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.546 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 pp -145.35 57.37 4.21 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.587 ' HD2' HG11 ' A' ' 15' ' ' VAL . 50.1 Cg_endo -85.11 42.14 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.79 1.416 . . . . 0.0 110.356 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.371 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.014 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.0 tt -55.69 -177.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.98 . . . . 0.0 109.885 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.495 ' HD1' HG22 ' A' ' 20' ' ' ILE . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 90' ' ' THR . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PRO . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' N ' HG13 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.495 HG22 ' HD1' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.717 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.978 ' HG3' HG23 ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.978 HG23 ' HG3' ' A' ' 25' ' ' PRO . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' LEU . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.78 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.565 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 21' ' ' ALA . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 91' ' ' ALA . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 83' ' ' PRO . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.916 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.87 ' HB1' ' CG2' ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HB2' HD12 ' A' ' 2' ' ' ILE . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.014 ' HB3' HG21 ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.916 ' HB3' HG22 ' A' ' 73' ' ' VAL . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.823 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -119.61 176.53 1.72 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.2 Cg_endo -74.72 86.03 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.649 1.341 . . . . 0.0 110.374 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.343 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.237 0.541 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt -111.01 170.41 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.803 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.652 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.701 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' OD2' HG13 ' A' ' 15' ' ' VAL . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.741 ' CD1' HG23 ' A' ' 13' ' ' VAL . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.954 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 5' ' ' PRO . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.028 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 46' ' ' LEU . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 21' ' ' ALA . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.698 HD12 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.028 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.687 ' HB2' HD12 ' A' ' 2' ' ' ILE . 53.6 t-80 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.51 ' OD2' ' CE1' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.919 ' O ' HG13 ' A' ' 73' ' ' VAL . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.9 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD21 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.54 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' OE1' HG21 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -134.83 165.44 36.69 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.0 Cg_endo -81.51 91.14 1.11 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.034 1.544 . . . . 0.0 110.458 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.141 179.864 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.159 0.504 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 76' ' ' HIS . 6.3 tt -46.17 172.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.834 HG23 HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' H ' HD13 ' A' ' 18' ' ' ILE . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.826 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD11 HG23 ' A' ' 90' ' ' THR . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.802 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.834 ' HB2' HD21 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.629 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.53 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.53 HG13 ' CA ' ' A' ' 37' ' ' SER . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.629 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 13.1 t-80 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HA ' HG22 ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.639 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' ' 62' ' ' LEU . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 59' ' ' LEU . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 90' ' ' THR . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.597 ' HB2' HD12 ' A' ' 2' ' ' ILE . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 73' ' ' VAL . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 85' ' ' ILE . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.844 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.864 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -142.82 36.54 0.23 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 48.9 Cg_endo -73.43 56.17 3.25 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.227 1.12 . . . . 0.0 110.39 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.291 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.504 0.669 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 1' ' ' ASN . 13.7 tt -47.35 174.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.414 -0.804 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.982 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.982 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 90' ' ' THR . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.889 HD11 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.961 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.891 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.891 HD13 ' OH ' ' A' ' 36' ' ' TYR . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' H ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.961 HG22 ' CB ' ' A' ' 21' ' ' ALA . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 18' ' ' ILE . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.849 HG22 ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 29' ' ' VAL . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 75' ' ' LEU . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 73' ' ' VAL . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.849 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 8' ' ' LEU . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.889 HG23 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.855 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.2 pp -138.79 153.96 72.51 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.752 ' HD3' HG21 ' A' ' 15' ' ' VAL . 44.7 Cg_endo -75.35 77.35 3.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.945 1.498 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' HD13 ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.178 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.557 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.972 0.415 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.982 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 90' ' ' THR . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.858 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 29' ' ' VAL . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 74' ' ' ALA . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.533 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 37' ' ' SER . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' CB ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 33' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.557 ' OG ' HG21 ' A' ' 2' ' ' ILE . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.504 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.982 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.905 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.6 pp . . . . . 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 74' ' ' ALA . 1.2 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.118 0.485 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.8 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.077 HG21 ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 90' ' ' THR . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' N ' HG13 ' A' ' 15' ' ' VAL . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 90' ' ' THR . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HG3' HG23 ' A' ' 29' ' ' VAL . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.711 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CA ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.457 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.829 HG22 ' CB ' ' A' ' 21' ' ' ALA . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 70' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 29.1 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' CA ' HG22 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 HD11 ' A' ' 59' ' ' LEU . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD12 ' CA ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.812 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' HD21 ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 1.077 ' OE1' HG21 ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.975 HG21 ' HB3' ' A' ' 81' ' ' SER . 43.6 mm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.226 0.536 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.014 HD21 ' CZ ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.954 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 1.014 ' CZ ' HD21 ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 12' ' ' ASP . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 11' ' ' THR . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG21 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.546 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 90' ' ' THR . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.917 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.606 ' CG2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.752 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.011 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.011 HD13 ' OH ' ' A' ' 36' ' ' TYR . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' PRO . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.917 HG22 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.625 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 61' ' ' GLY . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' SER . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 33' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.569 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' OE1' HG21 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.628 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.528 HG23 ' C ' ' A' ' 91' ' ' ALA . 1.1 pt . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 76' ' ' HIS . 8.5 tt . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' ILE . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 23' ' ' GLU . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 HD12 ' A' ' 18' ' ' ILE . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.544 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.957 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 17' ' ' SER . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.805 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB3' HD12 ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' OH ' ' CG1' ' A' ' 72' ' ' VAL . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.948 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.565 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 2.6 t60 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.594 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD11 HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.557 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.948 HG13 ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 83' ' ' PRO . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 33' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.558 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 2' ' ' ILE . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.608 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' THR . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' ALA . 2.6 pp . . . . . 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.131 0.491 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.512 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.781 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 1.048 ' CE1' HD11 ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.913 HG23 ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' H ' HD13 ' A' ' 18' ' ' ILE . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.099 HD11 HG23 ' A' ' 90' ' ' THR . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.909 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.658 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HB3' HD12 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 75' ' ' LEU . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.647 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.909 HG22 ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.5 ' CA ' HG23 ' A' ' 15' ' ' VAL . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.014 HG22 ' HA ' ' A' ' 83' ' ' PRO . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 31' ' ' ARG . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.014 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 1.099 HG23 HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 15' ' ' VAL . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 76' ' ' HIS . 3.5 tt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.109 0.481 . . . . 0.0 109.796 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.778 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.935 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 14' ' ' ASP . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.726 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.996 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.73 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.599 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.867 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.996 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.935 ' HA ' HG23 ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 87' ' ' THR . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.546 ' NE2' ' HD3' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 69' ' ' THR . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.567 ' NE2' HG21 ' A' ' 13' ' ' VAL . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.541 ' C ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.026 0.441 . . . . 0.0 109.823 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.966 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 15' ' ' VAL . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.081 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.691 HG12 HG23 ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.803 ' OH ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.444 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 36' ' ' TYR . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.591 ' O ' HG22 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.803 HD22 ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB2' ' HE ' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.718 HG23 ' OD1' ' A' ' 55' ' ' ASP . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.74 HD22 ' HE2' ' A' ' 36' ' ' TYR . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.712 ' HA ' HG23 ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 23.7 t60 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.492 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HA ' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.966 HD21 ' CB ' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 1.081 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.881 HG23 ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.881 ' HG2' HG23 ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.558 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 12' ' ' ASP . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 11' ' ' THR . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.781 HG22 HG23 ' A' ' 20' ' ' ILE . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.781 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.864 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 35' ' ' THR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.953 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.953 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.821 HG22 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.864 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' HG23 ' A' ' 87' ' ' THR . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 83' ' ' PRO . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 ' H ' ' A' ' 8' ' ' LEU . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.453 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 69' ' ' THR . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.651 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 76' ' ' HIS . 11.2 mm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.299 0.571 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.545 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.92 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.92 ' CE2' HD11 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 18' ' ' ILE . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 57' ' ' ALA . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' C ' HD12 ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.619 ' O ' HG22 ' A' ' 35' ' ' THR . 0.3 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.831 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 18' ' ' ILE . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.676 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.493 ' CE2' ' CG2' ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 36' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.785 ' CB ' HD11 ' A' ' 2' ' ' ILE . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.836 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.752 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.825 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.59 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.642 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' THR . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.717 HD11 HG23 ' A' ' 90' ' ' THR . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.642 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' ' ' THR . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.831 ' O ' HG23 ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.55 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.55 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.956 HG22 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.521 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.97 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG22 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.717 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.981 HG21 ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.069 0.461 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.446 ' CE1' HD11 ' A' ' 8' ' ' LEU . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.826 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 62' ' ' LEU . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CG2' HG22 ' A' ' 18' ' ' ILE . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.979 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.454 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.528 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.613 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.958 HD23 ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.958 ' HD3' HD23 ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.979 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.519 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD22 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' HG22 ' A' ' 87' ' ' THR . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 32' ' ' TYR . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.981 ' HB3' HG21 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 8' ' ' LEU . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' CG ' ' A' ' 67' ' ' GLU . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 HH21 ' A' ' 4' ' ' ARG . 1.3 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.825 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' VAL . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.059 HD12 ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.575 HG22 ' CD1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.673 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.59 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.549 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 21' ' ' ALA . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 59' ' ' LEU . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.059 ' CD1' HD12 ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' HG22 ' A' ' 29' ' ' VAL . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 33' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.618 ' CB ' HG22 ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.931 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.44 0.638 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 81' ' ' SER . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.736 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.736 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' A' ' 64' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.891 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 32' ' ' TYR . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.891 HG22 ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 59' ' ' LEU . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 18.8 mm-40 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HA ' HG23 ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 22' ' ' TRP . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB2' HD13 ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.954 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 85' ' ' ILE . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.708 HG21 ' OG ' ' A' ' 81' ' ' SER . 1.6 tt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.307 0.575 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.99 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.789 ' H ' HD12 ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.99 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 18' ' ' ILE . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' THR . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG23 ' HA3' ' A' ' 65' ' ' GLY . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' C ' ' OG ' ' A' ' 17' ' ' SER . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 90' ' ' THR . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.868 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.564 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.543 ' HB3' HD12 ' A' ' 43' ' ' ILE . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 37' ' ' SER . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 49' ' ' ALA . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.868 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 58' ' ' GLU . 24.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.681 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.417 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.708 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 85' ' ' ILE . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 HG22 ' CG ' ' A' ' 67' ' ' GLU . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.95 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 92' ' ' ILE . 2.2 pp . . . . . 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.256 0.551 . . . . 0.0 109.989 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' THR . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.983 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 29' ' ' VAL . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.711 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.859 ' HB3' HG13 ' A' ' 70' ' ' VAL . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.599 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.599 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' CB ' ' A' ' 21' ' ' ALA . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 59' ' ' LEU . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 31.0 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.827 ' HA ' HG23 ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CG ' HG22 ' A' ' 87' ' ' THR . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.619 HG11 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.711 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.589 HG22 ' CG ' ' A' ' 67' ' ' GLU . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 2.8 mm100 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.892 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.428 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.252 0.549 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 90' ' ' THR . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.813 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 HG22 ' A' ' 18' ' ' ILE . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.813 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.687 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.724 HD22 ' OH ' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.724 ' OH ' HD22 ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.3 t-160 -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HB3' HG22 ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.745 HD21 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.69 HE21 HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 1.008 HG23 HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 92' ' ' ILE . 1.4 pp . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.014 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.0 tt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.171 0.51 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.495 ' HD1' HG22 ' A' ' 20' ' ' ILE . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 90' ' ' THR . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PRO . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.523 ' N ' HG13 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.495 HG22 ' HD1' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.717 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.978 ' HG3' HG23 ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.978 HG23 ' HG3' ' A' ' 25' ' ' PRO . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' LEU . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.78 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.565 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 21' ' ' ALA . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 91' ' ' ALA . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 83' ' ' PRO . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.916 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.87 ' HB1' ' CG2' ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HB2' HD12 ' A' ' 2' ' ' ILE . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.014 ' HB3' HG21 ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.916 ' HB3' HG22 ' A' ' 73' ' ' VAL . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.823 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.402 0.62 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.803 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.652 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.701 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.616 ' OD2' HG13 ' A' ' 15' ' ' VAL . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.741 ' CD1' HG23 ' A' ' 13' ' ' VAL . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.954 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 5' ' ' PRO . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 1.028 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 46' ' ' LEU . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 21' ' ' ALA . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.698 HD12 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.028 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.687 ' HB2' HD12 ' A' ' 2' ' ' ILE . 52.3 t60 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.919 ' O ' HG13 ' A' ' 73' ' ' VAL . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD21 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.54 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.599 ' NE2' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 76' ' ' HIS . 6.3 tt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.251 0.548 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.834 HG23 HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' H ' HD13 ' A' ' 18' ' ' ILE . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.826 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD11 HG23 ' A' ' 90' ' ' THR . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.802 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.834 ' HB2' HD21 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.629 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.53 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.53 HG13 ' CA ' ' A' ' 37' ' ' SER . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.629 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t60 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HA ' HG22 ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.639 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' ' 62' ' ' LEU . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 59' ' ' LEU . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 90' ' ' THR . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.597 ' HB2' HD12 ' A' ' 2' ' ' ILE . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 73' ' ' VAL . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 85' ' ' ILE . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.844 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.864 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.26 0.552 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.982 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.982 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 90' ' ' THR . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.889 HD11 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.961 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.891 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.891 HD13 ' OH ' ' A' ' 36' ' ' TYR . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' H ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.961 HG22 ' CB ' ' A' ' 21' ' ' ALA . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 18' ' ' ILE . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.849 HG22 ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 29' ' ' VAL . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 75' ' ' LEU . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 73' ' ' VAL . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.849 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 8' ' ' LEU . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.889 HG23 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.855 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.262 0.553 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.557 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.5 OUTLIER -70.44 178.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 0.0 109.933 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -137.62 3.89 2.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.034 -1.041 . . . . 0.0 110.912 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER 61.76 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.422 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -79.77 -169.16 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.167 1.614 . . . . 0.0 110.19 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -132.4 -74.96 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.923 . . . . 0.0 110.58 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.93 140.68 11.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -99.42 166.16 11.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.119 . . . . 0.0 110.34 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -127.51 177.22 6.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE2' HD11 ' A' ' 8' ' ' LEU . 62.1 m-85 -131.47 139.8 49.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 4.3 m -99.4 -73.67 0.62 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 109.902 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.6 m-20 -126.12 111.53 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.868 . . . . 0.0 109.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 18' ' ' ILE . 5.4 p -106.71 135.75 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 110.435 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.982 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 50.1 m-20 -146.83 150.85 36.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 90' ' ' THR . 2.1 p -45.84 -26.81 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 110.655 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 73.2 m-20 -134.71 44.8 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.266 -0.896 . . . . 0.0 110.284 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 167.1 118.44 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.363 -0.835 . . . . 0.0 109.642 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.872 HD11 HG23 ' A' ' 90' ' ' THR . 83.6 mt -140.61 136.72 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.98 . . . . 0.0 111.081 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 2.1 mttt -113.39 125.1 53.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 109.195 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 10' ' ' PHE . 14.1 pt -123.96 154.3 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.973 -1.08 . . . . 0.0 110.902 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.858 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -139.72 117.18 11.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.581 -0.699 . . . . 0.0 109.725 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 34.2 p90 -99.29 170.81 8.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.136 -0.977 . . . . 0.0 110.443 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 132.61 34.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 147.07 89.08 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.221 -0.924 . . . . 0.0 109.312 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 29' ' ' VAL . 49.2 Cg_endo -82.83 38.21 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.698 1.368 . . . . 0.0 111.163 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 25' ' ' PRO . 77.7 mt-30 36.44 27.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.535 -0.728 . . . . 0.0 111.8 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 25' ' ' PRO . . . -139.82 20.26 2.9 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.09 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.1 tt0 41.24 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.285 -1.126 . . . . 0.0 110.141 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 74' ' ' ALA . 9.7 t -78.95 157.85 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.153 -0.967 . . . . 0.0 110.81 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.0 t -102.0 -19.56 15.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.745 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -153.8 153.11 31.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.582 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -130.59 122.5 27.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.974 . . . . 0.0 110.415 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 3.2 ttt180 -94.51 96.39 9.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.551 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 53.2 t -102.22 112.63 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.098 -1.001 . . . . 0.0 110.39 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.533 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -114.4 143.69 44.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.326 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -131.87 128.03 37.78 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.123 -0.986 . . . . 0.0 109.952 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 43' ' ' ILE . 24.7 p -115.86 159.85 20.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.421 -0.799 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.71 143.24 16.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -71.27 62.65 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.888 1.468 . . . . 0.0 110.502 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.2 OUTLIER 171.89 -68.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 0.0 110.331 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -38.67 68.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.166 -0.959 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.52 -154.38 16.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 37' ' ' SER . 19.9 tt -124.54 162.37 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -1.189 . . . . 0.0 110.631 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.603 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -140.74 158.79 43.46 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.47 -0.769 . . . . 0.0 109.856 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -109.59 128.83 55.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.327 -0.858 . . . . 0.0 110.698 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 21.1 tp -108.2 138.19 44.91 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.328 -0.857 . . . . 0.0 109.714 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 31' ' ' ARG . 8.8 t80 -130.01 66.34 77.47 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.229 -0.919 . . . . 0.0 111.038 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 48.9 Cg_endo -89.51 69.06 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.772 1.407 . . . . 0.0 110.944 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.94 102.12 0.26 Allowed Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.438 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 48.2 Cg_endo -75.6 -177.15 3.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.94 1.495 . . . . 0.0 110.374 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -130.22 -34.75 1.62 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.19 -27.89 1.11 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.52 -22.56 18.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.963 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.44 91.32 4.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 110.181 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -100.83 31.93 3.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.336 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.858 HG22 ' CB ' ' A' ' 21' ' ' ALA . 64.1 p -139.02 177.81 7.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.0 110.277 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -137.26 162.4 33.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.197 -0.94 . . . . 0.0 110.475 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.99 92.14 3.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 110.361 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -80.17 72.38 6.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.409 -0.807 . . . . 0.0 109.207 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -98.08 116.95 31.35 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.473 -0.767 . . . . 0.0 110.34 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.0 55.13 0.21 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 22.3 mt -106.19 -126.97 0.24 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.196 -1.179 . . . . 0.0 110.047 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 172.53 -55.21 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 111.259 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 63' ' ' ARG . 43.3 Cg_endo -71.19 167.13 27.05 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.803 1.423 . . . . 0.0 111.162 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -129.28 54.05 0.79 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.3 t -131.22 -171.04 2.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.928 -1.337 . . . . 0.0 111.016 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -72.47 111.75 7.93 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.58 -0.7 . . . . 0.0 110.58 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.71 123.02 35.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 92.2 m -82.9 96.94 8.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 110.045 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 6.1 t -100.51 149.86 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.281 -0.887 . . . . 0.0 110.434 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 109.82 11.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.833 . . . . 0.0 110.425 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' HB ' HD23 ' A' ' 84' ' ' LEU . 38.4 t -92.37 121.88 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 83' ' ' PRO . 25.4 t -126.94 122.68 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.653 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -72.89 165.51 24.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 109.096 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 33' ' ' ARG . 87.8 mt -136.93 177.95 7.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 111.211 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' ASP . 7.0 t60 -177.49 89.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.607 -0.683 . . . . 0.0 109.373 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER 64.63 -58.2 0.25 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.0 110.209 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' HIS . 18.4 t0 -174.46 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.126 -0.984 . . . . 0.0 109.937 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mmt -128.02 170.4 12.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -133.45 67.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.557 ' OG ' HG21 ' A' ' 2' ' ' ILE . 19.5 m -55.58 159.74 2.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.332 -0.855 . . . . 0.0 110.563 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -43.93 125.48 4.2 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 109.998 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 73' ' ' VAL . 42.9 Cg_endo -70.1 115.64 4.23 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.952 1.501 . . . . 0.0 110.476 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 tp -83.51 118.38 23.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.936 . . . . 0.0 109.986 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 mm -85.74 152.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.0 110.487 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -142.95 82.07 0.22 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.453 HG22 ' CG ' ' A' ' 67' ' ' GLU . 19.5 m -84.47 102.5 12.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -1.122 . . . . 0.0 110.184 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 46.0 tp60 -118.17 153.84 33.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -0.874 . . . . 0.0 110.053 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -94.6 111.95 23.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.99 HG22 ' HA ' ' A' ' 15' ' ' VAL . 1.3 m -59.95 105.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.182 -0.949 . . . . 0.0 109.632 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.982 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -44.29 102.29 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.553 -0.717 . . . . 0.0 112.167 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.905 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.6 pp -55.55 167.39 0.77 Allowed Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.721 -0.612 . . . . 0.0 109.993 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.4 Cg_endo -73.35 83.98 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.708 1.372 . . . . 0.0 110.371 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.288 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.237 0.541 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 74' ' ' ALA . 1.2 tt -61.5 159.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.85 . . . . 0.0 110.349 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.534 ' O ' ' C ' ' A' ' 4' ' ' ARG . 8.6 p-10 -149.42 73.32 1.19 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.163 -0.961 . . . . 0.0 110.913 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER 2.21 96.03 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.058 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.557 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 47.7 Cg_endo -75.01 179.2 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.132 1.596 . . . . 0.0 110.31 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -176.15 154.19 1.37 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.08 -1.012 . . . . 0.0 110.354 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.63 44.34 5.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.8 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -52.65 153.99 2.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -1.081 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.73 165.18 12.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 45.9 m-85 -121.96 132.09 54.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -0.958 . . . . 0.0 110.273 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 m -102.67 -53.17 2.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -155.29 111.28 3.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 109.813 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.077 HG21 ' OE1' ' A' ' 88' ' ' GLN . 13.9 p -99.53 111.46 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 110.463 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -109.46 150.1 28.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.775 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.659 ' HA ' HG22 ' A' ' 90' ' ' THR . 4.8 p -41.52 -34.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 110.235 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' N ' HG13 ' A' ' 15' ' ' VAL . 59.1 p30 -134.64 47.15 2.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 0.0 109.806 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 6.3 t 176.74 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 109.831 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 90' ' ' THR . 12.2 mt -127.74 127.65 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.935 . . . . 0.0 111.014 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 1.5 mppt? -102.35 126.12 49.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.474 -0.766 . . . . 0.0 109.171 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' ILE . 1.7 pt -137.43 152.9 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.928 -1.107 . . . . 0.0 111.243 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -130.98 132.63 45.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.566 -0.709 . . . . 0.0 109.435 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.563 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.8 p90 -104.47 149.58 25.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.125 -0.984 . . . . 0.0 110.373 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -46.57 143.7 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.89 . . . . 0.0 109.899 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.468 ' CB ' ' OD2' ' A' ' 55' ' ' ASP . 27.0 t -86.18 135.92 36.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 110.44 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HG3' HG23 ' A' ' 29' ' ' VAL . 46.5 Cg_endo -73.89 -163.91 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.082 1.569 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -117.7 12.42 13.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -130.34 12.19 5.77 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.35 105.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 110.01 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.711 HG23 ' HG3' ' A' ' 25' ' ' PRO . 54.0 t -73.47 121.24 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.464 -0.773 . . . . 0.0 110.888 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 t -85.93 -5.7 59.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.902 . . . . 0.0 109.483 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -169.33 152.02 4.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.43 -0.794 . . . . 0.0 109.812 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CA ' HD12 ' A' ' 75' ' ' LEU . 8.4 p90 -158.06 156.51 31.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -114.23 109.17 17.97 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.931 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' O ' ' CE1' ' A' ' 36' ' ' TYR . 23.4 t -93.2 93.63 4.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.85 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -89.88 139.76 30.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.434 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -140.28 153.56 46.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 109.638 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.1 p -140.96 170.47 15.67 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.025 -1.047 . . . . 0.0 111.434 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.04 168.79 11.65 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' C ' ' CG ' ' A' ' 40' ' ' GLU . 51.0 Cg_endo -85.0 36.06 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.961 1.506 . . . . 0.0 110.506 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' CG ' ' C ' ' A' ' 39' ' ' PRO . 18.5 mt-10 -151.89 -72.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.049 -1.032 . . . . 0.0 109.825 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -70.73 -45.65 64.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 109.408 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 128.28 -132.93 7.52 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 15.6 tt -114.44 158.26 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.347 -1.09 . . . . 0.0 111.444 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.592 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 35.0 t-80 -138.68 175.52 9.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.682 -0.636 . . . . 0.0 109.29 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.87 120.81 10.66 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.962 -1.086 . . . . 0.0 110.906 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.457 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.9 tp -103.83 132.47 50.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.865 . . . . 0.0 109.45 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.1 p90 -131.52 58.31 37.2 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.141 -0.974 . . . . 0.0 110.855 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 50.5 Cg_endo -84.68 89.21 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.884 1.465 . . . . 0.0 110.077 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.92 121.45 2.37 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.205 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 45.8 Cg_endo -74.01 -164.07 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.946 1.498 . . . . 0.0 110.78 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -115.9 -19.32 10.46 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.578 -0.701 . . . . 0.0 110.338 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.36 27.25 4.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.06 -32.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.259 -1.142 . . . . 0.0 110.853 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.03 125.62 34.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.092 -1.005 . . . . 0.0 110.369 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.563 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -108.95 15.87 23.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.789 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.829 HG22 ' CB ' ' A' ' 21' ' ' ALA . 43.5 p -124.97 170.71 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.803 . . . . 0.0 110.096 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -134.3 150.05 50.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.114 -0.991 . . . . 0.0 110.803 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.88 88.76 2.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.978 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 70' ' ' VAL . 20.7 mt -81.33 85.02 6.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.099 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 29.1 mt-30 -109.82 130.3 55.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.727 . . . . 0.0 110.631 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.651 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 106.94 66.25 0.63 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.0 mt -125.86 -170.54 2.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.222 -1.164 . . . . 0.0 110.586 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -83.28 135.31 44.39 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.452 -0.78 . . . . 0.0 109.597 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 15' ' ' VAL . 53.6 Cg_endo -79.33 131.27 9.55 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 O-C-N 124.082 1.57 . . . . 0.0 111.578 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' CA ' HG22 ' A' ' 92' ' ' ILE . . . 71.86 70.34 1.23 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -170.45 135.71 1.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -1.219 . . . . 0.0 110.838 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.59 100.73 0.91 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.248 -0.908 . . . . 0.0 109.198 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -80.66 129.19 34.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.925 . . . . 0.0 111.43 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -108.18 100.76 10.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 0.0 109.211 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.532 HG11 HD11 ' A' ' 59' ' ' LEU . 13.4 t -94.57 142.81 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.08 -1.012 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 33.1 m -117.24 97.03 5.7 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.521 -0.737 . . . . 0.0 109.416 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 99.2 t -76.04 120.09 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.336 -0.852 . . . . 0.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 83' ' ' PRO . 40.5 t -127.16 123.87 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 0.0 110.311 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -89.98 159.62 16.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.86 . . . . 0.0 109.791 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD12 ' CA ' ' A' ' 32' ' ' TYR . 9.0 mt -131.04 -179.13 5.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.092 -1.005 . . . . 0.0 110.949 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 77' ' ' ASP . 4.2 t60 -151.39 -155.17 0.6 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 1.4 t0 -46.74 -33.02 4.0 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.827 -1.17 . . . . 0.0 109.327 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 3.9 t0 176.49 63.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.7 -0.625 . . . . 0.0 109.474 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 49.9 mtp -125.95 -169.79 2.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.176 -0.952 . . . . 0.0 111.354 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -152.22 61.26 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.59 -0.693 . . . . 0.0 109.651 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -44.8 142.86 1.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.338 -0.851 . . . . 0.0 110.783 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.28 139.29 3.33 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.402 -0.811 . . . . 0.0 110.317 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.812 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.0 Cg_endo -73.17 136.67 24.89 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 124.225 1.645 . . . . 0.0 110.999 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.4 tp -100.24 116.0 31.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.33 153.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 110.833 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' HA3' HD21 ' A' ' 8' ' ' LEU . . . -158.73 89.91 0.11 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.1 t -82.31 164.36 21.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.282 -1.128 . . . . 0.0 110.546 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 1.077 ' OE1' HG21 ' A' ' 13' ' ' VAL . 9.8 tm0? 179.67 139.89 0.12 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.914 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.68 120.62 22.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.111 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -79.62 126.93 31.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 110.355 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -52.36 179.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.93 . . . . 0.0 109.7 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -130.13 18.36 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.985 -1.072 . . . . 0.0 113.042 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 46.3 Cg_endo -70.42 57.95 1.83 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 110.196 -0.732 . . . . 0.0 110.196 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.277 -179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.283 0.563 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.975 HG21 ' HB3' ' A' ' 81' ' ' SER . 43.6 mm -63.43 139.26 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 110.254 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 9.5 t0 -120.3 -7.3 9.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 110.2 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 2.9 mtm180 63.4 119.36 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.51 -160.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.977 1.514 . . . . 0.0 110.333 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.4 144.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 110.463 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.57 86.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.014 HD21 ' CZ ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.15 . . . . 0.0 109.202 179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.954 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -140.03 153.94 46.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.047 -1.033 . . . . 0.0 110.491 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 1.014 ' CZ ' HD21 ' A' ' 8' ' ' LEU . 65.5 m-85 -123.05 135.31 54.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.802 . . . . 0.0 109.914 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 12' ' ' ASP . 8.5 m -96.47 -77.06 0.49 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.27 -0.893 . . . . 0.0 110.33 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 11' ' ' THR . 57.8 m-20 -121.39 133.93 55.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG21 ' OE1' ' A' ' 88' ' ' GLN . 14.4 p -113.41 159.85 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.315 -0.866 . . . . 0.0 110.072 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 17' ' ' SER . 5.2 t70 -160.15 143.89 14.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.546 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.4 p -46.23 -28.35 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 110.378 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -135.91 32.77 2.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.268 -0.895 . . . . 0.0 109.843 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -172.54 115.71 0.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.628 HD11 HG23 ' A' ' 90' ' ' THR . 57.9 mt -132.39 111.12 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 110.56 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 11' ' ' THR . 13.7 tttt -92.11 102.12 14.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.252 -0.905 . . . . 0.0 108.771 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 pt -102.65 162.26 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.371 -0.831 . . . . 0.0 111.13 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.917 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 129.82 24.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 110.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 43.9 p90 -103.44 144.71 31.03 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.178 -0.951 . . . . 0.0 110.099 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -43.02 122.86 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 23' ' ' GLU . 5.1 p -42.63 161.29 0.18 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.863 . . . . 0.0 110.136 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.46 -177.72 3.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.012 1.533 . . . . 0.0 110.25 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.9 mt-30 -112.68 -54.8 2.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.7 -109.02 2.56 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.7 112.58 10.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.215 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.606 ' CG2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -92.24 128.72 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.777 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 76' ' ' HIS . 33.0 t -73.87 -24.95 59.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.313 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 75' ' ' LEU . 19.6 ttm-85 -167.46 149.52 5.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 0.0 110.3 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -117.0 100.14 7.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.0 110.011 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.752 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.5 ttp180 -74.74 131.08 40.55 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 94.2 t -107.02 93.46 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.444 -0.785 . . . . 0.0 109.828 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -101.46 141.21 34.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.245 -0.91 . . . . 0.0 110.607 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.011 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -136.99 136.1 38.2 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.426 -0.796 . . . . 0.0 110.008 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -112.93 164.29 13.61 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.401 -0.812 . . . . 0.0 110.778 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 143.33 5.41 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 110.269 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -76.17 52.69 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.027 1.541 . . . . 0.0 110.369 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -164.12 -60.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 0.0 110.174 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 0.4 OUTLIER -95.77 -18.21 20.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.34 -145.88 16.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' TYR . 14.5 tt -120.98 153.6 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -1.212 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 60.6 m80 -135.49 -178.56 5.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.511 -0.743 . . . . 0.0 109.842 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' OE2' ' CD1' ' A' ' 47' ' ' PHE . 4.0 tt0 -148.35 129.03 14.14 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.011 HD13 ' OH ' ' A' ' 36' ' ' TYR . 3.8 tp -96.36 131.86 42.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -94.69 -23.98 0.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.421 -0.799 . . . . 0.0 112.695 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -72.3 101.74 1.28 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 O-C-N 122.527 0.751 . . . . 0.0 110.276 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -100.16 172.19 4.83 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 110.404 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 45.1 Cg_endo -74.17 -165.75 0.28 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 124.093 1.575 . . . . 0.0 110.658 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.43 -47.61 2.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.301 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.33 -36.86 0.05 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.7 10.67 38.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.359 -1.083 . . . . 0.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 50' ' ' PRO . 9.6 mt-10 -123.37 118.58 27.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 0.0 110.31 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 12.7 m-20 -120.78 18.15 11.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.911 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.917 HG22 ' CB ' ' A' ' 21' ' ' ALA . 50.9 p -126.29 173.86 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.388 -0.82 . . . . 0.0 110.316 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.13 155.49 45.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 92.46 4.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.467 -0.77 . . . . 0.0 110.298 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.625 HD21 ' CE1' ' A' ' 36' ' ' TYR . 12.8 mt -86.93 81.38 8.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 28.4 mt-30 -100.97 135.25 42.73 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.569 -0.707 . . . . 0.0 110.548 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 104.92 55.73 0.73 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 61' ' ' GLY . 6.8 mt -114.32 -162.2 0.8 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.19 -1.183 . . . . 0.0 110.793 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 41' ' ' ASP . 26.2 mmt180 -79.49 156.2 75.9 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.4 Cg_endo -83.52 95.17 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.085 1.571 . . . . 0.0 111.548 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.48 74.34 1.04 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -151.08 128.68 11.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.338 -1.095 . . . . 0.0 110.817 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' CG2' ' A' ' 87' ' ' THR . 5.2 tp10 -56.97 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.062 -1.024 . . . . 0.0 109.284 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' SER . 5.0 t80 -71.4 119.47 15.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.0 111.078 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' SER . 47.2 m -93.79 114.76 27.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 26.3 t -106.98 144.74 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 111.655 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 p -123.75 111.47 16.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' C ' ' CG2' ' A' ' 73' ' ' VAL . 73.9 t -91.62 140.64 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.183 -0.948 . . . . 0.0 110.3 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 83' ' ' PRO . 4.3 t -147.71 126.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.144 -0.972 . . . . 0.0 110.772 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -80.24 175.59 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.33 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.752 HD11 ' HB2' ' A' ' 33' ' ' ARG . 59.0 mt -143.49 177.25 8.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.942 -1.099 . . . . 0.0 111.477 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 78' ' ' ASP . 23.8 t-80 -177.73 101.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER 62.32 -74.14 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.226 -0.921 . . . . 0.0 109.845 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 10.8 m-20 -158.74 58.09 0.43 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.245 -0.909 . . . . 0.0 110.126 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.47 157.12 31.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 111.068 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' OE2' ' NH1' ' A' ' 33' ' ' ARG . 34.7 mt-10 -141.1 79.97 1.72 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 2' ' ' ILE . 95.5 p -70.97 169.46 14.83 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.432 -0.793 . . . . 0.0 111.252 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -51.92 126.37 33.44 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.566 ' HB3' HG22 ' A' ' 73' ' ' VAL . 49.6 Cg_endo -75.45 134.32 16.95 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 111.012 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.3 tp -85.45 114.19 22.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.845 . . . . 0.0 109.271 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.6 mm -77.23 157.14 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.214 -0.929 . . . . 0.0 111.284 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -163.19 89.13 0.1 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.569 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 57.1 m -86.49 131.66 34.13 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -1.195 . . . . 0.0 110.96 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' OE1' HG21 ' A' ' 13' ' ' VAL . 14.6 tm0? -133.09 146.21 51.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 109.785 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 69.8 p -86.0 117.14 24.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 110.164 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.628 HG23 HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -59.24 138.93 57.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -0.95 . . . . 0.0 110.008 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -61.47 -161.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 110.142 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.557 ' HB ' ' HD2' ' A' ' 93' ' ' PRO . 1.1 pt -150.3 175.95 2.55 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.5 Cg_endo -84.96 107.85 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.717 1.377 . . . . 0.0 110.731 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.134 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 2' ' ' ILE . 1.3 t-20 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.092 0.473 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 1' ' ' ASN . 8.5 tt 44.6 -177.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-O 121.421 0.629 . . . . 0.0 110.539 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 2.1 p30 -64.41 -36.88 85.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.959 -1.088 . . . . 0.0 110.953 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' H ' HG23 ' A' ' 2' ' ' ILE . 11.0 mtm180 60.77 112.53 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 0.0 109.722 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.74 -179.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.975 1.513 . . . . 0.0 110.871 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HE2' ' OE2' ' A' ' 23' ' ' GLU . 26.0 mtmt -128.87 -59.43 1.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . -163.07 93.59 0.12 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -48.15 177.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.336 -1.097 . . . . 0.0 110.401 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -144.0 146.28 32.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -94.62 131.79 40.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 110.091 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -100.44 -50.47 3.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.165 -0.96 . . . . 0.0 110.09 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -151.56 117.95 5.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 110.142 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 HD12 ' A' ' 18' ' ' ILE . 11.2 p -94.66 123.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.504 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -117.5 130.95 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 0.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.544 ' HB ' ' N ' ' A' ' 92' ' ' ILE . 1.2 p -44.76 -31.42 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.12 -0.988 . . . . 0.0 110.31 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 17.9 t70 -113.96 18.75 17.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.957 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -175.79 150.91 1.07 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 0.0 110.459 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 17' ' ' SER . 19.7 mm -137.8 116.27 13.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.347 -0.846 . . . . 0.0 110.53 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -88.31 107.87 19.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 109.378 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 pt -114.25 152.85 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 111.023 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.805 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.58 121.01 16.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 109.865 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 49.2 p90 -109.3 -171.0 1.76 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -78.0 112.63 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.303 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 4.7 m -43.86 165.89 0.12 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.1 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 24' ' ' SER . 44.2 Cg_endo -70.78 161.88 44.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.775 1.408 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 25' ' ' PRO . 33.7 mt-30 -142.11 -65.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.42 -84.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -164.52 81.05 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -1.107 . . . . 0.0 110.172 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 13.4 t -83.63 115.26 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.339 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -86.88 -5.08 59.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.151 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.612 ' HB3' HD12 ' A' ' 75' ' ' LEU . 5.0 mtm180 -172.3 157.87 4.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' OH ' ' CG1' ' A' ' 72' ' ' VAL . 5.8 t80 -128.39 111.07 12.93 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 109.797 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.67 ' HB2' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.58 122.63 43.57 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.601 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.65 116.67 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.672 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.34 145.9 36.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.948 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -146.53 143.25 28.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.565 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 3.7 p -150.82 -164.52 2.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.971 -1.081 . . . . 0.0 111.901 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.38 154.59 60.64 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 45.6 Cg_endo -74.07 51.4 2.42 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.654 1.344 . . . . 0.0 110.845 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 164.04 -62.73 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.34 -0.85 . . . . 0.0 109.741 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.3 -46.89 66.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.878 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 133.12 -160.05 23.77 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.8 tt -127.72 166.44 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 111.724 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 2.6 t60 -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.9 139.88 49.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.798 -1.189 . . . . 0.0 111.542 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 25.6 tp -136.3 110.94 8.63 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 55.5 12.07 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.0 -1.062 . . . . 0.0 111.839 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 44.5 Cg_endo -72.8 102.51 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.658 1.346 . . . . 0.0 109.143 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.07 133.53 0.45 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.728 -0.608 . . . . 0.0 110.804 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 45.1 Cg_endo -71.74 158.4 53.32 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 124.066 1.561 . . . . 0.0 110.953 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.95 -44.17 7.13 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.576 -0.702 . . . . 0.0 110.233 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.29 -48.31 0.48 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' OE1' ' CA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -94.02 3.37 55.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -1.107 . . . . 0.0 110.196 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.2 pp20? -79.98 121.87 26.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 110.546 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -130.06 1.76 4.76 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.158 -0.964 . . . . 0.0 109.958 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' ALA . 59.5 p -139.2 173.85 11.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.282 -0.886 . . . . 0.0 109.887 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -135.61 145.1 46.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.058 -1.026 . . . . 0.0 110.859 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 2.2 tt0 -102.79 81.66 2.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 17' ' ' SER . 41.4 mt -77.53 110.12 12.05 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -133.58 124.12 26.31 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.003 -1.061 . . . . 0.0 111.233 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.594 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.05 72.85 0.64 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD11 HG12 ' A' ' 18' ' ' ILE . 4.0 mt -129.27 -155.14 0.68 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.172 -1.193 . . . . 0.0 110.383 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 140.24 22.25 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 48.9 Cg_endo -79.25 147.7 20.75 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.897 1.472 . . . . 0.0 110.98 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.36 63.98 4.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.7 p -169.79 131.52 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -1.152 . . . . 0.0 110.361 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 1.3 tp10 -84.16 101.7 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.615 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -78.67 119.24 21.63 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 110.674 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.557 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -85.44 96.62 9.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 0.0 109.542 179.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.948 HG13 ' HB3' ' A' ' 36' ' ' TYR . 10.5 t -100.58 135.51 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.949 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.26 128.89 55.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 109.649 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 12.0 t -100.06 134.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 83' ' ' PRO . 2.8 t -140.48 139.04 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.148 -0.97 . . . . 0.0 110.717 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' O ' HD23 ' A' ' 75' ' ' LEU . . . -94.57 168.1 11.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.443 -0.785 . . . . 0.0 109.551 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 33' ' ' ARG . 80.1 mt -137.86 152.74 49.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.915 -1.116 . . . . 0.0 111.81 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.558 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.5 t-160 -129.31 -151.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 7.7 m-20 -47.71 -26.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.97 -1.081 . . . . 0.0 108.444 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER 166.01 61.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -117.77 156.89 27.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.36 56.82 1.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.479 ' HB2' HG21 ' A' ' 2' ' ' ILE . 1.1 t -43.99 157.74 0.05 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.481 -0.762 . . . . 0.0 110.871 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -41.76 124.69 2.47 Favored Pre-proline 0 N--CA 1.484 1.262 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.608 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -70.52 109.86 2.57 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 123.99 1.521 . . . . 0.0 110.155 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 8' ' ' LEU . 15.8 tp -57.81 157.9 6.99 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.563 -0.711 . . . . 0.0 110.352 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.518 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mm -114.51 133.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.33 -0.856 . . . . 0.0 110.464 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 8' ' ' LEU . . . -144.67 79.27 0.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 69' ' ' THR . 2.2 m -96.37 151.26 19.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -1.124 . . . . 0.0 110.473 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -164.08 146.92 9.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' THR . 2.7 t -96.85 113.96 25.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.888 . . . . 0.0 110.101 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -41.55 147.2 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.318 -0.864 . . . . 0.0 110.077 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' ILE . . . -94.26 34.61 1.26 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.233 -0.917 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' ALA . 2.6 pp 38.42 175.17 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.96 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 47.6 Cg_endo -89.03 102.97 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.404 1.213 . . . . 0.0 110.588 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.041 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.15 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 76' ' ' HIS . 2.5 tt -70.9 178.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.142 -0.974 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 35.0 t70 -87.97 -32.15 19.01 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -0.984 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 56.25 84.14 0.21 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.0 109.312 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.512 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 46.5 Cg_endo -71.83 177.25 7.21 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 124.146 1.603 . . . . 0.0 111.349 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -176.57 133.24 0.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.492 -0.755 . . . . 0.0 109.727 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' LEU . . . 86.08 47.29 5.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -47.27 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -1.033 . . . . 0.0 110.7 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.781 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -136.09 161.39 35.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 1.048 ' CE1' HD11 ' A' ' 8' ' ' LEU . 29.2 m-85 -118.12 137.11 53.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.175 -0.953 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 19' ' ' LYS . 60.7 m -108.65 -48.43 3.32 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.304 -0.873 . . . . 0.0 110.341 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.87 135.22 15.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.934 . . . . 0.0 110.282 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.913 HG23 ' CD1' ' A' ' 18' ' ' ILE . 15.0 p -121.86 134.55 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 110.684 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' H ' HD13 ' A' ' 18' ' ' ILE . 30.6 t0 -146.93 144.88 29.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.309 -0.869 . . . . 0.0 110.014 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 90' ' ' THR . 3.5 p -48.64 -31.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.09 -1.006 . . . . 0.0 110.151 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 17' ' ' SER . 6.2 p-10 -122.3 38.44 4.14 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 110.326 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 3.8 t 174.35 110.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.215 -0.928 . . . . 0.0 110.622 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.099 HD11 HG23 ' A' ' 90' ' ' THR . 15.0 mm -123.6 102.35 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 0.0 109.645 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HD3' ' CG2' ' A' ' 11' ' ' THR . 8.2 tttp -94.27 112.39 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.93 . . . . 0.0 110.079 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.92 156.06 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.192 -0.943 . . . . 0.0 110.552 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.909 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.54 136.7 52.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 110.085 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.658 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 28.2 p90 -113.94 156.79 23.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.007 -1.058 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 5' ' ' PRO . 20.5 tt0 -40.43 110.19 0.14 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.47 -0.769 . . . . 0.0 110.549 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 23' ' ' GLU . 20.8 p -42.6 163.75 0.13 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.187 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.09 153.33 46.54 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.01 1.531 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -123.3 -24.68 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 110.324 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.17 28.88 7.69 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 52.74 76.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.241 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 75' ' ' LEU . 2.7 p -64.76 159.44 3.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.248 -0.908 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -40.91 10.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.258 -0.901 . . . . 0.0 110.481 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' HB3' HD12 ' A' ' 75' ' ' LEU . 1.3 ttm180 -142.12 -176.33 4.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.672 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -163.2 122.37 2.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.48 -0.762 . . . . 0.0 109.69 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 75' ' ' LEU . 7.8 ttp85 -99.45 123.26 43.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 110.516 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 3.1 t -105.59 136.51 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -135.13 142.65 46.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.986 -1.071 . . . . 0.0 111.233 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -143.81 149.73 37.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 53.6 p -147.35 171.95 14.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.807 -1.183 . . . . 0.0 112.032 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.24 153.96 81.83 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 48.1 Cg_endo -76.79 47.06 2.06 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.903 1.476 . . . . 0.0 110.594 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 6.6 pt-20 -178.69 -46.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 110.088 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 31.3 t70 -81.56 -41.22 21.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' SER . . . 127.0 -147.06 16.73 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 4.1 tt -122.39 164.09 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 111.497 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -132.87 168.65 18.03 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -141.5 122.24 14.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.874 -1.141 . . . . 0.0 110.915 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.531 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 11.1 tp -85.12 115.83 23.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.647 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.29 -30.0 0.38 Allowed Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.532 -0.73 . . . . 0.0 111.972 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.7 Cg_endo -72.64 97.63 0.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 O-C-N 122.837 0.914 . . . . 0.0 109.782 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -101.3 86.62 0.77 Allowed Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.649 -0.657 . . . . 0.0 111.47 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 42.2 Cg_endo -68.3 146.8 70.5 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.826 1.435 . . . . 0.0 109.639 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -150.15 175.79 11.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.065 . . . . 0.0 110.508 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.14 -43.06 2.93 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -128.96 -22.6 3.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 0.0 110.556 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' PRO . 13.4 tp10 -92.39 136.34 33.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.086 -1.009 . . . . 0.0 110.939 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -138.87 13.92 2.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.909 HG22 ' CB ' ' A' ' 21' ' ' ALA . 9.7 p -139.89 166.47 24.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.533 -0.729 . . . . 0.0 110.154 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.658 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -110.92 148.41 32.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.02 . . . . 0.0 110.093 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -118.64 86.66 2.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.386 -0.821 . . . . 0.0 110.319 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.8 mt -85.83 76.58 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 109.334 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.7 mt-30 -102.52 145.39 29.66 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.541 -0.724 . . . . 0.0 110.618 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.19 23.57 14.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 20.5 mt -72.34 157.48 37.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.976 -1.309 . . . . 0.0 109.996 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.2 ttt180 -93.84 -43.44 0.31 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.223 -0.923 . . . . 0.0 111.222 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 63' ' ' ARG . 52.1 Cg_endo -85.4 174.78 6.72 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.535 1.282 . . . . 0.0 111.164 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.5 ' CA ' HG23 ' A' ' 15' ' ' VAL . . . -146.09 60.06 0.48 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 68' ' ' TYR . 11.9 t -152.49 -169.49 3.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.432 -1.04 . . . . 0.0 110.168 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' N ' ' HA ' ' A' ' 89' ' ' SER . 5.5 tt0 -44.93 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.359 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 7.0 t80 -90.99 161.18 15.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.288 -0.883 . . . . 0.0 110.096 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.21 115.07 26.88 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.2 t -123.51 154.0 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.192 -0.942 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . 24.0 m -134.87 155.21 51.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.24 -0.912 . . . . 0.0 110.484 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 78.9 t -133.78 117.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.26 -0.9 . . . . 0.0 109.942 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.014 HG22 ' HA ' ' A' ' 83' ' ' PRO . 94.1 t -129.29 126.41 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.076 -1.015 . . . . 0.0 110.768 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.19 171.58 14.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.27 -0.894 . . . . 0.0 109.532 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 31' ' ' ARG . 85.1 mt -134.93 156.33 49.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.897 -1.127 . . . . 0.0 111.836 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.655 ' HB2' HD12 ' A' ' 2' ' ' ILE . 2.0 t60 -162.58 170.16 19.03 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.7 p-10 -44.89 119.41 1.96 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 110.074 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 77' ' ' ASP . 9.0 t0 38.73 54.17 1.95 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.645 -0.66 . . . . 0.0 110.381 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -129.46 168.5 16.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.196 -0.94 . . . . 0.0 111.223 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -154.55 60.54 0.68 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.4 m -37.2 137.82 0.34 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.745 -0.597 . . . . 0.0 110.828 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.7 mp0 -40.06 130.72 1.59 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.574 -0.704 . . . . 0.0 109.944 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.014 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.5 Cg_endo -71.31 134.03 23.94 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 O-C-N 124.043 1.549 . . . . 0.0 110.193 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 9.8 tp -98.22 160.96 13.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.433 -0.792 . . . . 0.0 110.357 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.532 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 8.5 mm -117.65 148.57 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 110.364 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.77 86.03 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -102.28 154.69 18.81 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.371 -1.076 . . . . 0.0 110.46 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -176.83 148.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.0 109.848 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.498 ' HA ' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -73.78 94.05 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.596 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.099 HG23 HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -56.28 142.32 38.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.875 . . . . 0.0 109.9 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 15' ' ' VAL . . . -55.8 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.158 -0.964 . . . . 0.0 109.995 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -133.59 161.02 66.26 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.188 -0.945 . . . . 0.0 110.515 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.54 116.97 1.17 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.12 1.589 . . . . 0.0 110.602 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.193 179.897 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.311 0.576 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.661 HD12 ' HB2' ' A' ' 76' ' ' HIS . 3.5 tt -56.71 -178.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.186 -0.946 . . . . 0.0 109.796 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 6.1 t70 -108.79 -31.13 7.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.059 -1.025 . . . . 0.0 110.893 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' HD3' ' NE2' ' A' ' 82' ' ' GLN . 0.6 OUTLIER 74.73 133.99 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.366 -0.834 . . . . 0.0 109.931 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 46.1 Cg_endo -80.08 -174.18 2.16 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.976 1.514 . . . . 0.0 110.51 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 171.74 140.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.291 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 67.96 1.82 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.546 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -72.87 158.59 35.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.292 -1.122 . . . . 0.0 110.197 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.99 161.22 27.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 109.991 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 70.5 m-85 -113.08 120.72 42.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -57.28 2.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.346 -0.846 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -142.2 128.61 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 110.353 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 5.0 p -107.98 137.65 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.778 ' H ' HD13 ' A' ' 18' ' ' ILE . 3.8 t0 -145.42 138.26 26.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -0.882 . . . . 0.0 110.145 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.935 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.6 p -49.33 -36.81 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 111.037 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 24.0 p-10 -107.01 14.88 25.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.823 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 15.7 p -177.04 131.01 0.17 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.943 -1.098 . . . . 0.0 110.923 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 14' ' ' ASP . 40.0 mm -120.01 123.22 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -94.09 101.67 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.114 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.726 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -108.48 153.06 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.172 -0.955 . . . . 0.0 110.928 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.996 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.41 115.44 13.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.448 -0.782 . . . . 0.0 110.005 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.73 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 10.0 p90 -98.65 146.59 25.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.167 -0.958 . . . . 0.0 110.247 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -45.83 122.16 3.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 0.0 110.341 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 p -52.93 143.0 32.99 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 45.0 Cg_endo -73.67 167.88 26.17 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.169 1.615 . . . . 0.0 110.284 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 33.9 mm-40 -142.54 10.34 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 28' ' ' GLN . . . -109.47 52.67 0.63 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 42.68 87.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -1.163 . . . . 0.0 109.989 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.94 148.16 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 110.582 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 2.2 m -114.32 -1.4 13.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 110.024 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER 171.59 159.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.326 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 13.1 p90 -139.54 134.78 32.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.446 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 73' ' ' VAL . 12.4 ttp180 -90.68 126.9 36.12 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 88.0 t -107.79 105.43 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.723 . . . . 0.0 109.298 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -110.25 142.17 42.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.905 . . . . 0.0 111.386 -178.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -135.14 128.81 32.81 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 51.4 p -122.65 160.22 26.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.033 -1.042 . . . . 0.0 111.903 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 137.77 25.11 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 44.1 Cg_endo -72.28 54.76 2.35 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 O-C-N 123.761 1.401 . . . . 0.0 110.753 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 39' ' ' PRO . 11.6 pt-20 178.54 -47.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.22 -0.925 . . . . 0.0 110.586 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.17 -32.89 16.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 110.037 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.87 -145.06 16.12 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 37' ' ' SER . 15.0 tt -138.76 158.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.077 -1.249 . . . . 0.0 111.255 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.599 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 3.0 t-160 -134.14 167.98 19.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.592 -0.692 . . . . 0.0 109.494 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.867 ' HG3' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -128.51 155.82 44.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.045 -1.035 . . . . 0.0 111.017 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 36' ' ' TYR . 8.3 tp -137.82 147.03 44.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.468 -0.77 . . . . 0.0 109.642 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -133.32 51.59 7.1 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 47' ' ' PHE . 47.1 Cg_endo -78.99 77.65 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.721 1.379 . . . . 0.0 110.219 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -44.11 141.38 2.5 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.45 -0.781 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 32' ' ' TYR . 47.3 Cg_endo -85.03 -164.96 0.26 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.995 1.523 . . . . 0.0 110.997 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 15.0 t0 -127.82 -7.43 5.57 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.492 -0.755 . . . . 0.0 110.241 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.81 -36.32 2.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -113.36 -36.59 4.94 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -1.082 . . . . 0.0 110.073 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.48 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.249 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' GLU . 3.7 p-10 -107.44 33.17 4.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.996 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.3 p -140.29 -179.36 5.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.252 -0.905 . . . . 0.0 110.383 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -149.1 151.5 34.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.128 -0.982 . . . . 0.0 110.806 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 2.5 mp0 -107.62 89.32 2.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.733 -0.604 . . . . 0.0 110.098 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' SER . 18.7 mt -79.97 69.82 6.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 8.9 mt-30 -85.68 124.96 32.79 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.242 0.544 . . . . 0.0 110.691 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 112.38 64.07 0.47 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 61' ' ' GLY . 4.5 mt -124.45 -172.61 2.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.152 -1.205 . . . . 0.0 110.494 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 138.87 24.72 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.935 ' HA ' HG23 ' A' ' 15' ' ' VAL . 47.2 Cg_endo -75.73 124.72 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.18 68.37 1.58 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' OG1' ' A' ' 90' ' ' THR . 4.8 m -164.28 120.5 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -1.205 . . . . 0.0 110.748 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 87' ' ' THR . 35.3 tt0 -65.51 86.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.488 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.44 137.43 46.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.94 . . . . 0.0 110.677 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.24 99.53 9.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 15.7 t -96.41 152.43 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 110.67 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.34 122.51 31.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 110.508 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 22' ' ' TRP . 80.8 t -91.25 132.49 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 83' ' ' PRO . 15.2 t -143.33 130.13 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.125 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.18 164.18 13.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.293 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 32' ' ' TYR . 14.2 mt -131.0 -177.27 4.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.855 -1.153 . . . . 0.0 111.103 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.6 t-80 -174.25 78.67 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 6.9 t0 76.73 -48.27 0.54 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.585 -0.697 . . . . 0.0 109.859 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -179.38 37.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.71 175.52 6.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.832 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.18 68.44 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.75 . . . . 0.0 109.228 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' GLN . 1.5 m -56.11 144.91 27.56 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.304 -0.873 . . . . 0.0 110.799 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.546 ' NE2' ' HD3' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -42.05 121.17 2.41 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.688 ' HB3' HG22 ' A' ' 73' ' ' VAL . 45.5 Cg_endo -71.97 122.33 8.37 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.026 1.54 . . . . 0.0 110.752 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 8' ' ' LEU . 44.2 tp -85.01 108.58 17.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.9 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.3 mm -58.46 159.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 110.896 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -154.95 76.61 0.21 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 69' ' ' THR . 2.1 m -80.06 159.4 26.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -1.092 . . . . 0.0 110.757 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.567 ' NE2' HG21 ' A' ' 13' ' ' VAL . 19.8 tm0? -176.45 142.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.329 -0.857 . . . . 0.0 110.12 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 3.9 m -84.81 104.26 14.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.19 -0.944 . . . . 0.0 110.338 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -56.02 116.14 2.82 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.291 -0.881 . . . . 0.0 110.841 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -52.62 -171.61 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 1.1 pp -144.4 36.58 0.21 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 111.761 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 49.9 Cg_endo -74.76 54.41 3.51 Favored 'Trans proline' 0 N--CA 1.482 0.843 0 O-C-N 123.354 1.186 . . . . 0.0 110.269 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.238 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.367 0.603 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.511 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -60.22 175.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -140.83 4.5 1.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.893 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' ASP . 1.3 mtt-85 57.39 114.01 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.0 110.586 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 -173.1 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.942 1.496 . . . . 0.0 110.633 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 2.3 tttt 176.94 144.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.332 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 53.13 2.64 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.966 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.21 137.87 43.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -1.112 . . . . 0.0 109.991 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.98 172.03 10.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' PHE . 36.6 m-85 -121.38 150.48 41.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 m -111.4 -47.85 3.14 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -152.54 116.92 4.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 18' ' ' ILE . 5.5 p -105.5 159.6 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.303 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.54 ' OD1' HG12 ' A' ' 15' ' ' VAL . 11.8 t0 -156.57 158.57 37.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.081 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 2.3 p -44.65 -28.89 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 24.1 p-10 -147.92 36.31 0.85 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -161.82 122.49 2.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.945 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.691 HG12 HG23 ' A' ' 13' ' ' VAL . 67.2 mt -144.66 121.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.799 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -102.86 103.49 13.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.352 -0.843 . . . . 0.0 109.124 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.552 HG23 HG22 ' A' ' 18' ' ' ILE . 26.2 pt -111.51 155.4 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.182 -0.949 . . . . 0.0 111.08 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.05 136.54 48.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.602 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 6.4 p90 -118.65 157.27 27.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.04 -1.037 . . . . 0.0 110.748 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 6' ' ' LYS . 15.1 tt0 -50.82 146.63 5.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 110.317 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.2 p -86.06 154.53 57.81 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.212 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 45.4 Cg_endo -76.27 -172.1 1.28 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.109 1.583 . . . . 0.0 110.46 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.424 ' HG2' ' C ' ' A' ' 25' ' ' PRO . 13.9 mm100 -133.81 2.25 3.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.184 -0.948 . . . . 0.0 110.597 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -125.8 40.72 1.79 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 27' ' ' GLY . 39.0 tt0 48.06 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.281 -1.129 . . . . 0.0 110.194 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -81.82 160.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 110.056 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -114.91 -12.75 12.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.06 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.726 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 177.83 135.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 110.457 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 48' ' ' PRO . 34.6 p90 -117.99 124.09 47.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.539 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 6.3 ttp180 -69.5 122.47 19.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.345 -0.847 . . . . 0.0 111.344 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.4 t -118.47 92.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -106.24 155.24 19.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 111.204 -178.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.803 ' OH ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -128.55 109.99 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.444 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -94.78 145.76 24.65 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.001 -1.062 . . . . 0.0 111.155 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.4 126.74 10.88 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.452 -0.78 . . . . 0.0 109.529 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.09 62.76 2.56 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.739 1.389 . . . . 0.0 110.633 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.45 -57.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.134 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.55 -23.93 14.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.68 -166.53 13.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 36' ' ' TYR . 6.6 tt -113.13 160.95 12.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.22 -1.165 . . . . 0.0 110.396 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.591 ' O ' HG22 ' A' ' 35' ' ' THR . 21.0 m80 -127.25 158.13 37.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 0.0 109.749 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.717 ' HA ' HG22 ' A' ' 35' ' ' THR . 2.1 mp0 -117.44 127.02 53.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.095 -1.003 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.803 HD22 ' OH ' ' A' ' 36' ' ' TYR . 5.4 tp -115.01 133.29 56.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.463 -0.773 . . . . 0.0 109.425 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' ARG . 22.7 m-85 -125.94 78.45 69.94 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.265 -0.897 . . . . 0.0 110.851 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 32' ' ' TYR . 52.1 Cg_endo -83.67 75.01 4.34 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.906 1.477 . . . . 0.0 109.936 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB2' ' HE ' ' A' ' 31' ' ' ARG . . . -53.93 108.85 1.24 Allowed Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.679 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 46.5 Cg_endo -74.53 -169.52 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 124.043 1.549 . . . . 0.0 110.575 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -123.84 -23.91 4.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.238 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.09 45.21 0.04 OUTLIER Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 14.3 pt-20 -170.25 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.245 . . . . 0.0 110.529 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 53' ' ' GLU . 3.5 mt-10 -49.28 129.8 18.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.32 -0.862 . . . . 0.0 110.67 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 56' ' ' THR . 25.7 p30 -136.44 4.91 2.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.005 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.718 HG23 ' OD1' ' A' ' 55' ' ' ASP . 57.3 p -130.4 -165.26 1.52 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.278 -0.889 . . . . 0.0 110.102 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -154.47 130.48 10.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.99 . . . . 0.0 111.059 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -98.16 81.0 2.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.621 -0.675 . . . . 0.0 109.262 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.74 HD22 ' HE2' ' A' ' 36' ' ' TYR . 15.9 mt -80.82 80.63 7.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.618 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.3 mt-30 -106.62 116.51 32.05 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.498 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.88 47.51 0.19 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 mt -103.78 179.87 4.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -1.129 . . . . 0.0 109.954 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -79.92 152.61 74.62 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.146 -0.972 . . . . 0.0 110.151 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.712 ' HA ' HG23 ' A' ' 15' ' ' VAL . 45.9 Cg_endo -82.73 111.46 2.0 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 124.25 1.658 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.21 76.49 1.09 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' OG1' ' A' ' 90' ' ' THR . 1.5 p -170.46 119.75 0.57 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.185 -1.185 . . . . 0.0 110.933 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 tt0 -65.61 91.27 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 63' ' ' ARG . 2.2 m-85 -77.67 113.76 15.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 111.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 83.4 m -80.04 77.02 6.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 86' ' ' GLY . 48.1 t -72.33 149.02 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.419 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -125.5 131.38 52.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 110.783 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.53 122.34 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.34 -0.85 . . . . 0.0 109.737 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.0 t -138.85 135.82 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -88.84 152.65 21.63 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 109.21 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 31' ' ' ARG . 4.7 mt -128.9 -166.26 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.862 -1.148 . . . . 0.0 111.161 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' MET . 23.7 t60 -176.7 66.9 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.846 -0.534 . . . . 0.0 109.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 67.84 -58.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 76' ' ' HIS . 31.1 t0 -148.78 64.73 1.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.492 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 2.7 mtt -140.23 153.76 46.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.545 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.81 78.71 1.76 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.511 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.59 150.57 41.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 110.697 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.84 123.57 2.48 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.346 -0.846 . . . . 0.0 110.143 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HA ' HG22 ' A' ' 73' ' ' VAL . 48.2 Cg_endo -72.84 137.48 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.05 1.553 . . . . 0.0 110.857 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.966 HD21 ' CB ' ' A' ' 8' ' ' LEU . 26.6 tp -98.81 98.96 10.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.383 -0.823 . . . . 0.0 109.662 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER -52.9 170.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 111.199 -179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -162.65 69.72 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 1.8 m -85.05 159.24 20.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.433 -1.039 . . . . 0.0 110.851 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 173.93 148.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.454 -0.779 . . . . 0.0 109.824 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 45.3 m -83.44 116.17 22.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.163 -0.961 . . . . 0.0 110.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -65.78 137.7 57.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.85 . . . . 0.0 110.217 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.081 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -53.98 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -126.48 163.29 41.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.104 -0.997 . . . . 0.0 110.584 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 49.2 Cg_endo -81.86 117.64 2.97 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.376 1.724 . . . . 0.0 110.225 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.278 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.181 0.515 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.881 HG23 ' HG2' ' A' ' 4' ' ' ARG . 16.2 tt -136.88 174.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.347 -0.845 . . . . 0.0 110.229 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 4' ' ' ARG . 14.2 t70 -63.92 -35.26 80.1 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.185 -0.947 . . . . 0.0 111.336 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.881 ' HG2' HG23 ' A' ' 2' ' ' ILE . 10.7 mtt180 60.46 121.84 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.117 -0.99 . . . . 0.0 110.295 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 45.0 Cg_endo -74.55 -177.74 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.89 1.468 . . . . 0.0 110.542 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 19.3 mmtt -152.49 -67.73 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.49 94.99 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -59.28 172.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -1.13 . . . . 0.0 110.012 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.558 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -128.33 154.34 46.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.521 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -106.36 131.72 53.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.749 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 12' ' ' ASP . 1.4 m -100.14 -71.71 0.69 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.574 ' N ' HG22 ' A' ' 11' ' ' THR . 34.5 t0 -135.19 121.9 20.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 13' ' ' VAL . 9.9 p -94.52 148.87 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.902 . . . . 0.0 110.205 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 10.0 t0 -157.1 144.39 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.087 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 64' ' ' PRO . 1.5 p -51.02 -30.12 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 110.3 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 5.8 p30 -126.91 41.87 3.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 110.173 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 1.3 t 175.34 119.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.968 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.781 HG22 HG23 ' A' ' 20' ' ' ILE . 33.5 mm -121.9 115.54 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.735 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.4 mttt -96.83 92.48 6.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.379 -0.825 . . . . 0.0 110.152 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.781 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -109.47 155.13 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -132.8 132.33 42.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.271 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.864 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 8.6 p90 -112.11 155.12 24.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -45.15 131.44 7.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.5 p -74.88 143.05 77.37 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.336 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.88 179.79 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.527 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -141.7 -51.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 0.0 110.314 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.88 -87.78 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.47 99.16 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.197 -1.178 . . . . 0.0 110.129 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -83.86 142.76 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.306 -0.871 . . . . 0.0 110.501 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -84.96 -39.43 18.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.173 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -157.81 156.65 31.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 110.325 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -116.99 99.07 6.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 110.284 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.13 111.06 5.5 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.881 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 4.3 t -109.72 97.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.193 -0.942 . . . . 0.0 109.728 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -101.37 148.51 25.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.448 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.0 p90 -147.56 157.21 43.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.453 -0.779 . . . . 0.0 109.544 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.516 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -143.65 174.58 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 111.309 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.7 170.74 9.21 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.749 -0.594 . . . . 0.0 110.18 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 40' ' ' GLU . 49.4 Cg_endo -81.69 40.25 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.948 1.499 . . . . 0.0 110.511 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 1.3 mm-40 174.05 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.44 -27.71 2.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.002 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.83 -152.5 18.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 37' ' ' SER . 1.6 tt -113.03 153.79 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.115 -1.227 . . . . 0.0 111.072 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 35' ' ' THR . 3.8 m-70 -133.38 -177.5 4.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.489 -0.757 . . . . 0.0 109.325 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 13.7 pt-20 -148.67 126.19 11.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.036 -1.04 . . . . 0.0 110.88 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 12.8 tp -92.14 115.45 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.325 -0.86 . . . . 0.0 109.429 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -88.97 -29.96 0.36 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.717 -0.615 . . . . 0.0 111.867 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.1 Cg_endo -71.59 100.38 1.04 Allowed 'Trans proline' 0 N--CA 1.479 0.67 0 O-C-N 122.781 0.885 . . . . 0.0 110.724 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.953 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -70.54 -179.63 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.672 -0.642 . . . . 0.0 110.528 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.953 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 47.3 Cg_endo -73.15 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.115 1.587 . . . . 0.0 110.446 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -123.89 -27.99 3.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.24 -51.45 0.39 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.11 15.38 19.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -1.177 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.4 71.53 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.41 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 16.8 p-10 -80.43 6.55 11.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.821 HG22 ' CB ' ' A' ' 21' ' ' ALA . 35.4 p -117.54 177.63 4.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 110.044 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.864 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -118.74 126.51 52.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.912 . . . . 0.0 110.705 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -103.34 80.04 1.78 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.64 -0.662 . . . . 0.0 109.238 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.7 mt -83.09 84.22 7.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.38 -0.825 . . . . 0.0 109.106 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 25.9 mt-30 -101.63 113.86 27.38 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.325 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.33 53.7 0.19 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 23.4 mt -111.23 -164.59 0.93 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.24 -1.153 . . . . 0.0 110.583 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -109.78 146.62 34.47 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.311 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.522 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 50.7 Cg_endo -78.74 144.8 19.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.111 1.585 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.35 66.23 2.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.89 127.27 0.88 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.244 -1.15 . . . . 0.0 110.538 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.51 92.84 4.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 0.0 109.763 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 5.1 m-85 -70.5 121.48 17.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' HG23 ' A' ' 87' ' ' THR . 7.1 m -100.84 96.09 7.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t -92.86 137.6 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 111.165 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.25 129.98 55.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.439 -0.788 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.6 t -107.42 124.16 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 110.395 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 83' ' ' PRO . 48.3 t -137.56 124.88 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.152 -0.967 . . . . 0.0 110.723 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -93.55 157.73 16.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.339 -0.851 . . . . 0.0 109.661 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mt -121.69 175.3 6.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 111.788 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -148.54 -154.17 0.54 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -46.49 -38.5 9.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.89 -1.131 . . . . 0.0 109.289 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 20.4 p-10 179.01 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.622 -0.674 . . . . 0.0 109.447 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.78 170.81 14.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.002 . . . . 0.0 111.186 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 81' ' ' SER . 7.5 mt-10 -129.07 70.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.544 -0.722 . . . . 0.0 109.092 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' GLU . 5.1 t -38.68 146.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.504 -0.748 . . . . 0.0 110.973 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 81' ' ' SER . 3.1 mp0 -41.35 123.69 2.2 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.464 -0.773 . . . . 0.0 110.07 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.692 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.1 Cg_endo -71.13 119.46 6.32 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.973 1.512 . . . . 0.0 110.508 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.616 HD21 ' H ' ' A' ' 8' ' ' LEU . 13.8 tp -88.95 160.52 17.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.062 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 11.3 mm -114.84 146.52 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 110.637 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -146.52 80.26 0.22 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 69' ' ' THR . 1.8 m -89.9 158.24 17.52 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.286 -1.126 . . . . 0.0 110.761 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -170.73 143.52 2.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 110.214 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.36 129.41 34.99 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.275 -0.89 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 132.43 49.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.229 -0.92 . . . . 0.0 110.319 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -82.44 101.7 10.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.254 -0.904 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.651 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -54.38 166.71 0.66 Allowed Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.352 -0.843 . . . . 0.0 110.317 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 49.2 Cg_endo -81.16 105.43 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.174 1.618 . . . . 0.0 110.447 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.26 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.0 t30 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.369 0.604 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.785 HD11 ' CB ' ' A' ' 76' ' ' HIS . 11.2 mm -114.92 114.39 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 4' ' ' ARG . 31.9 t70 -65.39 -12.32 51.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.199 -0.938 . . . . 0.0 111.064 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' O ' ' O ' ' A' ' 3' ' ' ASP . 7.7 ptt85 30.05 102.85 0.01 OUTLIER Pre-proline 0 N--CA 1.516 2.848 0 O-C-N 121.781 -0.575 . . . . 0.0 111.862 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.545 ' CB ' ' HB3' ' A' ' 23' ' ' GLU . 43.4 Cg_endo -69.15 178.48 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.713 1.375 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -173.43 157.75 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.539 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.92 35.36 54.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.92 HD11 ' CE2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -43.84 155.74 0.07 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.217 -1.166 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -119.12 172.15 7.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.968 . . . . 0.0 110.017 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.92 ' CE2' HD11 ' A' ' 8' ' ' LEU . 61.7 m-85 -131.01 145.93 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.283 -0.886 . . . . 0.0 110.054 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 2.0 m -114.77 -55.75 2.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.23 -0.919 . . . . 0.0 110.268 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -150.63 130.81 13.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.0 110.294 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.768 HG23 HG12 ' A' ' 18' ' ' ILE . 14.8 p -116.78 115.32 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.905 . . . . 0.0 110.072 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 17' ' ' SER . 5.3 m-20 -116.47 156.07 27.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.0 p -47.06 -29.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 110.114 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -138.28 43.33 2.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.384 -0.823 . . . . 0.0 110.248 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 178.84 115.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.297 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 13' ' ' VAL . 76.2 mt -132.53 130.55 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.296 -0.878 . . . . 0.0 110.333 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -109.75 112.42 24.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.366 -0.834 . . . . 0.0 109.725 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 57' ' ' ALA . 13.2 pt -120.83 155.72 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -0.982 . . . . 0.0 110.413 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -135.53 135.91 40.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.303 -0.873 . . . . 0.0 110.527 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 49.3 p90 -122.36 156.52 33.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.222 -0.924 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB3' ' CB ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -42.97 120.93 1.93 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 110.247 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.09 165.33 0.82 Allowed Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.317 -0.865 . . . . 0.0 110.458 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.81 138.17 23.16 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.202 1.633 . . . . 0.0 110.151 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -137.93 -7.4 1.62 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.24 -0.913 . . . . 0.0 111.267 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -115.15 66.71 0.28 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 44.08 96.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -1.07 . . . . 0.0 110.229 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.38 131.62 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' ARG . 20.2 t -95.31 -25.95 16.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.045 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' C ' HD12 ' A' ' 75' ' ' LEU . 42.7 ttp180 -176.98 163.76 2.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.229 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 16.4 p90 -137.39 130.51 30.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 110.137 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -89.24 116.96 27.85 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.281 -0.887 . . . . 0.0 110.382 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' CG2' ' CE2' ' A' ' 32' ' ' TYR . 84.2 t -95.7 93.36 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.3 OUTLIER -90.47 148.79 22.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.958 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.2 p90 -153.02 155.96 37.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 109.396 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -136.08 164.1 28.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.827 -1.171 . . . . 0.0 111.917 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.453 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -139.31 -177.37 0.68 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.911 -0.493 . . . . 0.0 109.964 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 38' ' ' SER . 50.2 Cg_endo -84.08 24.52 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.078 1.567 . . . . 0.0 110.864 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -83.42 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -14.86 11.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.168 -0.958 . . . . 0.0 110.223 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 81.82 -149.36 28.27 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 19.5 tt -93.93 153.78 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -1.142 . . . . 0.0 111.07 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.619 ' O ' HG22 ' A' ' 35' ' ' THR . 0.3 OUTLIER -140.43 171.31 14.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.54 -0.725 . . . . 0.0 109.347 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 13.0 mt-10 -120.3 112.82 19.51 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.008 . . . . 0.0 111.435 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . 2.5 tp -100.12 150.18 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.294 -0.879 . . . . 0.0 108.916 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 9.6 p90 -146.16 68.8 12.72 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.766 -1.209 . . . . 0.0 111.748 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' O ' ' C ' ' A' ' 49' ' ' ALA . 49.3 Cg_endo -79.6 80.07 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.8 1.421 . . . . 0.0 109.098 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -27.84 138.48 0.1 Allowed Pre-proline 0 N--CA 1.508 2.43 0 O-C-N 122.088 -0.382 . . . . 0.0 111.661 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.5 -162.86 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 124.15 1.605 . . . . 0.0 110.689 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.33 -36.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 110.102 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.07 -49.54 0.44 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -108.66 1.7 21.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -1.227 . . . . 0.0 110.299 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -89.78 67.32 7.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.033 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p-10 -94.41 22.69 5.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.324 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.831 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.0 p -131.84 174.72 9.86 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.926 . . . . 0.0 110.143 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' HG12 ' A' ' 20' ' ' ILE . . . -125.8 131.41 52.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.007 -1.058 . . . . 0.0 111.253 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 58' ' ' GLU . 8.8 mp0 -100.06 77.8 2.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.2 87.64 6.08 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.365 -0.835 . . . . 0.0 109.407 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 34.4 mt-30 -105.59 117.24 33.52 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.552 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 102.64 79.15 1.35 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 18' ' ' ILE . 13.2 mt -127.3 -154.56 0.64 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.225 -1.162 . . . . 0.0 110.435 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.51 136.22 33.4 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.334 -0.854 . . . . 0.0 110.059 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.676 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.48 112.55 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.069 1.563 . . . . 0.0 111.58 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.04 69.16 1.43 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -159.39 134.7 8.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.986 -1.303 . . . . 0.0 110.285 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.04 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 108.862 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.493 ' CE2' ' CG2' ' A' ' 70' ' ' VAL . 5.3 t80 -69.18 111.2 4.97 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.335 -0.853 . . . . 0.0 110.476 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 87' ' ' THR . 0.2 OUTLIER -94.81 98.35 10.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 36' ' ' TYR . 23.2 t -103.27 149.14 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.254 -0.904 . . . . 0.0 110.825 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -132.09 126.19 33.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.916 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 96.7 t -95.39 122.52 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -0.878 . . . . 0.0 110.113 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 83' ' ' PRO . 99.7 t -129.62 132.37 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.161 -0.962 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -91.16 172.18 8.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.496 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 31' ' ' ARG . 22.4 mt -134.54 -174.74 3.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.844 -1.16 . . . . 0.0 111.167 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.785 ' CB ' HD11 ' A' ' 2' ' ' ILE . 12.7 t-80 172.18 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.79 -56.21 0.58 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 76' ' ' HIS . 8.8 t70 -173.38 47.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 0.0 109.825 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.43 146.79 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 110.996 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 81' ' ' SER . 3.0 mt-10 -110.17 56.59 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 2' ' ' ILE . 4.7 t -32.87 142.17 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.371 0.605 . . . . 0.0 111.402 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.1 mp0 -42.76 120.82 2.73 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.832 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.836 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.5 Cg_endo -68.95 113.61 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.923 1.486 . . . . 0.0 111.076 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 8' ' ' LEU . 38.1 tp -80.15 121.72 25.92 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.309 -0.869 . . . . 0.0 109.443 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mm -82.28 146.26 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 111.338 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -143.59 78.19 0.27 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 69' ' ' THR . 0.2 OUTLIER -86.06 161.91 18.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -1.107 . . . . 0.0 110.811 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.38 131.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.493 -0.754 . . . . 0.0 109.823 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -72.89 123.16 22.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.752 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -76.74 138.51 39.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.203 -0.935 . . . . 0.0 110.096 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.617 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -71.21 -174.69 1.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.825 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -129.61 22.89 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.045 -1.034 . . . . 0.0 112.359 179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 50.6 Cg_endo -74.84 71.44 4.88 Favored 'Trans proline' 0 N--CA 1.482 0.801 0 O-C-N 122.554 0.765 . . . . 0.0 110.722 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.169 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.338 0.589 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.515 ' CG2' ' OG ' ' A' ' 81' ' ' SER . 12.2 tt -104.66 174.16 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.402 -0.811 . . . . 0.0 110.573 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 13.8 t70 -57.18 -24.31 53.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.142 -0.974 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HA ' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 63.44 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.109 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 47.2 Cg_endo -73.42 178.56 6.5 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.916 1.482 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER 172.52 146.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.414 -0.804 . . . . 0.0 110.058 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.78 78.65 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -92.28 152.85 19.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.277 -1.131 . . . . 0.0 110.224 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -107.16 168.19 9.39 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.132 -0.98 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' CE2' HD11 ' A' ' 8' ' ' LEU . 28.1 m-85 -127.69 133.6 49.59 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.222 -0.924 . . . . 0.0 110.446 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.642 HG21 ' CE ' ' A' ' 19' ' ' LYS . 3.2 m -96.7 -73.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.908 . . . . 0.0 110.015 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 11' ' ' THR . 5.3 t0 -137.34 130.05 30.15 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 109.864 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.3 p -104.24 137.67 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -0.997 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.7 t70 -141.5 147.35 37.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.822 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.97 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.9 p -46.79 -33.24 2.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' SER . 4.0 p30 -133.84 40.68 3.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 110.249 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 177.67 113.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.89 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.717 HD11 HG23 ' A' ' 90' ' ' THR . 78.3 mt -133.48 128.78 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.209 -0.932 . . . . 0.0 110.615 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.642 ' CE ' HG21 ' A' ' 11' ' ' THR . 14.0 mtpp -96.05 114.6 26.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 56' ' ' THR . 27.6 pt -120.99 151.4 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 111.009 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.956 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.85 125.7 20.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.467 -0.77 . . . . 0.0 109.605 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 35.7 p90 -107.26 173.59 6.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.077 -1.014 . . . . 0.0 110.804 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 137.3 38.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.502 -0.749 . . . . 0.0 110.179 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -86.88 148.73 46.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.299 -0.875 . . . . 0.0 110.185 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 29' ' ' VAL . 45.8 Cg_endo -74.95 -169.04 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -104.33 -31.06 9.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 109.919 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 28' ' ' GLN . . . -92.68 63.42 2.23 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.831 ' O ' HG23 ' A' ' 29' ' ' VAL . 13.6 pt20 38.5 -149.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.757 -0.849 . . . . 0.0 110.231 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 28' ' ' GLN . 4.0 t -163.82 114.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.785 -0.572 . . . . 0.0 109.997 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 46.9 t -69.44 -18.19 63.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.195 -0.941 . . . . 0.0 109.509 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.529 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER 168.19 159.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.751 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 p90 -136.98 118.63 14.96 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.91 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.75 109.51 15.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.609 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 34.3 t -101.55 99.38 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -104.65 144.25 31.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 110.533 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.07 133.36 42.9 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.0 109.6 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.55 ' CA ' HG13 ' A' ' 43' ' ' ILE . 66.2 p -113.22 148.51 35.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.283 -0.886 . . . . 0.0 111.255 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.555 ' OG ' ' CZ ' ' A' ' 68' ' ' TYR . 1.4 m -128.98 142.11 44.02 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.809 -0.557 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -74.32 63.11 5.33 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.953 1.501 . . . . 0.0 110.507 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 1.2 tt0 172.28 -66.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.143 -0.973 . . . . 0.0 110.586 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 29.4 t0 -76.51 -32.08 58.08 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.115 -0.991 . . . . 0.0 110.3 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.18 -131.1 8.03 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.55 HG13 ' CA ' ' A' ' 37' ' ' SER . 9.2 tt -139.57 152.33 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 110.607 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 14.6 t-80 -126.25 177.32 6.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.0 109.117 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 33.0 mt-10 -133.46 147.7 51.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.894 -1.129 . . . . 0.0 111.858 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 36' ' ' TYR . 12.5 tp -140.23 123.99 17.3 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -150.52 49.99 0.68 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 120.838 -1.163 . . . . 0.0 111.778 -178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.1 101.28 1.08 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.55 1.29 . . . . 0.0 109.07 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -32.87 138.16 0.24 Allowed Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.808 -0.558 . . . . 0.0 110.92 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 46.2 Cg_endo -74.23 176.6 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.135 1.597 . . . . 0.0 110.779 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 59.5 t0 -119.19 -29.55 5.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 110.346 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.07 -16.61 3.92 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 17.73 7.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -1.201 . . . . 0.0 110.571 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.76 116.38 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.442 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 5.5 m-20 -124.32 18.72 9.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.89 . . . . 0.0 109.994 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.956 HG22 ' CB ' ' A' ' 21' ' ' ALA . 68.9 p -117.45 -172.5 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -146.48 149.64 34.05 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.126 -0.984 . . . . 0.0 110.638 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -108.56 89.05 2.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.53 -0.731 . . . . 0.0 110.09 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.521 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.9 mt -81.14 78.58 7.93 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.288 -0.883 . . . . 0.0 108.932 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 23.4 mt-30 -100.54 137.27 39.17 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.615 -0.678 . . . . 0.0 110.483 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.24 65.9 1.31 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 27.1 mt -120.76 -178.68 3.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.293 -1.122 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' NH2' ' OD2' ' A' ' 41' ' ' ASP . 2.0 mmp_? -79.21 142.96 59.77 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.309 -0.869 . . . . 0.0 109.937 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.97 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.0 Cg_endo -85.72 127.38 3.16 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.99 1.521 . . . . 0.0 111.734 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.17 68.72 1.51 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' OG1' ' A' ' 90' ' ' THR . 2.1 m -167.64 130.17 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.006 -1.291 . . . . 0.0 110.8 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG22 ' A' ' 87' ' ' THR . 32.9 tt0 -64.84 96.98 0.2 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.417 -0.802 . . . . 0.0 108.984 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -69.88 118.18 12.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 111.35 -178.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.464 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -93.42 79.79 4.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 4.9 t -77.39 150.54 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 0.0 110.49 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.02 93.54 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.502 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.32 132.13 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.9 t -137.55 137.43 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.023 -1.048 . . . . 0.0 110.996 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' C ' ' HG ' ' A' ' 75' ' ' LEU . . . -94.23 167.54 11.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.468 -0.77 . . . . 0.0 109.445 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.529 HD12 ' HB3' ' A' ' 31' ' ' ARG . 55.8 mt -138.03 156.86 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.91 -1.118 . . . . 0.0 111.577 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' ASP . 2.5 t60 -136.8 -156.28 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -45.42 -35.56 3.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 109.301 179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 10.6 t70 -179.88 55.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -120.31 175.34 6.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.35 -0.844 . . . . 0.0 111.339 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 8.2 tt0 -138.93 66.1 1.43 Allowed 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -37.84 147.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.454 -0.778 . . . . 0.0 110.976 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.5 mp0 -42.92 132.14 3.09 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.35 91.5 0.67 Allowed 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.049 1.552 . . . . 0.0 110.514 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.896 HD21 ' HB3' ' A' ' 8' ' ' LEU . 54.8 tp -61.97 100.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 1.4 tp -67.89 160.27 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 111.331 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.85 78.47 0.29 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.5 HG22 ' CG ' ' A' ' 67' ' ' GLU . 6.2 m -86.85 142.91 27.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.087 . . . . 0.0 111.169 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.4 135.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.686 -0.634 . . . . 0.0 109.676 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m -69.65 115.0 8.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.021 -1.049 . . . . 0.0 110.329 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.717 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -72.71 133.53 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 110.533 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 90' ' ' THR . . . -54.96 -165.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 109.793 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -139.68 164.75 36.03 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.02 -1.05 . . . . 0.0 110.417 179.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.2 Cg_endo -79.99 112.77 2.9 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.155 1.608 . . . . 0.0 110.22 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.184 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.149 0.499 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.981 HG21 ' HB3' ' A' ' 81' ' ' SER . 0.5 OUTLIER -83.45 167.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 10.5 t0 -105.06 -7.81 18.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.137 -0.977 . . . . 0.0 110.965 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 18.1 mtm180 59.25 136.48 0.03 OUTLIER Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 121.372 -0.83 . . . . 0.0 110.463 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.47 -177.24 0.84 Allowed 'Trans proline' 0 C--N 1.294 -2.319 0 O-C-N 124.134 1.597 . . . . 0.0 110.53 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 42.9 mttt -135.65 -46.19 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.205 -0.934 . . . . 0.0 110.747 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.11 110.76 0.45 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -68.83 159.38 32.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.39 -1.064 . . . . 0.0 110.4 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -122.87 159.3 28.47 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.197 -0.939 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' CE1' HD11 ' A' ' 8' ' ' LEU . 21.0 m-85 -111.68 114.89 28.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.3 m -93.42 -51.46 4.96 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.316 -0.865 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.57 112.59 4.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 110.211 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -102.58 126.98 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.02 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -133.72 156.15 48.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.0 110.26 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.826 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.6 p -57.58 -26.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 0.0 110.714 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' SER . 8.4 t0 -118.73 27.08 9.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.122 -0.986 . . . . 0.0 110.765 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.545 ' N ' HD12 ' A' ' 62' ' ' LEU . 16.1 t 176.87 138.34 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.134 -0.979 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.6 mm -129.89 102.75 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 0.0 110.111 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.27 122.93 28.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.604 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' CG2' HG22 ' A' ' 18' ' ' ILE . 13.0 pt -142.79 154.38 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.979 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -131.67 113.91 14.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.777 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 8.5 p90 -91.2 142.89 27.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -41.63 144.49 0.38 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.401 -0.812 . . . . 0.0 110.129 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.454 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 0.7 OUTLIER -84.14 145.76 46.78 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.195 -0.941 . . . . 0.0 111.05 -179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.78 179.32 6.59 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.176 1.619 . . . . 0.0 110.206 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HG2' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -51.81 -26.81 10.59 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.897 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 132.63 -67.93 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -47.13 109.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -1.155 . . . . 0.0 110.033 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -149.37 145.72 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -105.77 -9.51 17.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 110.09 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.485 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER 173.65 -179.47 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.93 . . . . 0.0 110.357 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.8 t80 -157.14 112.87 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' HB2' HD11 ' A' ' 75' ' ' LEU . 2.0 ttp180 -83.47 143.55 30.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 110.583 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 71.9 t -137.96 100.74 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -0.837 . . . . 0.0 109.566 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -110.87 147.44 34.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.178 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.36 130.51 46.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.967 179.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.54 ' CA ' HG13 ' A' ' 43' ' ' ILE . 1.1 p -111.95 156.18 22.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 0.0 110.642 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.09 134.07 13.48 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.428 -0.795 . . . . 0.0 109.909 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.02 62.74 3.28 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 123.909 1.478 . . . . 0.0 110.155 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.69 -61.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -88.13 -27.23 22.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.065 -1.022 . . . . 0.0 110.42 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.97 -142.17 14.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.8 tt -134.71 161.17 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.187 -1.184 . . . . 0.0 110.887 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.613 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -132.16 168.44 18.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.421 -0.799 . . . . 0.0 109.667 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 35' ' ' THR . 21.6 mt-10 -123.71 140.94 52.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 111.047 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.958 HD23 ' HD3' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -142.21 162.31 35.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.508 -0.745 . . . . 0.0 109.345 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 17.5 p90 -161.48 85.07 1.72 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.968 -1.082 . . . . 0.0 110.993 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.958 ' HD3' HD23 ' A' ' 46' ' ' LEU . 51.0 Cg_endo -83.24 70.25 6.65 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 123.937 1.493 . . . . 0.0 109.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -35.48 114.98 0.55 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.895 -0.503 . . . . 0.0 110.7 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 48.6 Cg_endo -77.16 160.22 33.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.041 1.548 . . . . 0.0 110.566 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -95.62 -63.67 1.13 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.7 26.12 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.2 tt0 -170.15 -57.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -1.195 . . . . 0.0 110.293 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 53' ' ' GLU . 5.8 mt-10 -42.21 133.72 3.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.581 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -140.26 14.91 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 109.842 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.979 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.9 p -116.11 163.12 16.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.306 -0.871 . . . . 0.0 110.148 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.35 43.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 0.0 110.874 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 60' ' ' GLN . 5.3 mt-10 -109.98 92.77 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.07 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.519 ' O ' HD11 ' A' ' 62' ' ' LEU . 18.0 mt -72.22 64.49 0.56 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.219 -0.925 . . . . 0.0 108.73 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 12.5 mt-30 -83.05 150.27 26.43 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.773 -0.579 . . . . 0.0 110.424 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 89.12 73.98 1.28 Allowed Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD22 ' CE2' ' A' ' 68' ' ' TYR . 20.6 mt -127.29 -166.51 1.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -1.135 . . . . 0.0 110.968 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.02 150.03 47.96 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.39 -0.819 . . . . 0.0 109.79 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -78.89 129.76 9.19 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.933 1.491 . . . . 0.0 111.66 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' C ' ' OG ' ' A' ' 66' ' ' SER . . . 80.92 72.64 1.22 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -170.68 129.3 0.81 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.239 . . . . 0.0 110.704 179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' HG22 ' A' ' 87' ' ' THR . 1.4 tp10 -75.42 99.07 4.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.263 -0.898 . . . . 0.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.66 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.4 m-85 -70.13 85.95 0.55 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 111.769 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 m -74.49 78.37 1.93 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 25.1 t -69.28 148.34 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.446 -0.784 . . . . 0.0 111.606 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -124.66 96.63 4.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.705 -0.622 . . . . 0.0 109.604 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 98.5 t -77.95 138.45 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.232 -0.917 . . . . 0.0 109.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 16.5 t -148.38 132.98 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.046 -1.034 . . . . 0.0 110.659 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . . . -90.02 171.94 9.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 32' ' ' TYR . 71.5 mt -140.66 -168.14 2.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.996 -1.065 . . . . 0.0 111.43 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -172.45 -159.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 15.1 m-20 -47.12 -25.5 0.89 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.867 -1.146 . . . . 0.0 109.082 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER 164.32 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.642 -0.661 . . . . 0.0 109.461 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 64.3 mmm -126.21 -174.84 3.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.328 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -147.26 67.49 1.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.379 0.609 . . . . 0.0 109.859 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.981 ' HB3' HG21 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -52.31 149.52 5.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.346 -0.846 . . . . 0.0 110.464 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 81' ' ' SER . 2.9 mp0 -41.54 130.14 2.3 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.414 -0.804 . . . . 0.0 109.992 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -72.08 125.4 10.86 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 123.969 1.51 . . . . 0.0 110.837 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' A' ' 8' ' ' LEU . 3.0 tp -88.64 156.12 19.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.336 -0.853 . . . . 0.0 109.71 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.509 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 10.8 mm -118.18 155.52 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.084 -1.01 . . . . 0.0 110.813 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.63 77.76 0.21 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' CG ' ' A' ' 67' ' ' GLU . 1.9 m -82.68 158.25 23.02 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.3 -1.118 . . . . 0.0 111.238 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER 174.82 129.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.714 . . . . 0.0 109.792 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.1 p -73.19 121.6 20.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.269 -0.894 . . . . 0.0 110.366 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.826 HG22 ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -55.98 132.48 50.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.341 -0.849 . . . . 0.0 110.252 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -76.89 87.55 3.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.18 -0.95 . . . . 0.0 110.534 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.643 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -51.33 165.22 0.42 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.4 -0.812 . . . . 0.0 110.161 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 48.1 Cg_endo -76.05 75.97 3.97 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.081 1.569 . . . . 0.0 110.316 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.259 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.251 0.548 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 HH21 ' A' ' 4' ' ' ARG . 1.3 tt -67.36 -177.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -149.38 10.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.094 -1.004 . . . . 0.0 110.858 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 81' ' ' SER . 1.3 mtt180 57.32 117.78 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.1 -1.0 . . . . 0.0 110.721 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 46.9 Cg_endo -75.95 -179.93 5.68 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.805 1.424 . . . . 0.0 109.978 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.2 tttp -178.4 151.48 0.61 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.107 -0.996 . . . . 0.0 110.351 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.97 70.13 1.36 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -92.18 163.36 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -1.132 . . . . 0.0 109.784 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.825 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -133.02 173.72 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.024 . . . . 0.0 110.476 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-85 -129.69 146.56 51.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.8 m -110.86 -63.72 1.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.272 -0.892 . . . . 0.0 109.536 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -135.4 146.62 48.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.681 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.1 p -125.37 148.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 111.066 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 37.0 t0 -166.73 148.63 6.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.404 -0.81 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.923 HG21 ' HD3' ' A' ' 93' ' ' PRO . 7.3 p -44.79 -36.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.132 -0.98 . . . . 0.0 110.387 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' VAL . 2.9 p30 -131.22 22.36 4.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.312 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.61 115.64 4.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.192 -0.942 . . . . 0.0 110.141 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.059 HD12 ' CD1' ' A' ' 62' ' ' LEU . 79.6 mt -145.11 149.86 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.372 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 3.0 mttp -133.69 122.47 23.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.275 -0.891 . . . . 0.0 109.395 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.575 HG22 ' CD1' ' A' ' 10' ' ' PHE . 28.6 pt -125.33 161.06 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.985 . . . . 0.0 110.968 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -133.76 116.93 16.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.755 . . . . 0.0 109.624 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 46.7 p90 -101.29 164.17 11.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.108 -0.995 . . . . 0.0 110.56 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.85 152.44 45.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 22.9 p -67.83 165.4 31.81 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 44.3 Cg_endo -73.01 159.65 47.42 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.95 1.5 . . . . 0.0 110.371 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -95.85 -49.48 5.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.38 -104.4 2.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.47 115.22 14.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.268 -1.136 . . . . 0.0 110.239 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 25' ' ' PRO . 3.3 t -91.76 109.97 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.889 . . . . 0.0 110.077 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 t -75.43 -15.54 60.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 109.923 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -172.66 149.99 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.829 . . . . 0.0 109.995 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -120.26 96.53 5.19 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 110.018 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.673 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -70.08 105.45 2.9 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 13.8 t -88.24 94.22 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -98.16 140.38 32.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.236 -0.915 . . . . 0.0 110.958 -179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.59 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -136.96 128.18 28.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.598 -0.689 . . . . 0.0 109.364 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.54 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 25.1 p -124.9 166.54 16.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.56 154.97 56.97 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.708 -0.62 . . . . 0.0 109.454 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 46.0 Cg_endo -73.48 51.52 2.21 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.785 1.413 . . . . 0.0 110.684 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 165.02 -65.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -52.25 -48.66 65.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.016 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.85 -162.12 19.19 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 18.3 tt -126.26 168.85 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.983 -1.304 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -159.59 -172.63 3.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.597 -0.689 . . . . 0.0 109.291 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -152.78 150.44 29.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.87 -1.144 . . . . 0.0 111.151 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.549 ' HG ' ' CD ' ' A' ' 48' ' ' PRO . 4.0 tp -109.22 143.66 38.36 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.485 -0.76 . . . . 0.0 109.601 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 96.2 m-85 -100.19 -12.47 0.16 Allowed Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.9 Cg_endo -72.07 91.72 0.73 Allowed 'Trans proline' 0 N--CA 1.481 0.788 0 O-C-N 122.276 0.619 . . . . 0.0 110.534 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -74.12 174.16 5.4 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.645 -0.659 . . . . 0.0 110.204 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 46.3 Cg_endo -73.97 -177.55 3.26 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.092 1.575 . . . . 0.0 110.479 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -124.9 -8.35 7.23 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.266 -0.896 . . . . 0.0 110.39 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.87 -61.97 0.57 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.61 6.87 45.74 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.181 -1.187 . . . . 0.0 110.44 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -103.17 120.74 41.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.125 -0.984 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' A' ' 22' ' ' TRP . 68.7 m-20 -126.22 7.08 7.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -0.94 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 21' ' ' ALA . 57.0 p -127.66 171.49 11.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.54 161.92 38.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.489 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 58' ' ' GLU . 5.1 pt-20 -108.11 96.37 6.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.806 . . . . 0.0 110.281 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 59' ' ' LEU . 17.9 mt -78.74 73.93 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.308 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 10.5 mt-30 -106.37 157.7 17.42 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.472 -0.768 . . . . 0.0 110.442 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.04 27.53 12.21 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.059 ' CD1' HD12 ' A' ' 18' ' ' ILE . 36.1 mt -81.56 168.35 18.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.122 -1.222 . . . . 0.0 110.463 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -108.91 -47.29 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.438 -0.789 . . . . 0.0 112.991 -178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 47.0 Cg_endo -79.81 172.1 14.61 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.214 1.113 . . . . 0.0 111.78 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -137.35 54.95 0.7 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -145.98 -170.03 3.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.097 -1.237 . . . . 0.0 110.394 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.36 94.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.244 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.59 ' CE2' ' HB2' ' A' ' 36' ' ' TYR . 7.6 t80 -82.64 126.68 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.77 95.87 7.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 58.7 t -86.71 148.57 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.094 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 29.8 t -127.39 90.22 3.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.54 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.55 129.61 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -0.912 . . . . 0.0 109.708 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG22 ' CB ' ' A' ' 83' ' ' PRO . 6.2 t -136.51 127.12 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' HG22 ' A' ' 29' ' ' VAL . . . -85.84 157.64 20.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.149 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 33' ' ' ARG . 26.7 mt -132.31 -168.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.48 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.527 ' CG ' ' N ' ' A' ' 77' ' ' ASP . 66.0 t60 -158.84 178.22 10.32 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -36.4 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.241 -0.912 . . . . 0.0 110.349 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 76' ' ' HIS . 1.6 p30 -172.55 62.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.89 . . . . 0.0 110.064 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -142.08 -164.39 1.79 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.204 -0.935 . . . . 0.0 111.201 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER 172.08 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.548 ' HB2' ' CG ' ' A' ' 4' ' ' ARG . 7.7 p -71.54 175.05 5.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.388 -0.82 . . . . 0.0 111.672 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -45.3 137.17 5.12 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.617 -0.677 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.618 ' CB ' HG22 ' A' ' 73' ' ' VAL . 50.6 Cg_endo -78.53 134.44 12.41 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 O-C-N 124.233 1.649 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.8 tp -88.87 97.29 11.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.256 -0.903 . . . . 0.0 109.342 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -61.5 169.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.948 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.65 84.52 0.12 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 14.7 t -69.85 165.45 21.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.269 -1.136 . . . . 0.0 110.395 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' THR . 49.9 tp60 -179.71 143.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -83.13 118.34 23.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -0.921 . . . . 0.0 110.032 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.931 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -99.93 131.13 46.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 110.367 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 65' ' ' GLY . . . -60.43 -168.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.227 -0.921 . . . . 0.0 109.889 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.729 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -142.32 163.58 38.62 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.249 -0.907 . . . . 0.0 110.371 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.923 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.5 Cg_endo -86.35 80.67 1.66 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.204 1.633 . . . . 0.0 110.404 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.318 -179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 76' ' ' HIS . 7.2 tp -118.15 169.45 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 0.0 110.606 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' N ' HG13 ' A' ' 2' ' ' ILE . 8.6 t0 -58.62 -55.29 36.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.469 -0.769 . . . . 0.0 110.831 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 62.9 67.12 1.14 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 109.905 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 81' ' ' SER . 43.1 Cg_endo -71.0 -174.29 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.114 1.586 . . . . 0.0 110.72 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 178.56 -27.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.292 -0.88 . . . . 0.0 110.496 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.01 103.2 1.86 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.736 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -93.4 156.97 16.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -1.1 . . . . 0.0 109.826 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.736 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -129.5 149.9 51.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 0.0 110.283 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.47 133.08 52.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 m -100.03 -46.32 5.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -159.62 125.33 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.311 -0.868 . . . . 0.0 109.919 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 13' ' ' VAL . 13.2 p -108.54 97.83 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.03 -1.044 . . . . 0.0 110.667 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' SER . 3.3 t0 -103.68 139.98 38.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.915 . . . . 0.0 109.623 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.645 HG21 ' HD3' ' A' ' 93' ' ' PRO . 3.1 p -42.61 -34.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.89 37.24 4.46 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.026 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -178.85 120.32 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.957 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.566 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 13.2 mm -126.98 114.62 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.146 -0.972 . . . . 0.0 110.892 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -91.86 120.22 32.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.707 ' C ' HD12 ' A' ' 20' ' ' ILE . 1.5 pp -125.21 155.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.039 -1.038 . . . . 0.0 111.159 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.891 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.19 116.08 10.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.571 -0.705 . . . . 0.0 109.324 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.667 ' HZ3' ' HB2' ' A' ' 57' ' ' ALA . 36.2 p90 -88.55 150.05 23.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.809 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' TRP . 6.2 tt0 -42.57 137.15 2.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 110.015 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 p -59.64 151.04 63.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.258 -0.901 . . . . 0.0 110.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 3' ' ' ASP . 47.5 Cg_endo -74.46 -177.27 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.118 1.588 . . . . 0.0 110.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -130.26 -31.72 1.84 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.322 -0.861 . . . . 0.0 110.34 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' GLN . . . -114.72 36.8 3.78 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 51.31 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -1.168 . . . . 0.0 110.217 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG11 ' HD2' ' A' ' 32' ' ' TYR . 14.1 t -74.4 129.56 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.255 -0.903 . . . . 0.0 110.467 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 t -82.02 -19.77 39.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.007 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 49' ' ' ALA . 2.1 ttt180 -156.96 145.9 20.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.349 -0.844 . . . . 0.0 110.001 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 73' ' ' VAL . 1.6 t80 -129.49 135.58 48.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 110.313 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.9 90.05 3.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 110.52 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.2 t -90.8 91.17 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.62 139.63 32.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.76 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -137.72 137.43 38.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.471 -0.768 . . . . 0.0 109.145 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 6.3 p -140.31 -175.83 4.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 112.054 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.28 161.89 39.7 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 47.6 Cg_endo -75.66 46.75 1.73 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.743 1.391 . . . . 0.0 111.154 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER 162.66 -60.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.272 -0.893 . . . . 0.0 109.707 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.37 -40.59 26.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.838 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.7 -158.3 14.87 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 11.4 tt -128.3 165.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -1.177 . . . . 0.0 111.78 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t-160 -149.44 136.41 19.68 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 pt-20 -110.35 128.02 55.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.71 -1.244 . . . . 0.0 112.083 -178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 21.0 tp -110.31 115.07 29.04 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' A' ' 47' ' ' PHE . 11.3 p90 -141.81 65.63 20.29 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.947 -1.095 . . . . 0.0 112.024 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' A' ' 49' ' ' ALA . 48.7 Cg_endo -79.65 55.09 5.49 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 O-C-N 123.695 1.366 . . . . 0.0 109.245 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . . . -10.25 91.2 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 45.7 Cg_endo -72.7 -162.55 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.171 1.616 . . . . 0.0 110.628 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.92 77.12 1.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 53' ' ' GLU . . . 45.65 47.1 13.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 10.9 mt-10 -149.6 -37.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 110.225 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.4 mt-10 -103.5 115.03 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.088 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.0 p-10 -117.03 14.82 15.07 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.891 HG22 ' CB ' ' A' ' 21' ' ' ALA . 3.0 p -135.12 160.95 36.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -0.936 . . . . 0.0 110.339 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -125.28 152.17 45.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.228 -0.92 . . . . 0.0 110.545 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.41 86.03 2.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.333 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 59' ' ' LEU . 16.0 mt -80.92 73.33 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.174 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 18.8 mm-40 -98.86 119.6 37.89 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.424 -0.797 . . . . 0.0 110.846 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.604 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 116.54 75.05 0.56 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -127.88 -162.61 1.19 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.08 -1.247 . . . . 0.0 110.476 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -96.01 158.05 34.78 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HA ' HG23 ' A' ' 15' ' ' VAL . 50.7 Cg_endo -84.35 106.75 1.17 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.981 1.516 . . . . 0.0 111.223 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.75 76.44 1.08 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 90' ' ' THR . 0.6 OUTLIER -162.33 127.93 3.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.172 -1.193 . . . . 0.0 110.695 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.46 89.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.269 -0.894 . . . . 0.0 109.641 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -71.62 133.01 45.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.881 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.14 107.41 17.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 36' ' ' TYR . 64.0 t -104.17 142.75 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.0 111.059 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.83 111.81 21.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.5 -0.75 . . . . 0.0 109.951 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 22' ' ' TRP . 52.2 t -88.25 112.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 83' ' ' PRO . 47.0 t -121.89 157.16 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.202 -0.936 . . . . 0.0 110.496 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -123.92 174.01 7.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 0.0 109.815 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 31' ' ' ARG . 94.8 mt -139.09 175.79 9.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.042 . . . . 0.0 111.572 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB2' HD13 ' A' ' 2' ' ' ILE . 1.8 t-160 -179.76 89.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 76' ' ' HIS . 26.8 m-20 59.15 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.512 -0.742 . . . . 0.0 109.877 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 76' ' ' HIS . 7.8 m-20 -135.0 67.24 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 78' ' ' ASP . 3.4 mtp -162.7 159.7 24.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.177 -0.952 . . . . 0.0 110.933 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 5.3 pt-20 -142.34 92.12 2.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 0.0 109.629 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 11.4 p -38.11 142.34 0.17 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.619 -0.676 . . . . 0.0 110.601 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 81' ' ' SER . 40.6 mm-40 -38.0 139.61 0.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.57 -0.706 . . . . 0.0 110.395 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.954 ' HA ' HG22 ' A' ' 73' ' ' VAL . 44.5 Cg_endo -70.83 79.24 1.3 Allowed 'Trans proline' 0 C--N 1.298 -2.081 0 O-C-N 124.303 1.686 . . . . 0.0 110.351 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 8' ' ' LEU . 47.2 tp -54.79 120.35 6.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.375 -0.828 . . . . 0.0 109.887 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 85' ' ' ILE . 10.1 mm -84.13 155.48 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 110.743 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.35 77.08 0.21 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 11.2 m -78.29 157.94 29.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -1.094 . . . . 0.0 110.201 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -167.6 141.28 3.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.832 . . . . 0.0 110.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 t -86.12 105.4 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.93 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -60.38 121.82 13.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.114 -0.991 . . . . 0.0 110.133 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.48 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.749 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.1 pp -137.38 164.27 42.89 Favored Pre-proline 0 C--N 1.295 -1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD3' HG21 ' A' ' 15' ' ' VAL . 48.7 Cg_endo -78.57 85.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.264 1.665 . . . . 0.0 110.569 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.125 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.19 0.519 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.708 HG21 ' OG ' ' A' ' 81' ' ' SER . 1.6 tt -121.37 -177.86 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.068 -1.02 . . . . 0.0 110.016 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.5 t70 -115.95 -9.72 11.73 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.173 -0.954 . . . . 0.0 110.437 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 2' ' ' ILE . 0.7 OUTLIER 60.15 129.18 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.221 0 O-C-N 121.29 -0.881 . . . . 0.0 110.424 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.12 178.63 3.99 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 123.995 1.524 . . . . 0.0 110.064 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -142.55 -61.75 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.071 . . . . 0.0 111.114 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.69 132.6 8.51 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.751 -1.214 . . . . 0.0 110.117 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.99 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.33 -173.53 2.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 109.875 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.789 ' H ' HD12 ' A' ' 8' ' ' LEU . . . -155.18 170.95 20.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.95 -1.094 . . . . 0.0 110.781 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.99 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 88.2 m-85 -139.31 126.66 21.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.55 -44.05 8.82 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 110.799 -179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -150.39 127.07 10.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 110.367 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.583 HG23 HG12 ' A' ' 18' ' ' ILE . 11.6 p -113.53 155.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.645 ' O ' HG22 ' A' ' 90' ' ' THR . 2.3 t70 -163.19 136.58 5.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG23 ' HA3' ' A' ' 65' ' ' GLY . 4.1 p -41.1 -31.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.534 -0.729 . . . . 0.0 110.534 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' C ' ' OG ' ' A' ' 17' ' ' SER . 13.8 p-10 -130.27 33.5 4.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.237 -0.915 . . . . 0.0 110.269 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.42 124.06 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 109.759 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.95 HD11 HG23 ' A' ' 90' ' ' THR . 39.1 mt -146.75 116.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.892 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' CD ' ' HB ' ' A' ' 11' ' ' THR . 0.1 OUTLIER -100.61 102.41 13.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 18' ' ' ILE . 1.2 pp -102.83 156.0 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.184 -0.948 . . . . 0.0 111.638 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.868 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -138.39 132.21 31.1 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.564 ' CB ' HG11 ' A' ' 72' ' ' VAL . 31.8 p90 -109.55 163.41 13.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.05 -1.031 . . . . 0.0 110.943 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.49 149.75 28.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.575 -0.703 . . . . 0.0 110.086 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 p -81.93 155.54 70.25 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 110.382 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.66 -174.5 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.997 1.525 . . . . 0.0 109.696 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -124.79 -10.99 7.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.013 . . . . 0.0 110.235 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 36.63 3.32 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 46.77 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.26 -1.141 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 75' ' ' LEU . 4.3 p -59.83 163.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -102.18 -35.02 9.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.17 145.8 28.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.309 -0.869 . . . . 0.0 110.081 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' CZ ' ' NE1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -110.55 155.97 21.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.941 -1.099 . . . . 0.0 110.082 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 13.8 ttt180 -121.76 90.77 3.37 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.166 -0.959 . . . . 0.0 110.764 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 46' ' ' LEU . 60.1 t -88.93 97.63 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -109.54 154.4 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.077 -1.014 . . . . 0.0 110.976 -179.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.9 128.09 17.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.532 -0.73 . . . . 0.0 109.622 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.543 ' HB3' HD12 ' A' ' 43' ' ' ILE . 13.9 p -111.99 147.68 35.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.408 -0.807 . . . . 0.0 111.08 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.95 168.78 10.44 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.548 -0.72 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.84 36.79 0.58 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.876 1.461 . . . . 0.0 110.092 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.57 -83.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.114 -0.991 . . . . 0.0 110.26 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.59 -8.18 59.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.634 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 93.34 -123.5 7.41 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 37' ' ' SER . 14.5 tt -125.71 150.88 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.1 -1.235 . . . . 0.0 111.031 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.489 ' CB ' ' CE2' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -126.33 158.76 35.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.518 -0.738 . . . . 0.0 109.387 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 35' ' ' THR . 24.6 mt-10 -116.52 94.81 4.77 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 26.5 tp -89.49 113.36 24.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.03 -1.044 . . . . 0.0 108.721 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 8.3 p90 -123.85 74.68 56.29 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.048 -1.032 . . . . 0.0 111.842 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -83.23 76.58 3.88 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 123.864 1.455 . . . . 0.0 109.328 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -34.94 108.64 0.35 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.843 -0.535 . . . . 0.0 110.799 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 49' ' ' ALA . 45.9 Cg_endo -72.01 -164.66 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.153 1.607 . . . . 0.0 110.623 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 -40.44 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 110.331 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.42 -55.96 0.11 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -86.24 -11.72 51.59 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -1.15 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -96.99 84.92 3.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.72 29.5 7.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.112 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.868 HG22 ' CB ' ' A' ' 21' ' ' ALA . 72.6 p -133.2 174.49 10.32 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.506 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . . . -131.04 146.45 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.269 -0.894 . . . . 0.0 110.452 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 27.0 mt-10 -112.28 85.77 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.077 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 59' ' ' LEU . 10.5 mt -83.81 77.95 9.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 58' ' ' GLU . 24.4 mt-30 -105.87 119.0 38.04 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.47 34.31 0.72 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 31.2 mt -77.16 -164.0 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.141 -1.211 . . . . 0.0 110.24 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -129.43 -56.91 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 111.237 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 63' ' ' ARG . 50.2 Cg_endo -87.92 173.26 5.11 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.366 1.193 . . . . 0.0 110.762 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.681 ' HA3' HG23 ' A' ' 15' ' ' VAL . . . -133.67 54.13 0.78 Allowed Glycine 0 C--N 1.299 -1.51 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' TYR . 3.6 t -131.34 -164.29 1.42 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.392 -1.064 . . . . 0.0 110.672 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 89' ' ' SER . 14.3 tt0 -57.27 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.501 -0.749 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' SER . 1.1 t80 -82.31 137.43 34.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.574 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 3.9 m -97.81 123.66 41.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.947 -1.096 . . . . 0.0 110.6 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 3.5 t -126.21 138.98 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.339 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.417 ' HB2' ' OG1' ' A' ' 35' ' ' THR . 24.8 m -117.56 116.84 27.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.82 . . . . 0.0 110.785 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG11 ' CB ' ' A' ' 22' ' ' TRP . 25.5 t -102.54 122.21 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 83' ' ' PRO . 10.8 t -139.04 144.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.885 -1.134 . . . . 0.0 111.077 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -94.41 165.53 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.445 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.642 HD12 ' HB3' ' A' ' 31' ' ' ARG . 60.0 mt -130.09 -175.03 3.49 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.039 -1.038 . . . . 0.0 110.9 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -176.46 85.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 1.1 t0 71.56 -55.72 0.65 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.252 -0.905 . . . . 0.0 109.924 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 51.2 p-10 -177.64 66.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.976 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.0 mtm -142.24 156.34 45.3 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.092 -1.005 . . . . 0.0 110.842 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.37 84.36 2.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.051 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.708 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.01 -178.99 1.36 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.339 -0.85 . . . . 0.0 110.926 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.03 117.09 4.43 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.359 -0.838 . . . . 0.0 109.845 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.751 ' HA ' HG22 ' A' ' 73' ' ' VAL . 43.9 Cg_endo -71.73 123.38 9.35 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.921 1.485 . . . . 0.0 110.396 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 8' ' ' LEU . 18.9 tp -78.68 121.32 24.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.64 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 85' ' ' ILE . 22.7 mm -92.37 148.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.635 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.07 85.45 0.19 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 HG22 ' CG ' ' A' ' 67' ' ' GLU . 4.2 m -97.9 111.03 23.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -1.137 . . . . 0.0 110.329 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.28 135.25 40.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.001 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 6.5 p -71.8 118.64 14.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.95 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -54.24 161.8 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.87 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . . . -89.34 92.52 9.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.039 -1.038 . . . . 0.0 110.732 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.05 ' O ' HD12 ' A' ' 92' ' ' ILE . 2.2 pp -40.16 155.26 0.18 Allowed Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 121.827 -0.546 . . . . 0.0 110.619 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -80.87 104.78 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.81 1.426 . . . . 0.0 110.636 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.111 -0.993 . . . . 0.0 110.055 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 t30 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.238 0.542 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -80.64 165.83 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.989 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -105.34 -4.78 21.13 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 110.867 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' ASP . 4.3 mtm180 56.99 115.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 52.3 Cg_endo -74.66 170.04 21.22 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.709 1.373 . . . . 0.0 111.249 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 5.6 ptmt 176.93 119.52 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.228 0.537 . . . . 0.0 109.601 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.49 55.14 0.85 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.022 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -69.38 148.6 49.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.317 -1.107 . . . . 0.0 110.374 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.768 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -125.93 -175.2 3.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.339 -0.851 . . . . 0.0 109.966 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.517 ' CE1' ' CG ' ' A' ' 88' ' ' GLN . 60.4 m-85 -140.71 130.7 24.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.065 -1.022 . . . . 0.0 110.449 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 52.5 m -86.13 -63.66 1.28 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.234 -0.916 . . . . 0.0 110.158 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.0 129.52 9.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 110.254 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.988 HG23 HD12 ' A' ' 18' ' ' ILE . 7.2 p -102.95 134.75 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.279 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' THR . 35.8 t0 -126.93 146.66 50.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.904 . . . . 0.0 110.362 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -45.09 -33.26 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.286 -0.884 . . . . 0.0 110.333 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 17' ' ' SER . 28.4 p-10 -128.05 43.34 3.15 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.137 -0.977 . . . . 0.0 110.134 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.983 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.4 OUTLIER 173.83 132.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.988 HD12 HG23 ' A' ' 13' ' ' VAL . 13.9 mm -132.65 129.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 1.9 mtpm? -105.4 101.45 10.98 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 109.439 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.588 HG12 ' HB3' ' A' ' 57' ' ' ALA . 41.4 pt -107.17 151.95 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.216 -0.928 . . . . 0.0 110.687 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -127.37 128.64 46.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 0.0 110.552 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.791 ' CZ3' ' HB2' ' A' ' 57' ' ' ALA . 9.4 p90 -122.4 147.13 46.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.257 -0.902 . . . . 0.0 110.254 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.8 tt0 -98.49 66.58 1.72 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.069 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.582 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.1 m -94.3 -43.13 0.3 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 111.931 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 24' ' ' SER . 50.6 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.437 1.23 . . . . 0.0 111.188 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 60.6 mt-30 -150.95 -39.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.467 -0.771 . . . . 0.0 109.681 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.71 -61.25 0.24 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.19 92.6 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.312 -1.111 . . . . 0.0 110.189 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -86.41 -168.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.648 ' N ' HG13 ' A' ' 29' ' ' VAL . 45.2 t -124.89 -66.05 0.99 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.68 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.711 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -131.68 170.16 15.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.259 -0.901 . . . . 0.0 110.179 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 29' ' ' VAL . 8.9 m-85 -128.2 122.76 32.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 110.143 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -95.39 110.08 22.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 61.4 t -103.01 95.26 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.844 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.21 140.48 40.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.153 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.859 ' HB3' HG13 ' A' ' 70' ' ' VAL . 7.2 p90 -148.3 154.97 40.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.394 -0.816 . . . . 0.0 109.492 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.541 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 20.9 p -149.84 -175.46 5.05 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.378 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 160.36 31.24 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.636 -0.665 . . . . 0.0 110.089 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 48.2 Cg_endo -76.29 51.61 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.924 1.486 . . . . 0.0 110.314 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.6 OUTLIER 168.88 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.348 -0.845 . . . . 0.0 109.88 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.06 -42.21 73.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.243 -0.91 . . . . 0.0 109.815 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 114.0 -173.07 14.7 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 37' ' ' SER . 7.9 tt -104.25 159.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -1.143 . . . . 0.0 111.009 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.57 150.04 51.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.538 -0.726 . . . . 0.0 109.4 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 0.6 OUTLIER -106.69 68.45 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.108 -0.995 . . . . 0.0 110.796 -179.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.599 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 1.1 tp -75.94 152.38 37.08 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 108.926 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -169.43 47.66 0.11 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.687 -1.258 . . . . 0.0 112.638 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.599 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.7 Cg_endo -70.64 80.49 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.256 1.135 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -38.89 114.21 0.83 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.578 -0.701 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.85 155.97 66.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.995 1.524 . . . . 0.0 110.101 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.629 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.56 -18.88 4.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.02 5.89 44.66 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.275 -1.133 . . . . 0.0 109.949 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -120.77 77.36 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.704 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.12 -6.13 31.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.095 -1.003 . . . . 0.0 109.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 ' CB ' ' A' ' 21' ' ' ALA . 14.2 p -119.38 -157.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -149.71 140.51 22.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.028 -1.045 . . . . 0.0 110.84 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' CD ' ' A' ' 60' ' ' GLN . 7.4 tt0 -104.77 79.24 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.297 0.57 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 59' ' ' LEU . 30.7 mt -79.99 88.39 5.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 31.0 mt-30 -109.66 141.13 42.66 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.505 -0.747 . . . . 0.0 110.833 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 109.74 43.68 1.11 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 61' ' ' GLY . 2.2 mt -115.57 -179.97 3.8 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CD ' ' CB ' ' A' ' 66' ' ' SER . 1.9 ptp180 -82.17 146.23 54.38 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.827 ' HA ' HG23 ' A' ' 15' ' ' VAL . 48.1 Cg_endo -74.62 117.06 4.81 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 O-C-N 124.025 1.539 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.67 77.75 1.16 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 63' ' ' ARG . 5.8 p -167.92 127.57 1.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -1.133 . . . . 0.0 110.497 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' CG ' HG22 ' A' ' 87' ' ' THR . 25.6 tt0 -69.15 92.84 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.995 . . . . 0.0 109.532 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.21 115.08 9.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.655 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -89.34 99.11 12.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 0.0 109.588 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 36' ' ' TYR . 14.8 t -106.52 146.57 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 111.127 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 t -119.34 130.23 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.643 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.619 HG11 ' CB ' ' A' ' 22' ' ' TRP . 40.6 t -105.09 122.89 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.297 -0.877 . . . . 0.0 110.494 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HA ' ' A' ' 83' ' ' PRO . 29.9 t -134.51 142.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.684 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.55 173.59 7.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.245 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.6 mt -138.99 -173.38 3.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.851 -1.156 . . . . 0.0 111.948 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 30' ' ' SER . 24.2 t60 -176.82 -156.71 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 76' ' ' HIS . 4.7 t0 -45.39 -42.63 10.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.923 -1.11 . . . . 0.0 109.699 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 13.0 t70 -174.03 50.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.466 -0.771 . . . . 0.0 109.602 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 28.0 mtp -120.23 163.83 17.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 111.091 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 81' ' ' SER . 2.5 mt-10 -137.21 70.14 1.4 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 80' ' ' GLU . 1.1 p -33.7 152.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.791 -0.568 . . . . 0.0 111.142 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -41.88 120.37 2.22 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.44 -0.787 . . . . 0.0 109.773 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HA ' HG22 ' A' ' 73' ' ' VAL . 41.0 Cg_endo -67.92 102.14 0.74 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.922 1.485 . . . . 0.0 110.643 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 8' ' ' LEU . 42.5 tp -70.81 159.72 34.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 0.0 110.016 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.454 ' N ' ' HG ' ' A' ' 84' ' ' LEU . 7.7 mm -114.66 146.64 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.92 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 79.0 0.28 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.589 HG22 ' CG ' ' A' ' 67' ' ' GLU . 2.6 m -83.9 108.63 17.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 110.069 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' CG ' ' CE1' ' A' ' 10' ' ' PHE . 2.8 mm100 -117.2 144.58 44.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.311 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -91.8 104.03 16.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.861 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.892 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -58.9 146.9 35.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.968 . . . . 0.0 110.296 -179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' C ' ' HB ' ' A' ' 15' ' ' VAL . . . -75.97 -155.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.372 -0.83 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -132.97 172.76 6.82 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.44 -0.787 . . . . 0.0 110.146 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 64' ' ' PRO . 46.9 Cg_endo -83.12 65.89 7.84 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.002 1.528 . . . . 0.0 110.397 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.283 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 2' ' ' ILE . 18.2 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' OG ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -48.9 177.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.16 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ARG . 15.4 t0 -137.83 -71.19 0.43 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.199 -0.938 . . . . 0.0 110.206 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 5.9 mtm180 168.65 116.17 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.264 -0.898 . . . . 0.0 110.277 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 48.1 Cg_endo -73.69 173.27 14.19 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.834 1.439 . . . . 0.0 110.005 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 164.83 142.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.423 -0.798 . . . . 0.0 110.245 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.37 44.85 2.09 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.745 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -74.73 123.29 24.68 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.962 -1.316 . . . . 0.0 109.17 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -106.15 166.02 10.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.177 -0.952 . . . . 0.0 110.548 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.67 101.53 7.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.267 -0.896 . . . . 0.0 110.285 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -65.01 0.91 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.921 . . . . 0.0 110.33 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -122.8 120.59 34.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -0.88 . . . . 0.0 109.966 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -113.42 77.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.337 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 90' ' ' THR . 0.6 OUTLIER -84.31 154.49 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.813 ' N ' ' HB3' ' A' ' 91' ' ' ALA . 1.5 p -49.93 -30.62 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.61 40.92 3.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.865 . . . . 0.0 109.976 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 47.2 t -175.52 100.73 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.331 -0.856 . . . . 0.0 109.914 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 90' ' ' THR . 32.4 mt -117.7 123.35 71.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.409 -0.807 . . . . 0.0 110.855 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.93 113.47 26.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -0.78 . . . . 0.0 109.178 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 HG22 ' A' ' 18' ' ' ILE . 34.4 pt -115.85 152.58 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.084 -1.01 . . . . 0.0 111.151 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.813 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.0 102.68 6.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.616 -0.678 . . . . 0.0 109.559 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.687 ' CH2' ' HB2' ' A' ' 57' ' ' ALA . 3.1 p90 -88.57 152.15 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -76.92 137.89 39.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.873 . . . . 0.0 110.303 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.6 156.81 58.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 29' ' ' VAL . 43.3 Cg_endo -72.76 -163.88 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.114 1.586 . . . . 0.0 110.533 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -104.9 -52.33 2.88 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.398 -0.814 . . . . 0.0 110.838 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -50.61 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 3.0 tp-100 174.23 103.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 109.567 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG23 ' HG3' ' A' ' 25' ' ' PRO . 14.2 t -69.87 127.02 31.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.43 -0.794 . . . . 0.0 110.681 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.0 t -90.88 -14.17 32.24 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.354 -0.841 . . . . 0.0 109.328 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -148.64 149.66 31.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.738 . . . . 0.0 109.606 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -131.02 107.84 9.36 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.106 -0.996 . . . . 0.0 110.308 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.519 ' HB2' HD11 ' A' ' 75' ' ' LEU . 6.0 mtt85 -90.58 95.6 10.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.304 -0.872 . . . . 0.0 110.384 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -87.04 94.49 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -92.37 138.44 31.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.0 111.076 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -132.68 126.03 31.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.204 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CA ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -110.91 153.18 25.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.917 . . . . 0.0 111.521 -178.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.34 127.76 16.94 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.652 -0.655 . . . . 0.0 109.246 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 43.7 Cg_endo -71.07 61.96 2.5 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.811 1.427 . . . . 0.0 110.516 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 2.6 mt-10 -173.45 -62.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.347 -0.845 . . . . 0.0 110.148 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.41 -35.48 15.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.96 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.59 -153.79 21.8 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG13 ' CA ' ' A' ' 37' ' ' SER . 12.0 tt -128.01 162.6 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -147.79 -169.76 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.2 155.41 24.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.965 -1.084 . . . . 0.0 111.397 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 5.8 tp -106.46 123.78 48.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 20.1 p90 -114.96 39.22 0.23 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.037 -1.039 . . . . 0.0 111.62 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 54.4 Cg_endo -77.26 74.29 5.14 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 O-C-N 123.396 1.209 . . . . 0.0 110.111 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -39.46 99.08 0.19 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.508 -0.745 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 48' ' ' PRO . 45.3 Cg_endo -71.12 -168.57 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.007 1.53 . . . . 0.0 110.563 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' ASP . 21.0 t70 -111.76 28.89 8.33 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.89 15.14 68.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -122.14 11.09 10.13 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.263 -1.139 . . . . 0.0 110.201 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -113.64 123.94 51.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.28 -0.888 . . . . 0.0 110.25 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -115.98 -7.27 11.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.11 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.813 HG22 ' CB ' ' A' ' 21' ' ' ALA . 71.2 p -125.3 -177.81 4.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.29 -0.881 . . . . 0.0 110.313 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -160.2 146.22 15.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.786 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -101.79 89.53 3.7 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.413 -0.804 . . . . 0.0 110.285 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.9 mt -78.99 69.94 5.24 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.675 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.1 mt-30 -89.2 117.81 28.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.624 -0.673 . . . . 0.0 110.787 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.633 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 114.53 73.59 0.58 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.724 HD22 ' OH ' ' A' ' 68' ' ' TYR . 8.7 mt -126.33 -157.16 0.78 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -1.216 . . . . 0.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -84.19 143.84 43.0 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.277 -0.889 . . . . 0.0 110.342 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 51.6 Cg_endo -82.43 110.92 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.977 1.514 . . . . 0.0 111.072 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 64.48 2.87 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 90' ' ' THR . 26.4 p -154.5 147.03 24.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -1.188 . . . . 0.0 110.422 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 96.29 0.24 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.724 ' OH ' HD22 ' A' ' 62' ' ' LEU . 15.8 t80 -69.61 110.62 4.93 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.511 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -95.56 108.09 20.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.805 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 21.1 t -107.35 150.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.787 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 11.4 t -135.14 88.86 2.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 97.2 t -70.92 125.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.254 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.999 HG22 ' HB3' ' A' ' 83' ' ' PRO . 48.8 t -127.99 116.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 29' ' ' VAL . . . -82.55 152.06 26.15 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 31' ' ' ARG . 29.1 mt -128.07 157.2 41.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.102 -0.998 . . . . 0.0 110.987 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.3 t-160 -134.88 85.54 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 5.7 t0 76.34 -50.06 0.59 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.509 -0.744 . . . . 0.0 109.677 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.02 57.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.94 . . . . 0.0 110.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 17.0 mmm -129.18 -165.29 1.5 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.047 -1.033 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' MET . 4.6 mt-10 -159.72 94.87 1.17 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' HG21 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -90.45 173.15 8.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -45.88 114.41 2.44 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 110.065 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.999 ' HB3' HG22 ' A' ' 73' ' ' VAL . 47.7 Cg_endo -73.19 145.82 39.69 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.972 1.512 . . . . 0.0 110.328 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.745 HD21 ' CB ' ' A' ' 8' ' ' LEU . 6.3 tp -92.64 146.51 23.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.305 -0.872 . . . . 0.0 109.941 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.4 mm -110.88 152.22 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -0.901 . . . . 0.0 110.776 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.18 84.96 0.16 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 2.5 m -100.2 136.29 40.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.308 -1.113 . . . . 0.0 110.416 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.69 HE21 HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.44 142.91 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 p -70.49 105.84 3.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 1.008 HG23 HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -54.29 147.19 13.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -47.48 173.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.546 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 1.4 pp -145.35 57.37 4.21 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.237 -0.914 . . . . 0.0 110.74 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.587 ' HD2' HG11 ' A' ' 15' ' ' VAL . 50.1 Cg_endo -85.11 42.14 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.79 1.416 . . . . 0.0 110.356 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.371 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.282 0.563 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.014 HG21 ' HB3' ' A' ' 81' ' ' SER . 2.0 tt -55.69 -177.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.98 . . . . 0.0 109.885 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' ARG . 35.3 t70 -131.89 6.53 4.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.104 -0.997 . . . . 0.0 110.37 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 58.97 126.3 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.413 -0.804 . . . . 0.0 110.327 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 43.2 Cg_endo -69.53 174.29 9.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.878 1.462 . . . . 0.0 110.319 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 5' ' ' PRO . 4.1 mmtp -157.81 160.96 38.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.03 67.16 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.194 -1.163 . . . . 0.0 110.194 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -78.5 138.98 38.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.111 -1.229 . . . . 0.0 109.139 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -119.05 162.96 17.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.118 -0.989 . . . . 0.0 110.777 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.495 ' HD1' HG22 ' A' ' 20' ' ' ILE . 94.9 m-85 -121.62 161.18 22.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 13.0 m -116.09 -37.49 3.82 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 109.805 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 10.4 t70 -168.51 135.97 2.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.66 161.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 110.595 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 90' ' ' THR . 14.6 t0 -169.51 141.05 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.375 -0.828 . . . . 0.0 109.938 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 64' ' ' PRO . 8.6 p -42.85 -37.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' N ' HG13 ' A' ' 15' ' ' VAL . 20.4 p-10 -127.84 43.05 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.786 . . . . 0.0 110.181 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 0.4 OUTLIER 179.42 125.22 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.294 -0.879 . . . . 0.0 109.892 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 90' ' ' THR . 71.9 mt -143.85 105.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.5 mppp? -83.27 126.93 33.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.495 HG22 ' HD1' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -137.63 153.24 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.798 -1.189 . . . . 0.0 111.396 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.717 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -140.54 120.28 13.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.633 -0.667 . . . . 0.0 109.254 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 46.5 p90 -104.6 168.17 9.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 2.3 mt-10 -78.09 123.82 27.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.402 -0.811 . . . . 0.0 110.405 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.53 153.35 70.45 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.978 ' HG3' HG23 ' A' ' 29' ' ' VAL . 47.3 Cg_endo -72.12 176.97 7.73 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.964 1.507 . . . . 0.0 110.52 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -79.31 -54.65 5.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . . . -58.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 175.24 105.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -1.076 . . . . 0.0 110.303 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.978 HG23 ' HG3' ' A' ' 25' ' ' PRO . 4.9 t -57.51 134.19 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.851 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 75' ' ' LEU . 31.2 t -85.42 -26.43 26.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.846 . . . . 0.0 109.203 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.78 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -150.91 145.28 25.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.47 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' CE2' ' O ' ' A' ' 54' ' ' GLU . 17.4 m-85 -101.44 106.88 18.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.902 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.669 ' HB2' HD11 ' A' ' 75' ' ' LEU . 5.7 ttp180 -104.02 126.72 51.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 108.79 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HB ' ' CB ' ' A' ' 46' ' ' LEU . 12.0 t -125.28 123.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.968 -1.082 . . . . 0.0 111.059 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.565 ' CG2' ' HG2' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -113.75 137.88 51.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.371 -0.83 . . . . 0.0 109.673 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -134.26 139.31 45.66 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' A' ' 69' ' ' THR . 6.2 p -122.27 155.8 35.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 110.898 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -141.91 151.22 58.87 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.579 -0.7 . . . . 0.0 110.122 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 46.5 Cg_endo -75.77 54.22 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.893 1.47 . . . . 0.0 110.255 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 175.33 -67.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.335 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.98 -35.31 79.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.897 . . . . 0.0 110.443 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 116.18 -131.18 9.44 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 4.8 tt -141.68 157.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.204 . . . . 0.0 110.995 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.28 175.73 9.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.345 -0.847 . . . . 0.0 110.09 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 8.7 mt-10 -133.77 140.45 46.96 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.226 -0.921 . . . . 0.0 110.512 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 18.4 tp -97.38 111.16 23.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -93.15 -36.21 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.75 -0.594 . . . . 0.0 112.278 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 46.4 Cg_endo -74.51 109.02 2.82 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 O-C-N 123.113 1.06 . . . . 0.0 111.508 -178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -94.31 126.21 49.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.612 -0.68 . . . . 0.0 109.572 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 54' ' ' GLU . 45.0 Cg_endo -73.09 128.74 13.34 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.847 1.446 . . . . 0.0 111.091 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 5.0 t70 48.46 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.51 -0.744 . . . . 0.0 110.369 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.16 -7.11 50.48 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -128.64 8.73 5.87 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.243 -1.151 . . . . 0.0 110.423 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.3 tp10 -69.13 116.16 9.25 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.168 -0.957 . . . . 0.0 110.05 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 13.2 p-10 -99.07 15.41 25.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.278 -0.889 . . . . 0.0 110.709 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.717 HG22 ' CB ' ' A' ' 21' ' ' ALA . 81.8 p -126.47 -169.69 2.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.152 -0.967 . . . . 0.0 110.246 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.66 154.34 3.01 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.318 -0.864 . . . . 0.0 110.569 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' NE2' ' A' ' 60' ' ' GLN . 3.7 mt-10 -109.58 95.7 5.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 59' ' ' LEU . 14.8 mt -80.54 85.13 6.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.984 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 17.5 mt-30 -117.37 127.91 54.51 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.457 -0.777 . . . . 0.0 110.893 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 124.99 39.59 0.45 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 14.0 mt -112.87 157.22 21.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -1.218 . . . . 0.0 110.936 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.664 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -111.85 -13.61 0.11 Allowed Pre-proline 0 CA--C 1.578 2.02 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.774 ' O ' HG23 ' A' ' 15' ' ' VAL . 52.0 Cg_endo -75.27 175.7 10.91 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 122.287 0.625 . . . . 0.0 111.581 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 91' ' ' ALA . . . -151.21 36.95 0.87 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -145.31 -169.93 3.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.269 -1.136 . . . . 0.0 110.045 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -41.47 122.86 2.02 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.175 -0.953 . . . . 0.0 110.174 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.653 ' CD2' ' CG2' ' A' ' 70' ' ' VAL . 9.1 t80 -109.82 128.36 55.27 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.556 -0.715 . . . . 0.0 109.766 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.439 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.6 m -94.05 98.39 10.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.007 -1.058 . . . . 0.0 110.416 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' CG2' ' CD2' ' A' ' 68' ' ' TYR . 24.8 t -113.61 119.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 110.32 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.557 ' CB ' ' HB2' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -101.52 111.33 23.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.823 . . . . 0.0 110.385 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 83' ' ' PRO . 6.8 t -82.6 128.8 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.916 HG22 ' HB3' ' A' ' 83' ' ' PRO . 3.9 t -122.67 132.67 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.0 111.055 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.87 ' HB1' ' CG2' ' A' ' 29' ' ' VAL . . . -101.27 135.85 42.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.612 -0.68 . . . . 0.0 109.659 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 31' ' ' ARG . 87.1 mt -105.27 133.37 50.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.065 -1.022 . . . . 0.0 110.915 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.507 ' HB2' HD12 ' A' ' 2' ' ' ILE . 49.2 t-80 -119.51 88.57 2.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.746 . . . . 0.0 109.31 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 69.62 -55.72 0.58 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.898 . . . . 0.0 109.876 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t70 -167.53 37.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -111.76 155.54 23.36 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.104 -0.998 . . . . 0.0 111.337 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.64 63.36 0.91 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.014 ' HB3' HG21 ' A' ' 2' ' ' ILE . 87.7 p -55.32 148.0 15.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.434 -0.791 . . . . 0.0 111.543 -178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.72 140.73 3.18 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.434 -0.791 . . . . 0.0 109.884 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.916 ' HB3' HG22 ' A' ' 73' ' ' VAL . 50.7 Cg_endo -76.32 134.52 15.75 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 O-C-N 124.184 1.623 . . . . 0.0 111.06 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.739 HD21 ' HB2' ' A' ' 8' ' ' LEU . 22.0 tp -76.13 90.33 3.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 84' ' ' LEU . 1.8 mm -41.53 151.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.331 -0.856 . . . . 0.0 111.017 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.61 88.16 0.14 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 67' ' ' GLU . 20.7 m -86.15 108.88 18.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.434 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -123.76 127.8 48.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.147 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.0 p -69.72 97.52 1.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.986 . . . . 0.0 110.08 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.823 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.89 139.59 57.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.171 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -72.5 -160.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 111.053 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -119.61 176.53 1.72 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 109.433 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 92' ' ' ILE . 45.2 Cg_endo -74.72 86.03 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.649 1.341 . . . . 0.0 110.374 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.343 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.237 0.541 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 76' ' ' HIS . 7.8 tt -111.01 170.41 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 26' ' ' GLN . 76.6 m-20 -70.62 -29.88 66.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 64.16 102.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 110.232 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 42.7 Cg_endo -70.82 -173.4 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.887 1.467 . . . . 0.0 109.935 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 3.6 tptm 179.47 -24.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.651 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.2 106.64 1.64 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.803 ' CB ' HD21 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -1.147 . . . . 0.0 109.254 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.652 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -124.59 178.15 5.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.688 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -136.29 115.64 12.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.349 -0.845 . . . . 0.0 110.339 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 1.3 m -77.21 -70.02 0.49 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.323 -0.861 . . . . 0.0 110.616 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 8.0 t0 -139.32 117.33 11.74 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.048 -1.033 . . . . 0.0 110.341 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 18' ' ' ILE . 5.8 p -92.05 134.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.701 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -140.02 133.22 29.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.155 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG23 ' HA ' ' A' ' 64' ' ' PRO . 1.8 p -41.48 -29.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 110.159 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' OD2' HG13 ' A' ' 15' ' ' VAL . 1.7 p30 -129.92 36.17 4.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 109.958 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 178.05 101.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.932 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.741 ' CD1' HG23 ' A' ' 13' ' ' VAL . 22.3 mm -110.85 114.43 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.871 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -95.2 111.22 23.09 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 108.986 179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -115.69 149.39 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 111.114 -178.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.954 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -128.52 118.98 23.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.593 -0.692 . . . . 0.0 109.568 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CE2' ' O ' ' A' ' 55' ' ' ASP . 40.2 p90 -100.36 151.83 21.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.191 -0.943 . . . . 0.0 110.7 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 5' ' ' PRO . 1.1 tm-20 -41.3 115.78 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.362 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.02 156.98 6.3 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.197 -0.939 . . . . 0.0 110.123 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.83 -171.88 0.85 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.977 1.514 . . . . 0.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 12.6 mm-40 -128.07 -50.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.374 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.4 -98.43 1.86 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -151.38 106.81 3.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -1.154 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.28 159.51 3.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.23 -0.919 . . . . 0.0 110.559 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 t -83.09 -45.05 14.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.028 ' HB3' HD12 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -165.35 162.09 19.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.257 -0.902 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -117.25 105.47 12.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 12.3 ttt-85 -75.85 104.22 6.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.44 118.54 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.298 -0.877 . . . . 0.0 109.746 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -131.0 146.49 52.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.614 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -133.24 142.37 48.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.438 -0.789 . . . . 0.0 108.993 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -128.2 157.8 39.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.914 -1.116 . . . . 0.0 112.392 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.59 124.7 25.63 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 43.8 Cg_endo -72.42 58.02 2.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.845 1.445 . . . . 0.0 110.988 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' CG ' ' N ' ' A' ' 41' ' ' ASP . 9.6 pt-20 -178.17 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.972 . . . . 0.0 110.314 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -99.55 -35.01 10.01 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.519 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -143.82 13.79 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 20.8 tt -137.26 161.17 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.987 -1.302 . . . . 0.0 111.994 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 35' ' ' THR . 2.2 m-70 -128.83 178.51 6.31 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 2.5 pm0 -149.28 168.87 22.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.858 -1.151 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 48' ' ' PRO . 11.3 tp -158.55 157.18 31.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.723 . . . . 0.0 109.58 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD3' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -138.75 55.15 7.51 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.013 . . . . 0.0 110.627 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 46' ' ' LEU . 50.2 Cg_endo -83.51 72.04 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.704 1.371 . . . . 0.0 110.272 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -41.36 143.04 0.87 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.57 -0.706 . . . . 0.0 110.297 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.86 -171.73 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.944 1.497 . . . . 0.0 110.736 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -122.18 -50.44 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.388 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.77 -18.4 0.49 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -123.82 16.59 9.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -1.207 . . . . 0.0 110.451 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 31.5 mt-10 -154.86 98.94 2.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.25 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.594 ' O ' ' CE2' ' A' ' 22' ' ' TRP . 4.9 m-20 -93.06 32.72 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -0.845 . . . . 0.0 110.126 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.954 HG22 ' CB ' ' A' ' 21' ' ' ALA . 75.9 p -116.81 177.63 4.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.214 -0.929 . . . . 0.0 110.219 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 20' ' ' ILE . . . -132.49 146.84 52.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.098 -1.001 . . . . 0.0 111.075 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -103.95 79.32 1.62 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.569 -0.707 . . . . 0.0 109.89 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.1 mt -82.03 91.25 6.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 15.5 mt-30 -108.09 126.36 52.66 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.556 -0.715 . . . . 0.0 110.708 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 111.64 55.89 0.48 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.698 HD12 ' CG1' ' A' ' 18' ' ' ILE . 11.6 mt -112.76 -170.84 1.75 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.242 -1.152 . . . . 0.0 111.04 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -85.79 144.05 38.94 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.463 -0.773 . . . . 0.0 110.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.4 Cg_endo -79.92 107.08 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.001 1.527 . . . . 0.0 110.556 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.55 73.19 1.12 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -157.83 124.5 4.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -1.119 . . . . 0.0 110.527 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 33.0 tt0 -57.01 89.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.315 -0.866 . . . . 0.0 109.731 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' SER . 0.4 OUTLIER -72.03 110.52 6.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.583 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 97.99 11.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.939 . . . . 0.0 109.185 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 11.5 t -96.76 147.96 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.071 -1.018 . . . . 0.0 111.421 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 m -128.16 119.11 24.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.33 132.17 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.209 -0.932 . . . . 0.0 110.373 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 80' ' ' GLU . 45.3 t -140.78 116.67 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.219 -0.926 . . . . 0.0 110.634 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -81.01 178.99 8.07 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.131 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.028 HD12 ' HB3' ' A' ' 31' ' ' ARG . 95.5 mt -136.48 154.22 50.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.949 -1.094 . . . . 0.0 110.864 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.687 ' HB2' HD12 ' A' ' 2' ' ' ILE . 52.3 t60 -155.66 90.21 1.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.48 -0.762 . . . . 0.0 109.823 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' OD2' ' CD2' ' A' ' 76' ' ' HIS . 2.8 m-20 68.34 -62.84 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.378 -0.826 . . . . 0.0 109.946 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' HIS . 48.7 m-20 -158.75 36.43 0.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.0 109.922 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -110.3 152.84 25.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.213 -0.929 . . . . 0.0 110.551 -179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.919 ' O ' HG13 ' A' ' 73' ' ' VAL . 4.0 mm-40 -102.19 21.95 14.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.157 -0.964 . . . . 0.0 109.9 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.586 ' O ' ' O ' ' A' ' 80' ' ' GLU . 43.9 t 33.64 114.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.55 ' C ' ' O ' ' A' ' 81' ' ' SER . 1.8 mp0 -28.15 112.0 0.25 Allowed Pre-proline 0 N--CA 1.514 2.761 0 O-C-N 121.588 -0.695 . . . . 0.0 109.891 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 44.8 Cg_endo -68.5 113.48 3.15 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.999 1.526 . . . . 0.0 111.949 -177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD21 ' CB ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -96.22 133.68 40.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 86' ' ' GLY . 12.2 mm -91.33 161.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 111.34 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 8' ' ' LEU . . . -156.26 84.44 0.14 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.54 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 24.7 m -88.02 127.32 35.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.221 -1.164 . . . . 0.0 110.469 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.599 ' NE2' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -141.44 131.45 24.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 m -69.75 112.02 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.241 -0.912 . . . . 0.0 110.468 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.62 119.19 8.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -55.67 -163.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 110.013 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.692 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -134.83 165.44 36.69 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.382 -0.824 . . . . 0.0 109.919 179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 15' ' ' VAL . 49.0 Cg_endo -81.51 91.14 1.11 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.034 1.544 . . . . 0.0 110.458 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.141 179.864 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.159 0.504 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 76' ' ' HIS . 6.3 tt -46.17 172.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -90.59 -25.43 20.18 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.211 -0.931 . . . . 0.0 110.016 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 52.54 130.69 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 CA-C-O 121.671 0.748 . . . . 0.0 111.261 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 6' ' ' LYS . 51.3 Cg_endo -87.42 -177.18 2.0 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.403 1.212 . . . . 0.0 110.336 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' PRO . 11.9 mttt -175.78 131.15 0.26 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.111 -0.993 . . . . 0.0 110.446 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.74 79.79 1.47 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -87.27 152.04 22.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -1.188 . . . . 0.0 110.095 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.04 177.96 5.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.13 -0.981 . . . . 0.0 110.363 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 8' ' ' LEU . 74.4 m-85 -127.11 131.85 50.72 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.209 -0.932 . . . . 0.0 110.295 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 19' ' ' LYS . 3.4 m -95.78 -34.93 11.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 110.137 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.36 98.74 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.834 HG23 HD12 ' A' ' 18' ' ' ILE . 9.4 p -80.46 114.55 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.193 -0.942 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' H ' HD13 ' A' ' 18' ' ' ILE . 5.4 m-20 -122.93 151.21 42.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.658 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.826 HG23 ' HA ' ' A' ' 64' ' ' PRO . 2.9 p -41.86 -36.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.534 -0.729 . . . . 0.0 109.98 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 17' ' ' SER . 10.7 m-20 -137.66 53.45 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.85 . . . . 0.0 109.884 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 60' ' ' GLN . 1.3 t 174.24 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -0.835 . . . . 0.0 110.247 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD11 HG23 ' A' ' 90' ' ' THR . 8.2 mm -95.24 101.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 110.102 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 34.4 mttt -88.2 110.73 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -118.67 153.72 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.748 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.802 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -129.99 118.62 21.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ3' ' C ' ' A' ' 56' ' ' THR . 48.8 p90 -100.85 146.85 26.79 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.106 -0.996 . . . . 0.0 110.426 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -43.06 125.23 3.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.349 -0.844 . . . . 0.0 110.255 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -53.72 167.0 0.53 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.316 -0.865 . . . . 0.0 110.273 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.52 118.81 5.64 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.084 1.57 . . . . 0.0 110.341 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 28.1 mm-40 -61.78 -63.25 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 110.295 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.59 -102.74 0.12 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.48 107.68 3.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.257 -1.143 . . . . 0.0 110.323 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.02 157.8 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.55 -23.93 9.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 5.3 mtt180 -153.03 148.19 26.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.383 -0.823 . . . . 0.0 110.343 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -120.62 120.95 37.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.572 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.834 ' HB2' HD21 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.94 109.36 11.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 111.034 -179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 30.2 t -112.03 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.748 HG22 ' HA ' ' A' ' 45' ' ' GLU . 1.1 p -113.25 153.68 28.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.101 -1.0 . . . . 0.0 111.004 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.629 ' CE2' ' HB3' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -126.0 144.52 50.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.316 179.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.53 ' CA ' HG13 ' A' ' 43' ' ' ILE . 24.1 p -122.11 146.33 47.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 111.543 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 140.26 36.41 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.535 ' O ' ' CG ' ' A' ' 40' ' ' GLU . 44.7 Cg_endo -72.1 61.3 3.21 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 O-C-N 123.911 1.48 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 39' ' ' PRO . 1.2 mt-10 171.51 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.176 -0.953 . . . . 0.0 110.814 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -71.6 -34.1 69.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.13 -0.982 . . . . 0.0 110.325 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.78 -126.21 5.6 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.53 HG13 ' CA ' ' A' ' 37' ' ' SER . 4.2 tt -142.8 152.86 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.071 -1.252 . . . . 0.0 111.067 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.629 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 9.4 t60 -117.41 -179.93 3.86 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HA ' HG22 ' A' ' 35' ' ' THR . 9.5 pt-20 -144.15 142.65 30.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.677 -1.264 . . . . 0.0 112.205 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.639 ' HG ' ' HD3' ' A' ' 48' ' ' PRO . 4.2 tp -132.49 132.71 42.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 6.9 p90 -152.7 56.82 1.86 Allowed Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.484 -1.385 . . . . 0.0 112.921 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.639 ' HD3' ' HG ' ' A' ' 46' ' ' LEU . 43.1 Cg_endo -68.87 84.12 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 N-CA-C 108.869 -1.243 . . . . 0.0 108.869 177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . -31.9 110.57 0.31 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.991 -0.443 . . . . 0.0 110.967 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.83 177.57 7.47 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.04 1.547 . . . . 0.0 110.715 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -120.33 -48.22 2.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.503 -0.748 . . . . 0.0 110.139 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.06 -25.97 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.11 12.27 33.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -1.169 . . . . 0.0 110.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -125.23 119.91 29.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.51 11.01 8.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 21' ' ' ALA . 46.3 p -133.54 177.63 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.111 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 22' ' ' TRP . . . -141.52 146.4 36.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 110.589 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.04 90.91 3.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.578 -0.702 . . . . 0.0 110.194 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.818 ' HB3' HD11 ' A' ' 62' ' ' LEU . 18.5 mt -81.16 76.74 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.18 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 26.5 mt-30 -99.48 128.16 45.58 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.514 -0.741 . . . . 0.0 110.662 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 106.39 41.62 1.73 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.818 HD11 ' HB3' ' A' ' 59' ' ' LEU . 10.0 mt -106.03 179.63 4.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.113 -1.228 . . . . 0.0 110.391 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 132.55 93.09 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 109.861 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.826 ' HA ' HG23 ' A' ' 15' ' ' VAL . 51.6 Cg_endo -80.16 117.79 3.56 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.926 1.487 . . . . 0.0 110.881 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 66' ' ' SER . . . 74.31 70.05 1.3 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 90' ' ' THR . 5.4 m -165.5 131.12 2.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -1.172 . . . . 0.0 110.405 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -72.21 96.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.1 -1.0 . . . . 0.0 109.331 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.16 131.3 35.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.387 -0.821 . . . . 0.0 110.647 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.465 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 1.4 m -93.15 83.5 4.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 9.3 t -78.34 147.18 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.0 110.962 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.97 115.36 21.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 109.904 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.6 t -98.19 124.3 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 83' ' ' PRO . 3.4 t -139.74 137.19 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.062 -1.024 . . . . 0.0 110.472 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -80.83 160.74 24.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 33' ' ' ARG . 14.3 mt -134.31 -166.1 1.75 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 0.0 111.043 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.597 ' HB2' HD12 ' A' ' 2' ' ' ILE . 77.0 t60 179.09 49.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.584 ' CB ' ' O ' ' A' ' 76' ' ' HIS . 3.4 t0 81.48 -32.37 0.1 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.904 -0.498 . . . . 0.0 110.389 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 1.5 m-20 -174.3 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.063 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -139.53 142.84 37.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.195 -0.941 . . . . 0.0 110.682 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 73.79 0.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.446 -0.784 . . . . 0.0 109.761 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.573 ' HB3' HG21 ' A' ' 2' ' ' ILE . 1.6 p -55.4 171.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.381 -0.824 . . . . 0.0 110.316 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' OE1' ' NH1' ' A' ' 4' ' ' ARG . 15.7 mp0 -51.62 124.11 25.08 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HA ' HG22 ' A' ' 73' ' ' VAL . 45.2 Cg_endo -73.46 142.04 32.5 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.982 1.517 . . . . 0.0 110.964 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 33.0 tp -117.27 99.27 6.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 109.9 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 85' ' ' ILE . 8.3 mm -59.24 148.18 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.278 -0.889 . . . . 0.0 110.566 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -140.67 80.54 0.26 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -86.39 144.16 27.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.267 -1.137 . . . . 0.0 110.604 -179.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 87' ' ' THR . 6.2 mm100 -161.35 142.65 11.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 109.96 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 102.16 13.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.046 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.844 HG23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.39 129.89 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 0.0 110.541 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 93' ' ' PRO . . . -63.19 -168.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.718 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.864 HD13 ' H ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -142.82 36.54 0.23 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 111.403 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 92' ' ' ILE . 48.9 Cg_endo -73.43 56.17 3.25 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 O-C-N 123.227 1.12 . . . . 0.0 110.39 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.291 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.504 0.669 . . . . 0.0 110.2 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 1' ' ' ASN . 13.7 tt -47.35 174.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.414 -0.804 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 4' ' ' ARG . 6.5 t70 -73.56 -28.53 61.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.21 -0.931 . . . . 0.0 110.728 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER 62.84 125.5 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 49.2 Cg_endo -78.36 -177.13 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.903 1.475 . . . . 0.0 110.52 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER 173.56 139.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.51 49.32 4.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.982 HD11 ' CE1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -66.53 149.02 51.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -1.19 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 179.88 3.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.181 -0.949 . . . . 0.0 110.509 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.982 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.1 m-85 -132.78 114.32 13.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 0.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -67.08 -44.85 79.02 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.291 -0.881 . . . . 0.0 110.302 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -165.48 142.73 5.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.243 -0.911 . . . . 0.0 110.113 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.45 146.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.399 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.639 ' O ' HG22 ' A' ' 90' ' ' THR . 4.2 t70 -154.19 144.85 22.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.752 HG21 ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -46.04 -32.44 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.23 -0.919 . . . . 0.0 110.456 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -133.92 34.08 3.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.177 -0.952 . . . . 0.0 110.079 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -171.26 114.87 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.424 -0.798 . . . . 0.0 109.909 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.889 HD11 HG23 ' A' ' 90' ' ' THR . 55.5 mt -134.75 123.29 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.624 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 38.0 mtpt -101.61 130.59 47.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.099 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.8 pt -125.13 153.64 32.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.109 -0.995 . . . . 0.0 111.021 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.961 ' CB ' HG22 ' A' ' 56' ' ' THR . . . -136.49 105.15 5.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.88 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CH2' ' O ' ' A' ' 56' ' ' THR . 45.1 p90 -90.53 149.11 22.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.6 119.76 14.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.279 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 159.38 24.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 29' ' ' VAL . 46.3 Cg_endo -74.53 -173.28 1.44 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.117 1.588 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -100.81 -55.99 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLN . . . -57.44 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 4.7 pt20 -174.91 110.96 0.13 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.393 -1.063 . . . . 0.0 110.072 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -82.91 154.74 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' ' NH2' ' A' ' 31' ' ' ARG . 30.7 t -104.23 -34.52 8.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -141.12 169.84 16.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.339 -0.851 . . . . 0.0 110.265 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -145.97 95.63 2.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.328 -0.857 . . . . 0.0 110.195 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 75' ' ' LEU . 19.8 ttp180 -70.74 117.89 12.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.117 -0.989 . . . . 0.0 109.769 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 43.4 t -102.7 134.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 110.143 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -136.96 144.67 43.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.476 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.891 ' OH ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -139.57 149.22 43.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 90.3 p -141.2 164.97 28.82 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.91 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.47 177.03 2.45 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.88 -0.512 . . . . 0.0 110.001 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 49.7 Cg_endo -84.8 34.19 0.5 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.069 1.562 . . . . 0.0 110.445 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 39' ' ' PRO . 2.7 mt-10 -168.43 -76.5 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.06 -1.025 . . . . 0.0 110.418 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -34.61 36.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.163 -0.961 . . . . 0.0 110.014 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 37' ' ' SER . . . 108.02 -145.43 16.25 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 17.6 tt -109.33 153.77 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.227 -1.161 . . . . 0.0 111.431 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.57 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -122.97 173.2 7.96 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 35' ' ' THR . 15.4 mt-10 -138.23 144.19 40.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.942 -1.099 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.891 HD13 ' OH ' ' A' ' 36' ' ' TYR . 7.6 tp -121.39 120.55 35.34 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.08 -26.5 0.31 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 112.638 -179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 43.2 Cg_endo -71.12 91.1 0.65 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 O-C-N 122.584 0.781 . . . . 0.0 110.299 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' CB ' ' H ' ' A' ' 32' ' ' TYR . . . -100.16 163.87 17.47 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 50.3 Cg_endo -78.04 -166.6 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.028 1.541 . . . . 0.0 110.365 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 53' ' ' GLU . 13.2 t70 -140.38 83.38 1.9 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.0 110.56 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 51' ' ' ASP . . . 41.26 28.43 0.3 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 51' ' ' ASP . 41.9 tt0 -128.68 -49.28 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.127 -1.219 . . . . 0.0 110.363 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 2.6 mt-10 -94.7 124.85 38.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.361 -0.837 . . . . 0.0 110.338 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 2.1 m-20 -102.29 14.02 33.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 110.093 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.961 HG22 ' CB ' ' A' ' 21' ' ' ALA . 53.1 p -138.4 -176.1 4.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.259 -0.901 . . . . 0.0 110.3 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . . . -159.46 157.86 30.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.105 -0.997 . . . . 0.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 88.89 2.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.98 93.27 9.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 17' ' ' SER . 13.8 mt-30 -112.91 143.04 44.88 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.975 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.582 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 91.31 66.61 1.16 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 18' ' ' ILE . 4.6 mt -121.96 -154.43 0.59 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.172 -1.193 . . . . 0.0 110.566 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 0.2 OUTLIER -81.14 141.12 49.82 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.446 -0.784 . . . . 0.0 110.299 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HA ' HG23 ' A' ' 15' ' ' VAL . 49.7 Cg_endo -82.92 102.65 1.13 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.062 1.559 . . . . 0.0 110.873 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.6 75.58 1.07 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -166.94 137.14 3.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -1.193 . . . . 0.0 110.322 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 87' ' ' THR . 3.1 tt0 -64.25 88.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.764 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -69.77 106.64 3.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.495 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.0 m -87.12 85.58 7.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.653 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 36' ' ' TYR . 16.0 t -85.27 132.54 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 110.677 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 84' ' ' LEU . 1.3 m -114.04 133.31 55.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 58.0 t -106.53 129.94 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.935 . . . . 0.0 109.837 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.849 HG22 ' HA ' ' A' ' 83' ' ' PRO . 67.8 t -123.33 117.95 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -0.922 . . . . 0.0 110.817 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' HA ' ' CD1' ' A' ' 32' ' ' TYR . . . -78.45 157.77 28.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 109.892 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 29' ' ' VAL . 87.2 mt -134.08 133.98 41.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.999 -1.063 . . . . 0.0 111.125 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 77' ' ' ASP . 3.7 t-160 -106.76 -159.07 0.68 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 76' ' ' HIS . 96.7 m-20 -44.22 -46.15 8.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.097 -1.002 . . . . 0.0 109.566 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 7.2 m-20 -159.33 53.27 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.588 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.8 mtp -129.84 -174.38 3.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.255 -0.903 . . . . 0.0 110.759 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HA ' HD23 ' A' ' 75' ' ' LEU . 13.2 mt-10 -153.31 70.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 109.372 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 73' ' ' VAL . 1.5 t -39.36 147.42 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.844 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -41.92 143.96 0.9 Allowed Pre-proline 0 N--CA 1.484 1.256 0 O-C-N 121.375 -0.828 . . . . 0.0 110.493 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.849 ' HA ' HG22 ' A' ' 73' ' ' VAL . 46.5 Cg_endo -73.49 91.3 0.88 Allowed 'Trans proline' 0 C--N 1.296 -2.207 0 O-C-N 124.266 1.666 . . . . 0.0 110.553 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 8' ' ' LEU . 23.8 tp -51.48 113.51 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 11.0 mm -77.15 150.03 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.897 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' VAL . . . -144.97 76.23 0.29 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -76.91 137.61 39.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -1.112 . . . . 0.0 110.485 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -157.92 130.38 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.117 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -72.17 123.5 23.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.889 HG23 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -78.34 134.11 37.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 110.255 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.34 -171.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.855 ' O ' HD12 ' A' ' 92' ' ' ILE . 1.2 pp -138.79 153.96 72.51 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.752 ' HD3' HG21 ' A' ' 15' ' ' VAL . 44.7 Cg_endo -75.35 77.35 3.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.945 1.498 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB2' HD13 ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.178 179.894 . . . . . . . . 1 1 . 1 stop_ save_